activity | 'cliff' base |
activity | 'cliff' top |
kv | 1.3 inhibitor |
histone deacetylase-10 inhibitor (hdac- | 10) |
mmp-10 inhibitor (matrix metalloproteinase- | 10) |
caspase- | 10 inhibitor |
adam- | 10 inhibitor (adamalysin, mdc) |
histone deacetylase- | 10 inhibitor (hdac-10) |
mmp- | 10 inhibitor (matrix metalloproteinase-10) |
gpr- | 103 antagonist (g-protein receptor) |
gpcr-109a agonist (g-protein coupled, niacin- | 109a) |
gpcr- | 109a agonist (g-protein coupled, niacin-109a) |
gpcr- | 109a modulator (g-protein-coupled) |
niacin- | 109a receptor agonist |
mmp-11 inhibitor (matrix metalloproteinase- | 11) |
histone deacetylase-11 inhibitor (hdac- | 11) |
histone deacetylase- | 11 inhibitor (hdac-11) |
mmp- | 11 inhibitor (matrix metalloproteinase-11) |
p2y- | 11 receptor agonist (purine metabromic) |
c-kit inhibitor (cd | 117, tyrosine kinase) |
gpr- | 119 agonist (g-protein coupled receptor) |
| 11b-hsd-1 inhibitor (11b-hydroxysteroid dehydrogenase-1) |
11b-hsd-1 inhibitor ( | 11b-hydroxysteroid dehydrogenase-1) |
cytochrome p450 inhibitor (cyp- | 11b1, corticosterone synthase) |
cytochrome p450 inhibitor (cyp- | 11b2, aldosterone synthase) |
mmp-12 inhibitor (matrix metalloproteinase- | 12) |
carbonic anhydrase- | 12 inhibitor |
mmp- | 12 inhibitor (matrix metalloproteinase-12) |
| 12-lipoxygenase inhibitor |
gpcr- | 120 agonist (g-protein coupled receptor) |
anti-neoplastic (leukemia l- | 1210) |
mmp-13 inhibitor (matrix metalloproteinase- | 13) |
interleukin-13 blocker (il- | 13) |
interleukin- | 13 blocker (il-13) |
mmp- | 13 inhibitor (matrix metalloproteinase-13) |
gpcr- | 139 agonist (g-protein coupled receptor) |
mmp-14 inhibitor (matrix metalloproteinase- | 14) |
steroid | 14-a-demethylase inhibitor |
lanosterol- | 14-a-demethylase inhibitor |
carbonic anhydrase- | 14 inhibitor |
caspase- | 14 inhibitor |
mmp- | 14 inhibitor (matrix metalloproteinase-14) |
mmp-15 inhibitor (matrix metalloproteinase- | 15) |
15-pgdh inhibitor ( | 15-hydroxyprostaglandin dehydrogenase) |
carbonic anhydrase | 15 inhibitor |
mmp- | 15 inhibitor (matrix metalloproteinase-15) |
| 15-lipoxygenase inhibitor |
| 15-pgdh inhibitor (15-hydroxyprostaglandin dehydrogenase) |
mmp-16 inhibitor (matrix metalloproteinase- | 16) |
mmp- | 16 inhibitor (matrix metalloproteinase-16) |
tumor necrosis factor blocker (tnf-a, tace, adam- | 17) |
cytochrome p450 inhibitor (cyp- | 17) |
mmp-17 inhibitor (matrix metalloproteinase- | 17) |
mmp- | 17 inhibitor (matrix metalloproteinase-17) |
| 17b-hsd1 inhibitor (17b-hydroxysteroid dehydrogenase-1, ec 1.1.1.62) |
| 17b-hsd2 inhibitor (17b-hydroxysteroid dehydrogenase-2) |
17b-hsd1 inhibitor ( | 17b-hydroxysteroid dehydrogenase-1, ec 1.1.1.62) |
17b-hsd2 inhibitor ( | 17b-hydroxysteroid dehydrogenase-2) |
anti-neoplastic (sarcoma | 180) |
ai inhibitor (aromatase) (cyp- | 19) |
cpt- | 1a activator (carnitine palmitoyl transferase) |
ghsr- | 1a antagonist/inverse agonist (ghrelin receptor) |
ck- | 1a enhancer (casein kinase) |
cpt- | 1a inhibitor (carnitine palmitoyl transferase) |
dyrk- | 1a inhibitor (dual-specificity tyrosine kinase) |
cytochrome p450 inhibitor (cyp- | 1a1) |
aldh- | 1a1 inhibitor (aldehyde dehydrogenase) |
interleukin-1b converting enzyme inhibitor (il- | 1b) |
interleukin- | 1b converting enzyme inhibitor (il-1b) |
dyrk- | 1b (dual-specificity tyrosine kinase, mirk) |
pank- | 1b inhibitor (pantothenate kinase) |
ptp- | 1b inhibitor (protein tyrosine phosphatase) |
hiv- | 1ca inhibitor (capsid assembly) |
ck- | 1d inhibitor (casein kinase) |
| 1heh inhibitor (nicotinamide ribose kinase) |
| 1hur inhibitor (ribosylation factor-1) |
| 1nut inhibitor (adenyl transferase) |
dpre1 inhibitor (decaprenylphosphoryl-b-d-ribose- | 2'-epimerase) |
mst-1 kinase inhibitor (mammalian sterile- | 20) |
mmp-20 inhibitor (matrix metalloproteinase- | 20) |
| 20-hete synthase inhibitor (hydroxyeicosatetraenoic acid) |
mmp- | 20 inhibitor (matrix metalloproteinase-20) |
ptpn- | 22 inhibitor (lymphoid tyrosine phosphatase, lyp) |
bacterial protein synthesis inhibitor ( | 23s-ribosome) |
anti-neoplastic (walker | 256) |
cdc- | 25b cell division cycle phosphatase inhibitor |
mmp-26 inhibitor (matrix metalloproteinase- | 26) |
mmp- | 26 inhibitor (matrix metalloproteinase-26) |
cytochrome p450 inhibitor (cyp- | 26a) |
hsp- | 27 inhibitor (heat shock protein) |
factor | 2a antagonist |
protein phosphatase | 2a inhibition (pp2a) |
glu-n1/ | 2a nmda receptor inhibitor |
nmda ligand (glu-n1/ | 2b selective) |
cytochrome p450 inhibitor (cyp-2d6 or cyp- | 2c19) |
cytochrome p450 inhibitor (cyp- | 2c8) |
cytochrome p450 inhibitor (cyp- | 2c9) |
cytochrome p450 inhibitor (cyp- | 2d6) |
cytochrome p450 inhibitor (cyp- | 2d6 or cyp-2c19) |
gpcr- | 30 agonist (g-protein coupled receptor) |
gpcr- | 30 antagonist |
pi-3kc inhibitor (phosphoinositide kinase) (vps- | 34) |
gpcr- | 35 agonist (g-protein-coupled) |
glycogen synthase kinase-a inhibitor (gsk- | 3a) |
c3a agonist (complement | 3a) |
c3a antagonist (complement | 3a) |
cytochrome p450 inhibitor (cyp- | 3a4, grapefruit effect) |
glycogen synthase kinase-3-beta inhibitor (gsk- | 3beta) |
nvp- | 3cl inhibitor (neurovirus peptidase) |
pi- | 3ka inhibitor (phosphoinositide kinase alpha) |
pi- | 3kb inhibitor (phosphoinositide kinase beta) |
pi- | 3kc inhibitor (phosphoinositide kinase) (vps-34) |
pi- | 3kd inhibitor (phosphoinositide kinase delta) |
pi- | 3kg inhibitor (phosphoinositide kinase gamma) |
| 4-hppd inhibitor (hydroxyphenyl pyruvate dioxygenase) |
udp-galactose- | 4'-epimerase (ec 5.1.3.2) |
gpcr- | 40 agonist (g-protein coupled receptor, ffa-1) |
gpcr- | 40 antagonist (g-protein coupled receptor, ffa-1) |
high volume industrial chem. epa ( | 450,000 kg/yr) |
| 5-alpha reductase-2 inhibitor |
| 5-alpha reductase inhibitor (testosterone) |
| 5-ht serotonin antagonist |
| 5-ht serotonin reuptake inhibitor (ssri) |
| 5-ht serotonin transport inhibitor (sert) |
| 5-ht serotonin uptake inhibitor |
| 5-ht1-a,b,d autoreceptor antagonist |
| 5-ht1a serotonin agonist |
| 5-ht1a serotonin antagonist |
| 5-ht1a serotonin binder |
| 5-ht1b serotonin agonist |
| 5-ht1b serotonin antagonist |
| 5-ht1b serotonin inverse agonist |
| 5-ht1bd serotonin agonist |
| 5-ht1d serotonin agonist |
| 5-ht1d serotonin antagonist |
| 5-ht1f serotonin agonist |
| 5-ht2 serotonin agonist |
| 5-ht2 serotonin antagonist |
| 5-ht2a serotonin agonist |
| 5-ht2a serotonin antagonist |
| 5-ht2b serotonin agonist |
| 5-ht2b serotonin antagonist |
| 5-ht2c serotonin agonist |
| 5-ht2c serotonin antagonist |
| 5-ht3 serotonin agonist |
| 5-ht3 serotonin antagonist |
| 5-ht3 serotonin ligand |
| 5-ht4 serotonin agonist |
| 5-ht4 serotonin antagonist |
| 5-ht5a serotonin antagonist |
| 5-ht6 serotonin agonist |
| 5-ht6 serotonin antagonist |
| 5-ht7 serotonin agonist |
| 5-ht7 serotonin antagonist |
| 5-htp serotonin uptake inhibitor |
| 5-lipoxygenase inhibitor (flap, ec 1.13.11.12) |
odcase inhibitor (orotidine | 5'-monophosphate decarboxylase, ec 4.1.1.23) |
inosine- | 5'-monophosphate dehydrogenase inhibitor (impdh) |
cytochrome p450 inhibitor (cyp- | 51) |
rad- | 51 inhibitor |
anti-neoplastic (l- | 5178) |
gpcr- | 52 (g-protein coupled receptor) |
| 6-pgdh inhibitor (6-phosphogluconate dehydrogenase) |
6-pgdh inhibitor ( | 6-phosphogluconate dehydrogenase) |
anti-neoplastic (hl- | 60 leukemia) |
reproductive toxicity (ca prop. | 65) |
reproductive toxicity (ca prop. | 65, female) |
reproductive toxicity (ca prop. | 65, male) |
mu opioid agonist (mor-1 | 6tm/e11) |
hsp- | 70 inhibitor (heat shock protein) |
human enterovirus inhibitor (hev- | 71/echo) |
allene oxide synthase inhibitor (cyp- | 74) |
hsp-78d inhibitor (grp- | 78 glucose regulated protein) |
hsp- | 78d inhibitor (grp-78 glucose regulated protein) |
factor | 7a antagonist |
| 7dhcr inhibitor (7-dehydrocholesterol reductase, ec 1.3.1.21) |
myd- | 88 inhibitor (myeloid differentiation protein) |
hsp- | 90 c-terminal inhibitor |
hsp- | 90 inhibitor (heat shock protein) |
psd- | 95/nmda inhibitor |
ul- | 97 kinase inhibitor |
| a1 adrenergic agonist |
adenosine | a1 agonist |
adenosine | a1 antagonist |
adenosine | a1 binder |
adenosine | a1 inverse agonist |
apo- | a1 upregulator |
| a1a adrenergic antagonist |
| a1b adrenergic antagonist |
| a1d adrenergic antagonist |
noradrenergic- | a2 |
| a2 adrenergic agonist |
| a2 adrenergic antagonist |
adenosine | a2 agonist |
thromboxane | a2 agonist |
thromboxane | a2 antagonist (txa2) |
phospholipase | a2 inhibitor (ec 3.1.1.4) |
iglu- | a2 modulator (ionotropic glutamate) |
anti-neoplastic (ovarian | a2780r) |
purinergic | a2a antagonist |
adenosine | a2a antagonist |
adenosine | a2a binder |
adenosine | a2b agonist |
adenosine | a2b antagonist |
adenosine | a2b binder |
nicotinic acetylcholine antagonist (nachr- | a2b2) |
calcium channel | a2d modulator |
| a2e production inhibitor |
| a3 adrenergic antagonist |
adenosine | a3 agonist |
gaba- | a3 agonist (gamma amino butyric acid) |
adenosine | a3 antagonist |
nicotinic acetylcholine agonist (nachr | a3/b2) |
adenosine | a3 binder |
nicotinic acetylcholine a3b4 antagonist (nachr | a3b4) |
nicotinic acetylcholine | a3b4 antagonist (nachr a3b4) |
nicotinic acetylcholine partial agonist (nachr- | a4/b2) |
leukotriene | a4 hydrolase inhibitor |
integrin antagonist ( | a4b1~a4b7) |
nicotinic | a4b2 agonist |
integrin antagonist ( | a5b1) |
integrin antagonist ( | a5b3) |
vitronectin antagonist ( | a5b3) |
anti-apoptosis protein inhibitor ( | aap) |
| abca-1 activator (atp-binding cassette transporter) |
| abcb1 transport inhibitor |
| abcg2 transport inhibitor |
anti-neoplastic (ascites | abdominal) |
abl protein kinase inhibitor (bcr- | abl) |
bcr- | abl and t315i-mutant kinase inhibitor |
| abl protein kinase inhibitor (bcr-abl) |
anti- | abortifacient |
| abortifacient (anti-gestagen) |
| abortifacient oxytocic |
| abortifacient (veterinary) |
anti-addictive (substance | abuse treatment, anti-craving) |
| ac inhibitor (acid ceramidase) |
| acaricide (ticks mites) |
| acat inhibitor (acetyl-coa-acyltransferase, ec 2.3.1.16) |
| acc inhibitor (acetyl-coa carboxylase)(ec6.4.1.2) |
| acc1 inhibitor (acetyl-coa-carboxylase-1, lipid synthesis) |
| acc2 inhibitor (acetyl coa carboxylase-2, mitochondrial) |
agr inhibitor ( | accessory gene regulator) |
| ace-2 inhibitor (angiotensin converting) |
| ace inhibitor (angiotensin-converting enzyme) |
ahas inhibitor ( | acetohydroxyacid synthase) |
| acetolactate synthase inhibitor (als) |
o-glc-ncase inhibitor (o-linked glucose-n- | acetyl) |
n- | acetyl-aspartyl-glutamate peptidase inhibitor (naag) |
acat inhibitor ( | acetyl-coa-acyltransferase, ec 2.3.1.16) |
acc1 inhibitor ( | acetyl-coa-carboxylase-1, lipid synthesis) |
acc2 inhibitor ( | acetyl coa carboxylase-2, mitochondrial) |
acc inhibitor ( | acetyl-coa carboxylase)(ec6.4.1.2) |
brd ligand (bromodomain | acetyl-lysine) |
cysk1 inhibitor (pyridoxal phosphate-dependent-o- | acetyl sulfhydrylase) |
lpx-c inhibitor (zinc-dependent | acetylase) |
mach4 agonist (muscarinic-4 | acetylcholine) |
muscarinic | acetylcholine-5 agonist (achr-5) |
nicotinic | acetylcholine-7 agonist (nachr-7) |
nicotinic | acetylcholine a3b4 antagonist (nachr a3b4) |
nicotinic | acetylcholine agonist (nachr) |
nicotinic | acetylcholine agonist (nachr a3/b2) |
| acetylcholine antagonist |
muscarinic-3 | acetylcholine antagonist (machr-3) |
nicotinic | acetylcholine antagonist (nachr) |
nicotinic | acetylcholine antagonist (nachr-a2b2) |
nicotinic- | acetylcholine binder, partial agonist (nachr) |
nicotinic | acetylcholine inhibitor (nachr-7) |
nicotinic | acetylcholine partial agonist (nachr-a4/b2) |
| acetylcholine release enhancer |
vacht ligand (vesicular | acetylcholine transporter) |
| acetylcholinesterase inhibitor (ache, ec 3.1.1.7) |
| acetylcholinesterase synthesis inhibitor (ache) |
kat3 inhibitor (histone | acetyltransferase) |
histone | acetyltransferase inhibitor (hat) |
acetylcholinesterase synthesis inhibitor ( | ache) |
ce inhibitor (carboxyl esterase, low | ache & bche) |
organophosphate nerve gas reactivator ( | ache, bche) |
acetylcholinesterase inhibitor ( | ache, ec 3.1.1.7) |
muscarinic acetylcholine-5 agonist ( | achr-5) |
essential fatty | acid |
ribosomal amino | acid |
amino | acid |
gaba-4 antagonist (gamma amino butyric | acid) |
gaba mimetic (gamma amino butyric | acid) |
gaba-a modulator (gamma amino butyric | acid) |
gaba-c agonist (gamma amino butyric | acid) |
20-hete synthase inhibitor (hydroxyeicosatetraenoic | acid) |
gaba-a3 agonist (gamma amino butyric | acid) |
vlcfa synthesis inhibitor (very long chain fatty | acid) |
mur-d ligase inhibitor (glutamic | acid) |
lpa-1 antagonist (lysophosphatidic | acid) |
gpba-1 agonist (g-protein-coupled bile | acid) |
gaba-c antagonist (gamma amino butyric | acid) |
gaba agonist (gamma amino butyric | acid) |
gaba-a agonist (gamma amino butyric | acid) |
gaba reuptake inhibitor (gamma amino butyric | acid) |
gaba inverse agonist (gamma amino butyric | acid) |
gaba-b antagonist (gamma amino butyric | acid) |
gaba-a antagonist (gamma amino butyric | acid) |
ffa-2 antagonist (free fatty | acid-2)(gpr3) |
naaa inhibitor (n-acylethanolamine | acid amidase) |
faah inhibitor (fatty | acid amide hydrolase) |
lysergic | acid antagonist |
p-cab (potassium-competitive | acid blocker) |
ac inhibitor ( | acid ceramidase) |
elovl-6 inhibitor (fatty | acid elongase-6, lce, face) |
uricosuric (uric | acid excretor, gout treatment) |
d-amino | acid oxidase inhibitor(daao) |
exitory amino | acid receptor agonist (eaa) |
retinoic | acid receptor agonist (rar) |
retinoic | acid receptor antagonist |
rar-b2 ligand (retinoic | acid receptor b2) |
retinoic | acid receptor binder |
asic blocker ( | acid sensitive ion channel) |
pfkasiii inhibitor (fatty | acid synthase) |
fas-ii inhibitor (fatty | acid synthase) |
pteroic | acid synthase inhibitor |
fasn-te inhibitor (fatty | acid synthase-thioesterase) |
urat-1 inhibitor (uric | acid transport) |
eaat-1 inhibitor (excitory amino | acid transport-1) |
eaat-2 inhibitor (excitory amino | acid transport-2) |
fatty | acid transport inhibitor |
huratat-1 inhibitor (human uric | acid transporter) |
asbt inhibitor (apical sodium-dependent bile | acid transporter) |
ibat inhibitor (ileal bile | acid transporter) |
amcase inhibitor ( | acidic mammalian chitinase, ec 3.2.1.14) |
urinary | acidifier |
gastric | acidifier |
urinary | acidifier (veterinary) |
aromatic amino | acids (precursor) |
anti-bacterial ( | acinetobacter baumannii gram-) |
anti-bacterial ( | acinetobacter calcoaceticus gram-) |
| ack1 inhibitor (activated cdc42 associated kinase) |
| acly inhibitor (atp-citrate lyase) |
anti- | acne |
fab-z inhibitor (b-hydroxacyl- | acp-dehydrase) |
fab-g inhibitor (b-ketoacyl- | acp-reductase) |
fab-i inhibitor (enoyl- | acp-reductase) |
enoyl- | acp reductase inhibitor |
fab-b/f inhibitor (b-ketoacetyl- | acp synthase 1/2) |
fab-h inhibitor (b-ketoacetyl | acp synthase-3) |
| acps inhibitor (acyl carrier protein synthase) |
| acrosin antagonist |
| acth inhibitor (adrenocorticotropic hormone) |
narcotic (short | acting) |
analgesic (long | acting) |
anti- | actinic keratosis |
ethr inhibitor (incr. ethionamide | action) |
thrombin- | activatable fibrinolysis inhibitor (tafia) |
| activation by halogen bonding |
mast cell | activation inhibitor |
microtox super- | active |
cns | active |
| active metabolite |
anti-neoplastic ( | active over nci cell panel) |
bbb+ | actively transported |
vitamin d | activity |
| activity 'cliff' base |
| activity 'cliff' top |
| acute gastroenteritis treatment |
anti-neoplastic ( | acute lymphoblastic leukemia, all) |
anti-neoplastic ( | acute monocytic leukemia) |
anti-neoplastic ( | acute myelogenous leukemia, aml) |
apl treatment ( | acute promyelocytic leukemia) |
fab-d inhibitor (malonyl co-a | acyl carrier) |
acps inhibitor ( | acyl carrier protein synthase) |
cact inhibitor (carnitine- | acylcarnitine transporter) |
naaa inhibitor (n- | acylethanolamine acid amidase) |
dgat-1 inhibitor (diacylglyceride | acyltransferase) |
acat inhibitor (acetyl-coa- | acyltransferase, ec 2.3.1.16) |
alzheimer therapy ( | ad) |
| adam-10 inhibitor (adamalysin, mdc) |
tumor necrosis factor blocker (tnf-a, tace, | adam-17) |
adam-10 inhibitor ( | adamalysin, mdc) |
| adamts-4 inhibitor (aggrecanase-1) |
| adamts-5 inhibitor |
| adamts-5 inhibitor (aggrecanase-2) |
anti- | addictive (alcohol/narcotic antagonist) |
anti- | addictive (alcohol/narcotic aversion therapy) |
anti- | addictive (cocaine, opiates, methamphetamine, etc.) |
anti- | addictive (narcotic antagonist) |
anti- | addictive (nicotine, smoking cessation) |
anti- | addictive (substance abuse treatment, anti-craving) |
food | additive (veterinary) |
nad synthetase inhibitor (nicotinamide | adenine dinucleotide) |
anti-neoplastic ( | adenocarcinoma) |
| adenosine a1 agonist |
| adenosine a1 antagonist |
| adenosine a1 binder |
| adenosine a1 inverse agonist |
| adenosine a2 agonist |
| adenosine a2a antagonist |
| adenosine a2a binder |
| adenosine a2b agonist |
| adenosine a2b antagonist |
| adenosine a2b binder |
| adenosine a3 agonist |
| adenosine a3 antagonist |
| adenosine a3 binder |
| adenosine deaminase inhibitor (ec 3.5.4.4) |
| adenosine kinase inhibitor (ec 2.7.1.20) |
ampk activator ( | adenosine monophosphate activated kinase) |
| adenosine monophosphate deaminase (ampda, ec 3.5.4.6) |
| adenosine receptor binder |
sam-dc inhibitor (s- | adenosylmethionine decarboxylase) |
| adenyl cyclase activator (ec 4.6.1.1) |
1nut inhibitor ( | adenyl transferase) |
| adenylate cyclase inhibitor (ec 4.6.1.1) |
adss inhibitor ( | adenylosuccinate synthetase, ec 6.3.4.4) |
| adept (antibody directed prodrug therapy) |
anti- | adhd (attention deficit hyperactivity disorder) |
fimh antagonist (fimbrae-mediated bacterial | adhesion) |
fak inhibitor (focal | adhesion kinase) |
vcam-1 inhibitor (vascular cell | adhesion molecule) |
vap-1 inhibitor (vascular | adhesion protein) |
anoikis (tumor | adhesion reducer) |
tissue | adhesive |
| adp antagonist |
parg inhibitor (poly- | adp-ribose glycohydrolase) |
poly | adp-ribose polymerase-1 inhibitor (parp-1, ec 2.4.2.30) |
poly | adp-ribose polymerase-2 inhibitor (parp-2) |
poly | adp ribose polymerase-3 inhibitor (parp-3) |
arf-1 inhibitor ( | adp-ribosylation factor) |
artd-8 inhibitor ( | adp-ribotransferase) |
ophthalmic | adrenergic |
| adrenergic |
sympathomimetic ( | adrenergic) |
b2 | adrenergic agonist |
b3 | adrenergic agonist |
a2 | adrenergic agonist |
a1 | adrenergic agonist |
b1 | adrenergic agonist (partial) |
anti- | adrenergic (andrenolytic) |
b3 | adrenergic antagonist |
a1b | adrenergic antagonist |
b1 | adrenergic antagonist |
a1d | adrenergic antagonist |
a3 | adrenergic antagonist |
a2 | adrenergic antagonist |
a1a | adrenergic antagonist |
beta | adrenergic antagonist (beta-blocker) |
| adrenergic inverse agonist |
| adrenocortical steroid |
| adrenocortical steroid (salt regulating) |
| adrenocortical steroid (topical) |
acth inhibitor ( | adrenocorticotropic hormone) |
| adss inhibitor (adenylosuccinate synthetase, ec 6.3.4.4) |
insecticide (mosquito | adult) |
rage inhibitor (receptor | advanced glycation end products) |
age inhibitor ( | advanced glycation end products) |
sphingosine-1-phosphate-5 agonist (s1p-5, | aequorin) |
anti-bacterial (pseudomonas | aeruginosa gram-) |
thymoleptic ( | affecting thymus) |
anti-arrhythmic (anti-fibrillatory, anti- | afib) |
prolificate for | agc kinases |
| age inhibitor (advanced glycation end products) |
anti-amd ( | age related macular degeneration) |
adamts-4 inhibitor ( | aggrecanase-1) |
adamts-5 inhibitor ( | aggrecanase-2) |
thrombogenic (platelet | aggregant) |
poly-q anti- | aggregant (anti-huntington's) |
platelet anti- | aggregant (paf) |
mutant sod-1 anti- | aggregant (superoxide dismutase) |
tau fibrilization inhibitor (polymerization, | aggregation) |
a-synuclein | aggregation inhibitor |
beta-amyloid peptide polymerization/ | aggregation inhibitor |
anti- | aggressive |
cell | aging inhibitor |
| agr inhibitor (accessory gene regulator) |
| agranulocytosic |
anti- | agranulocytosic |
fungicide ( | agricultural) |
anti-bacterial (francisella tularensis, bio-warfare | agt.) |
| ahas inhibitor (acetohydroxyacid synthase) |
aryl hydrocarbon hydroxylase inhibitor ( | ahh) |
| ahr agonist (aryl hydrocarbon receptor) |
| ahr antagonist (aryl hydrocarbon receptor) |
| ai inhibitor (aromatase) (cyp-19) |
| aicar transformylase inhibitor |
integrin antagonist ( | aiibb3) |
| akr1c3 inhibitor (aldo-keto reductase) |
protein kinase b inhibitor ( | akt) |
protein kinase b inhibitor ( | akt-1) |
protein kinase b inhibitor ( | akt-2) |
protein kinase b inhibitor ( | akt-3) |
ddl inhibitor (d- | alanine-d-alanine ligase) |
ddl inhibitor (d-alanine-d- | alanine ligase) |
aminopeptidase inhibitor ( | alanyl and/or leucine) |
anti-fungal (candida | albicans) |
| alcohol denaturant |
anti-addictive ( | alcohol/narcotic antagonist) |
anti-addictive ( | alcohol/narcotic aversion therapy) |
nafld treatment (non- | alcoholic fatty liver disease) |
aldh-2 inhibitor ( | aldehyde dehydrogenase) |
aldh-1a1 inhibitor ( | aldehyde dehydrogenase) |
| aldh-1 inhibitor (aldose reductase, ec 1.1.1.21) |
| aldh-1a1 inhibitor (aldehyde dehydrogenase) |
| aldh-2 inhibitor (aldehyde dehydrogenase) |
| aldh-3 inhibitor (aldose reductase) |
akr1c3 inhibitor ( | aldo-keto reductase) |
dihydroneopterin | aldolase inhibitor |
aldh-3 inhibitor ( | aldose reductase) |
aldh-1 inhibitor ( | aldose reductase, ec 1.1.1.21) |
mineralocorticoid ( | aldosterone) antagonist |
cytochrome p450 inhibitor (cyp-11b2, | aldosterone synthase) |
raas inhibitor (renin-angiotensin- | aldosterone system) |
| aldrin epoxidation inhibitor |
marine toxin/metabolite ( | algal/sponge/fish) |
| algicide |
| alk-2 inhibitor |
| alk inhibition (anaplastic lymphoma kinase) |
tgf-b1 inhibitor (transforming growth factor, | alk5 dependent) |
| alkaline phosphatase inducer |
| alkaline phosphatase inhibitor (ec 3.1.3.1) |
| alkalizing agent |
| alkaloid-like (marine/animal) |
| alkaloid-like (plant/fungal) |
dna | alkylator |
| alkyltransferase inhibitor |
anti-neoplastic (acute lymphoblastic leukemia, | all) |
| allene oxide synthase inhibitor (cyp-74) |
anti- | allergic |
| allergic rhinitis treatment |
| allosteric hemoglobin effector |
| allosteric inhibitor (nam) |
pam (positive | allosteric modifier) |
pgf2a | allosteric modulator (prostaglandin-f2a) |
anti- | alopecia (hair restorer) |
anti-viral (neurotropic, | alpha) |
pi-3ka inhibitor (phosphoinositide kinase | alpha) |
fr-a inhibitor (folate receptor- | alpha) |
| alpha-glucosidase inhibitor (ec 3.2.1.20) |
5- | alpha reductase-2 inhibitor |
5- | alpha reductase inhibitor (testosterone) |
| alpha retinoid x agonist (rxr) |
| alpha retinoid x antagonist |
acetolactate synthase inhibitor ( | als) |
| als treatment (amyotrophic lateral sclerosis, lou gehrig's disease) |
| alzheimer therapy (ad) |
| amcase inhibitor (acidic mammalian chitinase, ec 3.2.1.14) |
anti- | amd (age related macular degeneration) |
anti- | amebic (anti-amoebic) |
anti- | amebic (entamoeba histolytica) |
| amebicide (intestinal) |
mutagen ( | ames test carcinogen suspect) |
| ames test negative (non-mutagenic) |
naaa inhibitor (n-acylethanolamine acid | amidase) |
faah inhibitor (fatty acid | amide hydrolase) |
ribosomal | amino acid |
| amino acid |
d- | amino acid oxidase inhibitor(daao) |
exitory | amino acid receptor agonist (eaa) |
eaat-1 inhibitor (excitory | amino acid transport-1) |
eaat-2 inhibitor (excitory | amino acid transport-2) |
aromatic | amino acids (precursor) |
gaba-4 antagonist (gamma | amino butyric acid) |
gaba mimetic (gamma | amino butyric acid) |
gaba-a modulator (gamma | amino butyric acid) |
gaba-c agonist (gamma | amino butyric acid) |
gaba-a3 agonist (gamma | amino butyric acid) |
gaba-c antagonist (gamma | amino butyric acid) |
gaba agonist (gamma | amino butyric acid) |
gaba-a agonist (gamma | amino butyric acid) |
gaba reuptake inhibitor (gamma | amino butyric acid) |
gaba inverse agonist (gamma | amino butyric acid) |
gaba-b antagonist (gamma | amino butyric acid) |
gaba-a antagonist (gamma | amino butyric acid) |
ssao inhibitor (semicarbazide-sensitive | amino oxidase, ec 1.4.3.6) |
aph3'-iiia inhibitor ( | aminoglycoside modifying enzyme) |
metap-2 inhibitor (methionine | aminopeptidase) |
metap-1 inhibitor (methionine | aminopeptidase) |
irap inhibitor (insulin-regulated | aminopeptidase) |
erap-1 inhibitor (endoplasmic reticulum | aminopeptidase) |
erap-2 inhibitor (endoplasmic reticulum | aminopeptidase) |
| aminopeptidase inhibitor |
| aminopeptidase inhibitor (alanyl and/or leucine) |
kat-2 inhibitor (kynurenine | aminotransferase, ec 2.6.1.7) |
anti-neoplastic (acute myelogenous leukemia, | aml) |
hypoammoniuric (anti- | ammoniuric) |
anti-amebic (anti- | amoebic) |
cyclic | amp inhibitor (camp) |
cyclic | amp phosphodiesterase inhibitor (camp) |
| ampa agonist |
| ampa antagonist |
adenosine monophosphate deaminase ( | ampda, ec 3.5.4.6) |
| ampk activator (adenosine monophosphate activated kinase) |
ark-5 inhibitor ( | ampk-related kinase) |
beta- | amyloid imaging |
beta- | amyloid peptide polymerization/aggregation inhibitor |
beta- | amyloid production inhibitor |
diagnostic aid: | amyloidosis |
| amyloidosis treatment (ttr, sodi, or p53) |
als treatment ( | amyotrophic lateral sclerosis, lou gehrig's disease) |
increased bone formation ( | anabolic) |
| anabolic (myotrophic) |
| anabolic (veterinary) |
| analeptic (stimulant) |
| analgesic |
| analgesic (anti-nociceptive) |
| analgesic (dental) |
| analgesic (inhalation) |
| analgesic (kappa selective) |
| analgesic (long acting) |
| analgesic (short duration) |
| analgesic (ulcer) |
| analgesic (urinary) |
| analgesic (veterinary) |
enkephalin | analog |
| anandamide uptake inhibitor |
anti- | anaphylactic |
| anaplasmodastat (veterinary) |
alk inhibition ( | anaplastic lymphoma kinase) |
| ancient flavoring |
anti-adrenergic ( | andrenolytic) |
androgen antagonist (anti- | androgen) |
| androgen agonist |
| androgen antagonist (anti-androgen) |
anti- | androgen (bf3 site) |
anti- | androgen (dna binding site) |
sarm (selective | androgen modulator) |
mnk/ar degrader (mitogen-activated kinase & | androgen receptor) |
car agonist (constituitive | androstane receptor) |
anti- | anemic |
folate deficiency (anti- | anemic) |
| anesthesia reverser |
| anesthetic |
sedative (pre- | anesthetic) |
| anesthetic (general) |
| anesthetic (inhalation) |
| anesthetic (intravenous) |
| anesthetic (local) |
| anesthetic (neuralgia) |
| anesthetic (ophthalmic) |
| anesthetic (oral) |
| anesthetic (spinal) |
| anesthetic (topical) |
| anesthetic (transport of fish) |
| anesthetic (veterinary) |
anti- | anginal |
anti- | angiogenic |
| angiogenic |
raas inhibitor (renin- | angiotensin-aldosterone system) |
ace-2 inhibitor ( | angiotensin converting) |
ace inhibitor ( | angiotensin-converting enzyme) |
| angiotensin-i antagonist |
| angiotensin i binder |
| angiotensin ii agonist |
| angiotensin ii antagonist |
| angiotensin ii binder |
carbonic | anhydrase-1 activator |
carbonic | anhydrase-1 inhibitor |
carbonic | anhydrase-12 inhibitor |
carbonic | anhydrase-14 inhibitor |
carbonic | anhydrase 15 inhibitor |
carbonic | anhydrase-2 activator |
carbonic | anhydrase-2 inhibitor |
carbonic | anhydrase-4 activator |
carbonic | anhydrase-4 inhibitor |
carbonic | anhydrase-5 inhibitor |
carbonic | anhydrase-6 inhibitor |
carbonic | anhydrase-7 inhibitor |
carbonic | anhydrase-9 inhibitor (membrane-assoc., ec 4.2.1.1) |
carbonic | anhydrase-beta inhibitor (b-ca, ec 4.2.1.1) |
teratogen ( | animal) |
alkaloid-like (marine/ | animal) |
anti-oxidant ( | animal feed) |
| animal growth promoter |
half-life in | animal/plasma |
| anion transport inhibitor |
oatp1-b1 inhibitor (organic | anion transporting polypeptide) |
oatp1-b3 inhibitor (organic | anion transporting polypeptide) |
oatp2-b1 inhibitor (organic | anion transporting polypeptide) |
trpa1 agonist (transient receptor potential | ankyrin) |
trpa1 antagonist (transient receptor potential | ankyrin) |
| annexin binder (lipocortin) |
| anoikis (tumor adhesion reducer) |
anti- | anorexic |
| anorexic (appetite suppressant) |
anti-hypoxic (anti- | anoxic) |
| antacid, anti-dyspepsia |
| anterior pituitary activator |
| anterior pituitary activator (swine) |
| anterior pituitary suppressant |
| anthelmintic (anti-helmintic) |
| anthelmintic (avian) |
| anthelmintic (nematode) |
| anthelmintic (oral) |
| anthelmintic (veterinary) |
dihydrofolate reductase inhibitor (dhfr, bacillus | anthracis) |
anti- | anthrax |
anti-bacterial ( | anthrax lethal factor inhibitor) |
| anti-abortifacient |
| anti-acne |
| anti-actinic keratosis |
| anti-addictive (alcohol/narcotic antagonist) |
| anti-addictive (alcohol/narcotic aversion therapy) |
| anti-addictive (cocaine, opiates, methamphetamine, etc.) |
| anti-addictive (narcotic antagonist) |
| anti-addictive (nicotine, smoking cessation) |
| anti-addictive (substance abuse treatment, anti-craving) |
| anti-adhd (attention deficit hyperactivity disorder) |
| anti-adrenergic (andrenolytic) |
anti-arrhythmic (anti-fibrillatory, | anti-afib) |
poly-q | anti-aggregant (anti-huntington's) |
platelet | anti-aggregant (paf) |
mutant sod-1 | anti-aggregant (superoxide dismutase) |
| anti-aggressive |
| anti-agranulocytosic |
| anti-allergic |
| anti-alopecia (hair restorer) |
| anti-amd (age related macular degeneration) |
| anti-amebic (anti-amoebic) |
| anti-amebic (entamoeba histolytica) |
hypoammoniuric ( | anti-ammoniuric) |
anti-amebic ( | anti-amoebic) |
| anti-anaphylactic |
androgen antagonist ( | anti-androgen) |
| anti-androgen (bf3 site) |
| anti-androgen (dna binding site) |
| anti-anemic |
folate deficiency ( | anti-anemic) |
| anti-anginal |
| anti-angiogenic |
| anti-anorexic |
anti-hypoxic ( | anti-anoxic) |
| anti-anthrax |
tranquilizer ( | anti-anxiety) |
| anti-apoptosis protein inhibitor (aap) |
bcl-2 inhibitor ( | anti-apoptotic protein) |
bcl-xl inhibitor ( | anti-apoptotic protein) |
| anti-arrhythmic (anti-fibrillatory, anti-afib) |
| anti-arrhythmic (ventricular) |
| anti-arthritic |
| anti-arthritic prodrug |
| anti-asthenia (weakness) |
| anti-asthmatic |
| anti-asthmatic (local) |
| anti-atherogenic |
| anti-atherosclerotic |
| anti-autistic (social withdrawal) |
| anti-av-block |
| anti-bacterial |
| anti-bacterial (acinetobacter baumannii gram-) |
| anti-bacterial (acinetobacter calcoaceticus gram-) |
| anti-bacterial (anthrax lethal factor inhibitor) |
| anti-bacterial (bacillus subtilis gram+) |
| anti-bacterial (biofilm forming) |
| anti-bacterial (clostridium difficle gram+) |
| anti-bacterial (conjunctivitis) |
| anti-bacterial (dental plaque) |
| anti-bacterial (edwardsiella tarda gram+) |
| anti-bacterial (enterococcus casselflavus gram-, vancomycin resistant) |
| anti-bacterial (enterococcus faecalis gram+) |
| anti-bacterial (escherichia coli gram-) |
| anti-bacterial (francisella tularensis, bio-warfare agt.) |
| anti-bacterial (gonococcus) |
| anti-bacterial (gram-) |
| anti-bacterial (gram+) |
| anti-bacterial (haemophilus influenzae gram-) |
| anti-bacterial (helicobacter pylori gram-) |
| anti-bacterial (intestinal) |
| anti-bacterial (klebsiella pneumoniae gram-) |
| anti-bacterial (micrococcus aureus gram+) |
| anti-bacterial (moraxella catarrhalis gram-) |
| anti-bacterial (mycobacteria) |
| anti-bacterial (mycobacterium avium gram+) |
| anti-bacterial (mycobacterium kansasii gram+) |
| anti-bacterial (mycobacterium tuberculosis) |
| anti-bacterial (mycobacterium tuberculosis, mdr) |
| anti-bacterial (neisseria meningitidis gram-) |
| anti-bacterial (ophthalmic) |
| anti-bacterial (penicillin-resistant streptococcus pneumoniae, prsp) |
| anti-bacterial (pseudomonas) |
| anti-bacterial (pseudomonas aeruginosa gram-) |
| anti-bacterial (quorum sensing inhibitor) |
| anti-bacterial (respiratory) |
| anti-bacterial (s. aureus, mrsa, methicillin & linezolid resistant) |
| anti-bacterial (salmonella typhi gram-ve) |
| anti-bacterial (staphylococcus aureus gram+) |
| anti-bacterial (staphylococcus saprophyticus gram+) |
| anti-bacterial (streptococcus haemolyticus gram+) |
| anti-bacterial (streptococcus mutans gram+) |
| anti-bacterial (streptococcus pneumoniae gram+) |
| anti-bacterial (streptococcus pyogenes gram+) |
| anti-bacterial synergist (mdr) |
| anti-bacterial (topical) |
| anti-bacterial (trachoma) |
| anti-bacterial (tuberculosis,dormant,non-replicating) |
| anti-bacterial (urinary) |
| anti-bacterial (vancomycin-resistant enterococcus faecalis, vre) |
| anti-bacterial (veterinary) |
| anti-bacterial (yersinia pestis) |
| anti-bilharzia |
| anti-biotic potentiator |
tachycardic ( | anti-bradycardic) |
| anti-cardiac failure |
| anti-cataleptic |
anti-cataracts ( | anti-cataractic) |
| anti-cataracts (anti-cataractic) |
anti-neoplastic ( | anti-cd-3) |
| anti-cerebral disease/injury/palsy |
| anti-cerebral edema |
| anti-cerebral insufficiency |
| anti-cerebral vascular disease |
| anti-cholelithogenic |
| anti-cholesteremic |
| anti-cholinergic |
| anti-cholinergic (gastric) |
| anti-cholinergic (ophthalmic) |
| anti-clotting (anti-coagulant) |
| anti-cns injury |
anti-clotting ( | anti-coagulant) |
| anti-convulsant (anti-epileptic) |
| anti-copd (chronic obstructive pulmonary disease) |
anti-addictive (substance abuse treatment, | anti-craving) |
| anti-depressant |
| anti-diabetic |
| anti-diabetic neuropathy |
| anti-diabetic (type-2, t2dm) |
| anti-diarrheal |
| anti-diuretic (polyuria) |
| anti-dna viral |
| anti-dyskinetic |
| anti-dyskinetic (giles de la tourette's syndrome) |
antacid, | anti-dyspepsia |
| anti-eczema |
| anti-edemic |
| anti-emetic (anti-nauseant) |
| anti-enuresis (bed-wetting) |
anti-convulsant ( | anti-epileptic) |
| anti-estrogen (serm, selective estrogen receptor modulator) |
anti-pyretic hypothermic ( | anti-febric) |
anti-arrhythmic ( | anti-fibrillatory, anti-afib) |
| anti-fibrinolytic |
| anti-filovirus ebola/marburg |
| anti-folate |
| anti-fouling paint |
| anti-fungal (anti-mycotic) |
| anti-fungal (anti-parasitic, fish) |
| anti-fungal (aspergillus fumigatus) |
| anti-fungal (aspergillus niger) |
| anti-fungal (barley mildew) |
| anti-fungal (botrydiplodia theobrome) |
| anti-fungal (candida albicans) |
| anti-fungal (candida glabrata, torulopsis) |
| anti-fungal (candida krusei) |
| anti-fungal (candida parapsilosis) |
| anti-fungal (candida stellaloidea) |
| anti-fungal (candida tropicalis) |
| anti-fungal (cryptoformans neoformans) |
| anti-fungal (epidermophyton floccosum) |
| anti-fungal (fonsecaea pedrosoi) |
| anti-fungal (fusarium oxysporum) |
| anti-fungal (microsporum canis) |
| anti-fungal (powdery mildew) |
| anti-fungal (pyricularia oryzae) |
| anti-fungal (rhizoctonia bataticola) |
| anti-fungal (saccharomyces cerevisiae) |
| anti-fungal (sporothrix schenckii) |
| anti-fungal (trichophyton mentagrophytes) |
| anti-fungal (trichophyton rubrum) |
| anti-fungal (trichophyton spp., ringworm, jock-itch) |
| anti-fungal (wheat rust) |
| anti-gerd (gastroesophagael reflux) |
| anti-gerd (gastroesophageal reflux disease) |
abortifacient ( | anti-gestagen) |
| anti-glaucoma |
| anti-glomerulonephritis |
| anti-glucocorticoid |
| anti-hallucinogen |
anthelmintic ( | anti-helmintic) |
| anti-hemolytic |
capillary protectant ( | anti-hemorrhagic) |
| anti-heparin |
| anti-hepatic disorders (liver) |
| anti-hepatoxic |
anti-perspirant ( | anti-hidrotic) |
| anti-histamine (non-sedating) |
| anti-histaminic |
| anti-hpv (human papilloma virus) |
poly-q anti-aggregant ( | anti-huntington's) |
| anti-hypercholesterolemic |
| anti-hyperlipidemic (hypolipidemic dyslipidemic) |
| anti-hyperlipoproteinemic |
| anti-hyperpigmentation |
| anti-hypertensive |
| anti-hypertensive (pulmonary, pah) |
| anti-hyperthyroid |
vasoconstrictor (vasopressor, | anti-hypotensive) |
| anti-hypoxic (anti-anoxic) |
anti-septic ( | anti-infective) |
| anti-inflammatory |
gastroprotective (gastric | anti-inflammatory) |
| anti-inflammatory (cytokine suppressing, csaid) |
| anti-inflammatory non-steroidal (nsaid) |
| anti-inflammatory (ophthalmic-topical) |
| anti-inflammatory (respiratory) |
| anti-inflammatory (topical) |
| anti-inflammatory (veterinary) |
sleep promoter ( | anti-insomnia) |
| anti-leukemic |
| anti-leukemic (lymphoblasts) |
| anti-malarial |
| anti-malarial (liver stage) |
| anti-menopause |
| anti-metabolite |
| anti-methemoglobinemic |
| anti-microbial |
| anti-microbial topical |
| anti-microbial (veterinary) |
| anti-migrane |
| anti-mitotic (suppresses cell division) |
| anti-myasthenic |
anti-fungal ( | anti-mycotic) |
| anti-narcoleptic (eugeroic) |
anti-emetic ( | anti-nauseant) |
| anti-neoplastic |
| anti-neoplastic (active over nci cell panel) |
| anti-neoplastic (acute lymphoblastic leukemia, all) |
| anti-neoplastic (acute monocytic leukemia) |
| anti-neoplastic (acute myelogenous leukemia, aml) |
| anti-neoplastic (adenocarcinoma) |
| anti-neoplastic (adjuvant) |
| anti-neoplastic (anti-cd-3) |
| anti-neoplastic (ascites abdominal) |
| anti-neoplastic (bladder) |
| anti-neoplastic (brain cerebral) |
| anti-neoplastic (breast) |
| anti-neoplastic (breast, hormone-dependent) |
| anti-neoplastic (burkitt's b-cell lymphoma) |
| anti-neoplastic (chemo-induced tumors) |
| anti-neoplastic (cll chronic lymphocytic leukemia) |
| anti-neoplastic (cns, neuroblastoma) |
| anti-neoplastic (colorectal) |
| anti-neoplastic (epidermal) |
| anti-neoplastic (erythroleukemia) |
| anti-neoplastic (esophagus) |
| anti-neoplastic (fibrosarcoma) |
| anti-neoplastic (gastro-intestinal, gist) |
| anti-neoplastic (glioma) |
| anti-neoplastic (hct colon) |
| anti-neoplastic (hela cervical uterine endometrial) |
| anti-neoplastic (hepatic, liver) |
| anti-neoplastic (hiv lymphoid) |
| anti-neoplastic (hl-60 leukemia) |
| anti-neoplastic (jurkat leukemia) |
| anti-neoplastic (l-5178) |
| anti-neoplastic (leukemia l-1210) |
| anti-neoplastic (lung non-small cell, nsclc) |
| anti-neoplastic (lung small cell) |
| anti-neoplastic (lymphoma el-4) |
| anti-neoplastic (mantle cell lymphoma) |
| anti-neoplastic mb (medulloblastoma) |
| anti-neoplastic (melanoma) |
| anti-neoplastic (multiple myeloma) |
| anti-neoplastic (myeloma myelogenous) |
| anti-neoplastic (nasopharynx) |
| anti-neoplastic (non-hodgkin lymphoma) |
| anti-neoplastic (osteosarcoma, bone) |
| anti-neoplastic (ovarian) |
| anti-neoplastic (ovarian a2780r) |
| anti-neoplastic (p388 leukemia) |
| anti-neoplastic (pancreatic) |
| anti-neoplastic, peritoneal |
| anti-neoplastic (placlitaxel/mdr resistant) |
| anti-neoplastic (plasmocytoma) |
| anti-neoplastic (pleural mesothelioma) |
| anti-neoplastic (potentiator) |
| anti-neoplastic (prostate) |
| anti-neoplastic (ptcl, peripheral t-cell lymphoma) |
| anti-neoplastic (renal / kidney) |
| anti-neoplastic (sarcoma 180) |
| anti-neoplastic (skin basal cell bcc) |
| anti-neoplastic (solid tumors) |
| anti-neoplastic (squamous) |
| anti-neoplastic (taxane refractory) |
| anti-neoplastic (teratocarcinoma) |
| anti-neoplastic (testicular) |
| anti-neoplastic (thyroid) |
| anti-neoplastic (topical) |
| anti-neoplastic (walker 256) |
| anti-nephritic |
| anti-neuralgic |
| anti-neuritic |
| anti-neutropenia (lack of neutrophils) |
analgesic ( | anti-nociceptive) |
| anti-obesity |
| anti-occlusion peripheral arteries |
| anti-osteomylitic |
| anti-osteoporitic |
| anti-oxidant |
ophthalmic ( | anti-oxidant) |
| anti-oxidant (animal feed) |
| anti-oxidant (food) |
| anti-oxidant (lipid) |
| anti-paget's disease |
| anti-parasitic |
anti-fungal ( | anti-parasitic, fish) |
| anti-parasitic (topical) |
| anti-parkinsonian |
| anti-peristaltic |
| anti-perspirant (anti-hidrotic) |
| anti-plaque |
| anti-plasmodial (berghei) |
| anti-plasmodial (chabaudi) |
| anti-plasmodial (falciparum) |
| anti-plasmodial (falciparum chloroquine resistant) |
| anti-plasmodial (plasmodium cynomolgi) |
| anti-plasmodial (veterinary) |
| anti-plasmodial (yoelii) |
| anti-plasmodium (vivax) |
| anti-pneumocystic carinii |
| anti-prion (tse, cjd, scrapie, misfolded protein) |
| anti-prolactin |
| anti-proliferative |
| anti-prostatic hypertrophy |
| anti-protozoal |
| anti-protozoal (babesia) |
| anti-protozoal (coccidia) |
| anti-protozoal (cryptosporidium parvum/ hominis) |
| anti-protozoal (giardia) |
| anti-protozoal (histomonas) |
| anti-protozoal (leishmaniasis) |
| anti-protozoal (toxoplasma gondii) |
| anti-protozoal (trichomonas) |
| anti-protozoal (trypanosoma) |
| anti-protozoal (trypanosoma cruzi or t.brucei, chagas, sleeping sickness) |
| anti-protozoal (veterinary) |
| anti-pruritic (keratolytic) |
| anti-pruritic (topical) |
| anti-psoriatic (keratolytic) |
| anti-psychotic (neuroleptic) |
| anti-pyretic hypothermic (anti-febric) |
| anti-retinopathic |
| anti-retroviral |
| anti-rheumatic |
| anti-rheumatoid arthritis |
| anti-rickettsial |
| anti-schistosomal (flukicide) |
| anti-schizophrenic |
| anti-sclerotic |
| anti-scorbutic |
| anti-seborrheic |
gastric | anti-secretory |
| anti-septic (anti-infective) |
| anti-septic (intestinal) |
| anti-septic (oral) |
| anti-septic shock |
| anti-septic (topical) |
| anti-septic (urinary) |
| anti-silicosis |
| anti-spasmodic |
| anti-spasmodic (gall bladder) |
| anti-spasmodic (gastric) |
| anti-spasmodic (respiratory) |
| anti-spasmodic (veterinary) |
| anti-spermatogenic |
| anti-syphilitic |
| anti-thrombotic |
| anti-tussive |
| anti-tyrosinaemia |
| anti-ulcer |
| anti-ulcerative colitis |
| anti-upper intestinal disorders |
| anti-urolithic |
| anti-vascular disorders |
| anti-venous disorders |
| anti-vertigo |
| anti-viral |
| anti-viral (bvdv, hcp) |
| anti-viral (cmv, herpes-2 cytomegalo) |
| anti-viral (coxsackie) |
| anti-viral (flavivirus, dengue, west nile) |
| anti-viral (hepatitis) |
| anti-viral (hepatitis c, hcv) |
| anti-viral (herpes genitalis) |
| anti-viral (hiv) |
| anti-viral (hiv, attachment/ entry inhibitor) |
| anti-viral (hiv, reverse transcriptase) |
| anti-viral (hiv, tat) |
| anti-viral (hsv-1 herpes simplex) |
| anti-viral (hsv-1 & hsv-2) |
| anti-viral (human rhinovirus) |
| anti-viral (influenza) |
| anti-viral measles (paramyxovirus) |
| anti-viral (neurotropic, alpha) |
| anti-viral (ophthalmic) |
| anti-viral orthopox (vaccinia/cow, smallpox) |
| anti-viral (polio t1 maheney) |
| anti-viral (poultry) |
rsv | anti-viral (respiratory syncytial fusion) |
| anti-viral (rous sarcoma) |
| anti-viral (rubella) |
| anti-viral (sars-corona) |
| anti-viral (vzv, pox) |
| anti-viral (warts) |
| anti-viral (west nile) |
| anti-wilson's disease |
| anti-xerophthalmic |
| anti-xerostomia (dry mouth) |
adept ( | antibody directed prodrug therapy) |
cyanide poisoning | antidote |
curare | antidote |
arsine poisoning | antidote |
| antidote (detoxicant) |
| antidote glycol methanol poisoning |
hbsag inhibitor (hepatitis-b surface | antigen) |
lymphocyte/leukocyte function assoc. | antigen antagonist (lfa-1) |
vla4 antagonist (very late | antigen, eosinophil integrin) |
prostate specific membrane | antigen inhibitor (psma) |
tranquilizer (anti- | anxiety) |
| anxiogenic |
| anxiolytic |
| anxiolytic (non-sedating) |
| apc inhibitor (pro-coagulant) |
| ape-1 inhibitor (apurinic/apyrimidinic endonuclease-1) |
| aph3'-iiia inhibitor (aminoglycoside modifying enzyme) |
insecticide ( | aphid) |
asbt inhibitor ( | apical sodium-dependent bile acid transporter) |
| apkc modulator (atypical protein kinase) |
| apl treatment (acute promyelocytic leukemia) |
| apo-a1 upregulator |
| apo-induced hyperactivity inhibitor |
autophagy inducer (non- | apoptosis) |
| apoptosis inducer |
caspase-activated | apoptosis inducer |
| apoptosis inhibitor |
bacterial | apoptosis promoter (pcd) |
xiap antagonist (x-linked inhibitor | apoptosis protein) |
anti- | apoptosis protein inhibitor (aap) |
ask-1 inhibitor ( | apoptosis-regulating kinase) |
bcl-2 inhibitor (anti- | apoptotic protein) |
bcl-xl inhibitor (anti- | apoptotic protein) |
| appetite stimulant (orexigenic) |
| appetite stimulant (veterinary) |
anorexic ( | appetite suppressant) |
ape-1 inhibitor ( | apurinic/apyrimidinic endonuclease-1) |
ape-1 inhibitor (apurinic/ | apyrimidinic endonuclease-1) |
mnk/ | ar degrader (mitogen-activated kinase & androgen receptor) |
| arachnicide (spiders) |
| arf-1 inhibitor (adp-ribosylation factor) |
| arginase ii inhibitor |
pad inhibitor (protein | arginine deaminase) |
prmt-1 inhibitor (protein | arginine methyl-transferase) |
carm-1 inhibitor (coactivator-assoc. | arginine transferase) |
| ark-5 inhibitor (ampk-related kinase) |
insecticide (spodoptura eridania, southern | army worm) |
ai inhibitor ( | aromatase) (cyp-19) |
| aromatic amino acids (precursor) |
sahr modulator (selective | aromatic hydrocarbon receptor) |
cell | arrest at g2/m phase |
sphingosine-1-phosphate agonist-1 (s1p-1, b- | arrestin) |
dopamine-2 agonist, b- | arrestin biased |
b- | arrestin signaling recruiter |
anti- | arrhythmic (anti-fibrillatory, anti-afib) |
anti- | arrhythmic (ventricular) |
| arsine poisoning antidote |
| artd-8 inhibitor (adp-ribotransferase) |
anti-occlusion peripheral | arteries |
anti- | arthritic |
anti- | arthritic prodrug |
anti-rheumatoid | arthritis |
| arthropod repellant |
| artificial rum flavoring |
| aryl esterase-a |
| aryl esterase-b |
| aryl hydrocarbon hydrolase inducer |
| aryl hydrocarbon hydroxylase inhibitor (ahh) |
ahr antagonist ( | aryl hydrocarbon receptor) |
ahr agonist ( | aryl hydrocarbon receptor) |
b- | aryl-sulfotransferase-4 inhibitor (bast-4) |
| asatricide |
| asbt inhibitor (apical sodium-dependent bile acid transporter) |
anti-neoplastic ( | ascites abdominal) |
atp-ase inhibitor (incl. vacuolar, v-atp- | ase) |
guanosine triphosphatase inhibitor (gtp- | ase) |
rac-1 inhibitor (rho-gtp- | ase) |
atp- | ase inhibitor (incl. vacuolar, v-atp-ase) |
| asic blocker (acid sensitive ion channel) |
| ask-1 inhibitor (apoptosis-regulating kinase) |
nmda agonist (n-methyl-d- | aspartate) |
nmda blocker (n-methyl-d- | aspartate) |
nmda antagonist (n-methyl-d- | aspartate) |
nmda antagonist (n-methyl-d- | aspartate, competitive) |
n-acetyl- | aspartyl-glutamate peptidase inhibitor (naag) |
| aspartyl protease inhibitor (bace-2) |
anti-fungal ( | aspergillus fumigatus) |
anti-fungal ( | aspergillus niger) |
telomerase inhibitor human (trap | assay) |
| assay of atp |
hiv-1ca inhibitor (capsid | assembly) |
bv-ca inhibitor (hepatitis b viral capsid | assembly) |
lipoprotein | assembly inhibitor |
lymphocyte/leukocyte function | assoc. antigen antagonist (lfa-1) |
carm-1 inhibitor (coactivator- | assoc. arginine transferase) |
carbonic anhydrase-9 inhibitor (membrane- | assoc., ec 4.2.1.1) |
fto inhibitor (fatty mass & obesity | assoc. protein) |
cenp-e inhibitor (centromere- | assoc. protein-e)(kinase-7) |
irak-4 inhibitor (interleukin receptor | associated kinase) |
ack1 inhibitor (activated cdc42 | associated kinase) |
gak inhibitor (cyclin-g | associated kinase) |
anti- | asthenia (weakness) |
anti- | asthmatic |
anti- | asthmatic (local) |
| astringent |
cell arrest | at g2/m phase |
atr inhibitor ( | ataxia rad-related) |
atr inhibitor ( | ataxia telangiectasia rad3 related) |
friedreich's | ataxia treatment |
anti- | atherogenic |
anti- | atherosclerotic |
dermatitis suppressant (herpetiformis or | atopic) |
assay of | atp |
atp-ase inhibitor (incl. vacuolar, v- | atp-ase) |
| atp-ase inhibitor (incl. vacuolar, v-atp-ase) |
abca-1 activator ( | atp-binding cassette transporter) |
potassium | atp channel opener (sarcolemmal) |
acly inhibitor ( | atp-citrate lyase) |
atp-prt inhibitor ( | atp phosphoribosyl transferase) |
| atp-prt inhibitor (atp phosphoribosyl transferase) |
| atp synthase inhibitor |
dead-box | atpase ddx3 |
| atr inhibitor (ataxia rad-related) |
| atr inhibitor (ataxia telangiectasia rad3 related) |
ikur inhibitor (potassium ion current, | atrium) |
muscle | atrophy treatment |
exhibits | atropisomerism |
anti-viral (hiv, | attachment/ entry inhibitor) |
anti-adhd ( | attention deficit hyperactivity disorder) |
no | attenuated mimic (nitric oxide) |
apkc modulator ( | atypical protein kinase) |
dehydrosqualene synthase inhibitor (crtm, staphylococcus | aureus) |
anti-bacterial (staphylococcus | aureus gram+) |
anti-bacterial (micrococcus | aureus gram+) |
anti-bacterial (s. | aureus, mrsa, methicillin & linezolid resistant) |
| aurora-a kinase inhibitor |
| aurora-b kinase inhibitor |
| aurora-c kinase inhibitor |
anti- | autistic (social withdrawal) |
dopamine | auto-receptor agonist |
immunomodulator ( | autoimmune therapy) |
| autophagy inducer (non-apoptosis) |
| autophagy inhibitor |
5-ht1-a,b,d | autoreceptor antagonist |
| autotaxin inhibitor |
synthetic | auxin |
anti- | av-block |
integrin antagonist ( | avb3) |
integrin antagonist ( | avb5) |
integrin antagonist ( | avb6) |
anti-addictive (alcohol/narcotic | aversion therapy) |
chemosterilant ( | avian) |
anthelmintic ( | avian) |
anti-bacterial (mycobacterium | avium gram+) |
vasopressin v2 antagonist ( | avpr2) |
| b-arrestin signaling recruiter |
| b-aryl-sulfotransferase-4 inhibitor (bast-4) |
| b-catenin agonist |
| b-catenin/tcf4 pathway inhibitor |
| b-glucuronidase inhibitor |
| b-raf kinase inhibitor (braf) |
| b-secretase inhibitor (bace-1) |
| b-tryptase inhibitor |
pde- | b1/2 inhibitor (phosphodiesterase) |
| b1 adrenergic agonist (partial) |
| b1 adrenergic antagonist |
oatp1- | b1 inhibitor (organic anion transporting polypeptide) |
oatp2- | b1 inhibitor (organic anion transporting polypeptide) |
tgf- | b1 inhibitor (transforming growth factor, alk5 dependent) |
vitamin | b1 source |
human immunoproteasome inhibitor ( | b1i selective) |
cb2 inverse agonist (cannabinoid | b2) |
rar-b2 ligand (retinoic acid receptor | b2) |
nicotinic acetylcholine partial agonist (nachr-a4/ | b2) |
nicotinic acetylcholine agonist (nachr a3/ | b2) |
| b2 adrenergic agonist |
bradykinin | b2 agonist |
tgf- | b2 inhibitor (transforming growth factor) |
rar- | b2 ligand (retinoic acid receptor b2) |
vitamin | b2 therapeutic |
bombesin-3 agonist ( | b3) |
| b3 adrenergic agonist |
| b3 adrenergic antagonist |
thermogenic- | b3-agonist |
eph- | b3 inhibitor (erythropoietin-producing hepatocarcinoma receptor) |
oatp1- | b3 inhibitor (organic anion transporting polypeptide) |
leukotriene | b4 agonist |
leukotriene | b4 antagonist |
eph- | b4 inhibitor |
leukotriene | b4 synthesis inhibitor (ltb4) |
anti-protozoal ( | babesia) |
b-secretase inhibitor ( | bace-1) |
aspartyl protease inhibitor ( | bace-2) |
dihydrofolate reductase inhibitor (dhfr, | bacillus anthracis) |
anti-bacterial ( | bacillus subtilis gram+) |
anti- | bacterial |
spase-1 inhibitor (signal peptidase | bacterial) |
anti- | bacterial (acinetobacter baumannii gram-) |
anti- | bacterial (acinetobacter calcoaceticus gram-) |
fimh antagonist (fimbrae-mediated | bacterial adhesion) |
anti- | bacterial (anthrax lethal factor inhibitor) |
| bacterial apoptosis promoter (pcd) |
anti- | bacterial (bacillus subtilis gram+) |
anti- | bacterial (biofilm forming) |
anti- | bacterial (clostridium difficle gram+) |
anti- | bacterial (conjunctivitis) |
anti- | bacterial (dental plaque) |
anti- | bacterial (edwardsiella tarda gram+) |
anti- | bacterial (enterococcus casselflavus gram-, vancomycin resistant) |
anti- | bacterial (enterococcus faecalis gram+) |
anti- | bacterial (escherichia coli gram-) |
anti- | bacterial (francisella tularensis, bio-warfare agt.) |
anti- | bacterial (gonococcus) |
anti- | bacterial (gram-) |
anti- | bacterial (gram+) |
| bacterial gyrase inhibitor |
anti- | bacterial (haemophilus influenzae gram-) |
anti- | bacterial (helicobacter pylori gram-) |
anti- | bacterial (intestinal) |
anti- | bacterial (klebsiella pneumoniae gram-) |
anti- | bacterial (micrococcus aureus gram+) |
anti- | bacterial (moraxella catarrhalis gram-) |
anti- | bacterial (mycobacteria) |
anti- | bacterial (mycobacterium avium gram+) |
anti- | bacterial (mycobacterium kansasii gram+) |
anti- | bacterial (mycobacterium tuberculosis) |
anti- | bacterial (mycobacterium tuberculosis, mdr) |
anti- | bacterial (neisseria meningitidis gram-) |
anti- | bacterial (ophthalmic) |
anti- | bacterial (penicillin-resistant streptococcus pneumoniae, prsp) |
| bacterial protein synthesis inhibitor (23s-ribosome) |
anti- | bacterial (pseudomonas) |
anti- | bacterial (pseudomonas aeruginosa gram-) |
anti- | bacterial (quorum sensing inhibitor) |
anti- | bacterial (respiratory) |
anti- | bacterial (s. aureus, mrsa, methicillin & linezolid resistant) |
anti- | bacterial (salmonella typhi gram-ve) |
| bacterial sliding clamp inhibitor |
anti- | bacterial (staphylococcus aureus gram+) |
anti- | bacterial (staphylococcus saprophyticus gram+) |
anti- | bacterial (streptococcus haemolyticus gram+) |
anti- | bacterial (streptococcus mutans gram+) |
anti- | bacterial (streptococcus pneumoniae gram+) |
anti- | bacterial (streptococcus pyogenes gram+) |
anti- | bacterial synergist (mdr) |
anti- | bacterial (topical) |
anti- | bacterial (trachoma) |
mur-a inhibitor ( | bacterial transferase) |
anti- | bacterial (tuberculosis,dormant,non-replicating) |
anti- | bacterial (urinary) |
anti- | bacterial (vancomycin-resistant enterococcus faecalis, vre) |
anti- | bacterial (veterinary) |
anti- | bacterial (yersinia pestis) |
bir2 selective (second | baculovirus iap repeat) |
anti-fungal ( | barley mildew) |
ebi-2 antagonist (epstein- | barr virus-induced) |
anti-neoplastic (skin | basal cell bcc) |
activity 'cliff' | base |
| basophil inhibitor |
b-aryl-sulfotransferase-4 inhibitor ( | bast-4) |
anti-fungal (rhizoctonia | bataticola) |
electrolyte for flow | battery |
anti-bacterial (acinetobacter | baumannii gram-) |
| bax activator |
gastrin antagonist (bombesin | bb) |
blood-brain non-penetrant (relatively | bbb-) |
blood-brain penetrant (relatively | bbb+) |
| bbb+ actively transported |
anti-neoplastic (skin basal cell | bcc) |
ce inhibitor (carboxyl esterase, low ache & | bche) |
organophosphate nerve gas reactivator (ache, | bche) |
| bcl-2 inhibitor (anti-apoptotic protein) |
| bcl-xl inhibitor (anti-apoptotic protein) |
abl protein kinase inhibitor ( | bcr-abl) |
| bcr-abl and t315i-mutant kinase inhibitor |
castor | bean poison |
anti-enuresis ( | bed-wetting) |
insecticide ( | bedbugs) |
ovarian inhibitor (worker | bees) |
larvicide (colorado potato | beetle) |
bph treatment ( | benign prostatic hyperplasia) |
cbr antagonist (central | benzodiazepine) |
| benzodiazepine agonist |
bz3 | benzodiazepine agonist peripheral (pbr) |
bz1 | benzodiazepine antagonist |
bz2 | benzodiazepine antagonist peripheral (pbr) |
| benzodiazepine binder |
bz1 | benzodiazepine inverse agonist |
anti-plasmodial ( | berghei) |
ikkb-1 inhibitor (i-kappa-kinase- | beta) |
ikkb-2 inhibitor (i-kappa kinase | beta) |
pi-3kb inhibitor (phosphoinositide kinase | beta) |
fr-b inhibitor (folate receptor- | beta) |
| beta adrenergic antagonist (beta-blocker) |
| beta-amyloid imaging |
| beta-amyloid peptide polymerization/aggregation inhibitor |
| beta-amyloid production inhibitor |
beta adrenergic antagonist ( | beta-blocker) |
btk inhibitor (bruton's tyrosine kinase, | beta cells) |
| beta galactosidase inhibitor (ec 3.2.1.23) |
| beta-glucosidase inhibitor |
carbonic anhydrase- | beta inhibitor (b-ca, ec 4.2.1.1) |
glycogen synthase kinase-3- | beta inhibitor (gsk-3beta) |
| beta-lactamase ctxm-a inhibitor |
| beta lactamase inhibitor (ec 3.5.2.6) |
meallo- | beta-lactamase inhibitors |
| beta-lactamase resistant |
| beta turn mimetic |
anti-androgen ( | bf3 site) |
dopamine-2 agonist, b-arrestin | biased |
gpba-1 agonist (g-protein-coupled | bile acid) |
asbt inhibitor (apical sodium-dependent | bile acid transporter) |
ibat inhibitor (ileal | bile acid transporter) |
hydrocholeretic ( | bile dilution) |
choleretic (cholagogue, | bile stimulant) |
anti- | bilharzia |
hepato- | biliary regulator |
glun2c modulator (glutamate | binding) |
abca-1 activator (atp- | binding cassette transporter) |
cbi-e (coactivator | binding inhibitor estrogen) |
cd4-mhc | binding inhibitor (major histocompatability complex) |
t-butylbicyclophosphorothionate | binding inhibitor (tbps) |
cbi-vdr (coactivator | binding inhibitor vitamin d) |
phencyclidine | binding (pcp) |
mbt antagonist (methyl-lysine | binding protein) |
srebp inhibitor (sterol regulatory element | binding protein) |
pbp2a inhibitor (penicillin- | binding protein) |
anti-androgen (dna | binding site) |
anti-bacterial (francisella tularensis, | bio-warfare agt.) |
| biofilm blocker (gram-) |
anti-bacterial ( | biofilm forming) |
| bioflavonoid |
| biological buffer |
molluscicide ( | biomphalaria glabrata) |
anti- | biotic potentiator |
| biotin carboxylase inhibitor (ec 6.3.4.14) |
| bipolar treatment (manic depression) |
| bir2 selective (second baculovirus iap repeat) |
| bird repellant |
fructose-1,6- | bisphosphatase inhibitor (fbpase, ec 3.1.3.11) |
| bitter flavor |
| bitter flavor masker |
anti-neoplastic ( | bladder) |
anti-spasmodic (gall | bladder) |
urinary incontinence (dysuria, overactive | bladder, oab) |
| bleaching agent (pigment synthesis inhibitor) |
anti-av- | block |
| blood-brain non-penetrant (relatively bbb-) |
| blood-brain penetrant activated |
| blood-brain penetrant (relatively bbb+) |
| blood stem cell mobilization agent |
| blood substitute |
mediates uptake | blood to liver (hepatocytes) |
| blue food coloring |
| bmp-2 stimulator (bone morphogenic protein) |
| bmp-6 inhibitor (bone morphogenic protein) |
boron neutron capture therapy ( | bnct) |
| bombesin-3 agonist (b3) |
| bombesin antagonist |
gastrin antagonist ( | bombesin bb) |
activation by halogen | bonding |
anti-neoplastic (osteosarcoma, | bone) |
| bone calcium regulator |
increased | bone formation (anabolic) |
| bone loss inhibitor (dental) |
bmp-2 stimulator ( | bone morphogenic protein) |
bmp-6 inhibitor ( | bone morphogenic protein) |
| bone resorption (osteoclast) inhibitor |
| bonta inhibitor (botulinum neurotoxin-a) |
larvicide (rice | borer) |
larvicide (hylemya platura, seed corn | borer) |
| boron neutron capture therapy (bnct) |
anti-fungal ( | botrydiplodia theobrome) |
bonta inhibitor ( | botulinum neurotoxin-a) |
ibd treatment (irritable | bowel disease) crohn's |
dead- | box atpase ddx3 |
| bph treatment (benign prostatic hyperplasia) |
tachycardic (anti- | bradycardic) |
| bradycardic (reduce pulse rate) |
| bradykinin-1 antagonist |
| bradykinin 2 antagonist |
| bradykinin b2 agonist |
b-raf kinase inhibitor ( | braf) |
anti-neoplastic ( | brain cerebral) |
| brain imaging |
blood- | brain non-penetrant (relatively bbb-) |
blood- | brain penetrant activated |
blood- | brain penetrant (relatively bbb+) |
| brandy flavoring |
| brd-2 inhibitor (bromodomain) |
| brd-3 inhibitor (bromodomain) |
| brd-4 inhibitor (bromodomain) |
| brd-9 inhibitor (bromodomain) |
| brd ligand (bromodomain acetyl-lysine) |
anti-neoplastic ( | breast) |
tnbc treatment (triple-negative | breast cancer) |
anti-neoplastic ( | breast, hormone-dependent) |
brd-2 inhibitor ( | bromodomain) |
brd-4 inhibitor ( | bromodomain) |
brd-3 inhibitor ( | bromodomain) |
brd-9 inhibitor ( | bromodomain) |
brd ligand ( | bromodomain acetyl-lysine) |
| bronchodilator |
| bronchographic |
| bronchospasmolytic |
btk inhibitor ( | bruton's tyrosine kinase, beta cells) |
| btk inhibitor (bruton's tyrosine kinase, beta cells) |
biological | buffer |
anti-neoplastic ( | burkitt's b-cell lymphoma) |
t- | butylbicyclophosphorothionate binding inhibitor (tbps) |
gaba-4 antagonist (gamma amino | butyric acid) |
gaba mimetic (gamma amino | butyric acid) |
gaba-a modulator (gamma amino | butyric acid) |
gaba-c agonist (gamma amino | butyric acid) |
gaba-a3 agonist (gamma amino | butyric acid) |
gaba-c antagonist (gamma amino | butyric acid) |
gaba agonist (gamma amino | butyric acid) |
gaba-a agonist (gamma amino | butyric acid) |
gaba reuptake inhibitor (gamma amino | butyric acid) |
gaba inverse agonist (gamma amino | butyric acid) |
gaba-b antagonist (gamma amino | butyric acid) |
gaba-a antagonist (gamma amino | butyric acid) |
| butyryl cholinesterase inhibitor |
| bv-ca inhibitor (hepatitis b viral capsid assembly) |
anti-viral ( | bvdv, hcp) |
| bz1 benzodiazepine antagonist |
| bz1 benzodiazepine inverse agonist |
| bz2 benzodiazepine antagonist peripheral (pbr) |
| bz3 benzodiazepine agonist peripheral (pbr) |
| c-kit inhibitor (cd 117, tyrosine kinase) |
| c-myc-max heterodimer disruptor |
| c-raf kinase inhibitor |
| c-src kinase inhibitor |
| c-src tyrosine kinase inhibitor |
mtor | c1/c2 inhibitor (mamalian target of rapamycin) |
protein kinase- | c1 modulator |
mtor c1/ | c2 inhibitor (mamalian target of rapamycin) |
| c3a agonist (complement 3a) |
| c3a antagonist (complement 3a) |
leukotriene | c4 antagonist |
complement | c5a antagonist |
kca1.1 potassium channel opener ( | ca and voltage gated) |
carbonic anhydrase-beta inhibitor (b- | ca, ec 4.2.1.1) |
bv- | ca inhibitor (hepatitis b viral capsid assembly) |
reproductive toxicity ( | ca prop. 65) |
reproductive toxicity ( | ca prop. 65, female) |
reproductive toxicity ( | ca prop. 65, male) |
p- | cab (potassium-competitive acid blocker) |
| cact inhibitor (carnitine-acylcarnitine transporter) |
carcinogen | cal.prop.65 or isscan |
calcium-sensing receptor antagonist (csr, | calcilytic) |
| calcineurin inhibitor |
cgrp antagonist ( | calcitonin gene-related peptide) |
ncx reverse inhibitor (sodium/ | calcium) |
ikca | calcium activated potassium channel blocker |
| calcium agonist |
camk-2 inhibitor ( | calcium/calmodulin dependent) |
| calcium channel a2d modulator |
| calcium channel activator |
l-type | calcium channel blocker |
t-type | calcium channel blocker |
| calcium channel blocker (l-type) |
n-type voltage gated | calcium channel blocker (vgcc, vdcc) |
cdpk-1 inhibitor ( | calcium-dependent protein kinase) |
bone | calcium regulator |
soicr suppressor (store-overloaded-induced | calcium release) |
| calcium selective chelator |
| calcium-sensing receptor antagonist (csr, calcilytic) |
anti-bacterial (acinetobacter | calcoaceticus gram-) |
| calmodulin antagonist |
camk-2 inhibitor (calcium/ | calmodulin dependent) |
capn2 inhibitor ( | calpain-2) |
| calpain mu (i) inhibitor |
| camk-2 inhibitor (calcium/calmodulin dependent) |
cyclic amp phosphodiesterase inhibitor ( | camp) |
cyclic amp inhibitor ( | camp) |
epac-2 antagonist (exchange protein | camp activated) |
crpc treatment (castration resistant prostate | cancer) |
tnbc treatment (triple-negative breast | cancer) |
| cancer preventative |
pten-deficient | cancer treatment |
dihydrofolate reductase inhibitor (dhfr, | candida) |
anti-fungal ( | candida albicans) |
anti-fungal ( | candida glabrata, torulopsis) |
anti-fungal ( | candida krusei) |
anti-fungal ( | candida parapsilosis) |
anti-fungal ( | candida stellaloidea) |
anti-fungal ( | candida tropicalis) |
anti-fungal (microsporum | canis) |
| cannabimimetic |
ecb (endogenous | cannabinoid) |
cb2 inverse agonist ( | cannabinoid b2) |
| cannabinoid cb1 agonist |
| cannabinoid cb1 antagonist |
| cannabinoid cb1 binder |
| cannabinoid cb1 inverse agonist |
| cannabinoid cb2 agonist |
| cannabinoid cb2 antagonist |
| cannabinoid cb2 binder |
| cannabinoid cb2 inverse agonist |
| cap-dependent m-rna translation inhibitor |
| capillary protectant (anti-hemorrhagic) |
| capn2 inhibitor (calpain-2) |
hiv-1ca inhibitor ( | capsid assembly) |
bv-ca inhibitor (hepatitis b viral | capsid assembly) |
boron neutron | capture therapy (bnct) |
| car agonist (constituitive androstane receptor) |
| carbonic anhydrase-1 activator |
| carbonic anhydrase-1 inhibitor |
| carbonic anhydrase-12 inhibitor |
| carbonic anhydrase-14 inhibitor |
| carbonic anhydrase 15 inhibitor |
| carbonic anhydrase-2 activator |
| carbonic anhydrase-2 inhibitor |
| carbonic anhydrase-4 activator |
| carbonic anhydrase-4 inhibitor |
| carbonic anhydrase-5 inhibitor |
| carbonic anhydrase-6 inhibitor |
| carbonic anhydrase-7 inhibitor |
| carbonic anhydrase-9 inhibitor (membrane-assoc., ec 4.2.1.1) |
| carbonic anhydrase-beta inhibitor (b-ca, ec 4.2.1.1) |
chcr-1 inhibitor (chinese hamster | carbonyl reductase) |
phosphoenolpyruvate | carboxykinase inhibitor (pepck) |
ce inhibitor ( | carboxyl esterase, low ache & bche) |
icmt inhibitor (isoprenylcysteine | carboxyl transferase) |
acc1 inhibitor (acetyl-coa- | carboxylase-1, lipid synthesis) |
acc2 inhibitor (acetyl coa | carboxylase-2, mitochondrial) |
acc inhibitor (acetyl-coa | carboxylase)(ec6.4.1.2) |
biotin | carboxylase inhibitor (ec 6.3.4.14) |
| carboxypeptidase a inhibitor |
| carboxypeptidase-b inhibitor |
glutamate | carboxypeptidase ii inhibitor (gcp-ii) |
| carcinogen cal.prop.65 or isscan |
human | carcinogen (iarc) |
| carcinogen (leukemic) |
| carcinogen (mouse liver) |
| carcinogen (rat, mouse) |
mutagen (ames test | carcinogen suspect) |
| carcinogenicity tested not positive |
respiratory stimulant ( | cardiac) |
ischemic stroke treatment ( | cardiac/cerebral) |
| cardiac depressant |
anti- | cardiac failure |
| cardiac glycoside |
| cardiac hypertrophy treatment |
| cardiac pet imaging (positron emission tomography) |
herg channel blocker (increase qt interval, | cardiac risk) |
| cardiac stimulant |
| cardio-toxin |
| cardiogenic inducer |
| cardioprotectant |
m2 muscarinic antagonist ( | cardioselective) |
| cardiotonic |
| cardiotoxic and/or neurotoxic |
| cardiovascular agent |
dental | caries (prophylactic) |
anti-pneumocystic | carinii |
| carm-1 inhibitor (coactivator-assoc. arginine transferase) |
| carminative (relieves flatulence) |
cact inhibitor ( | carnitine-acylcarnitine transporter) |
cpt-1a inhibitor ( | carnitine palmitoyl transferase) |
cpt-1a activator ( | carnitine palmitoyl transferase) |
| carotenoid synthesis inhibitor |
diagnostic aid: | carrier |
fab-d inhibitor (malonyl co-a acyl | carrier) |
acps inhibitor (acyl | carrier protein synthase) |
chondroprotectant ( | cartilage) |
ck1-inhibitor ( | casein kinase) |
ck-1a enhancer ( | casein kinase) |
ck-1d inhibitor ( | casein kinase) |
ck2 inhibitor ( | casein kinase) |
| caspase-1 inhibitor |
| caspase-10 inhibitor |
| caspase-14 inhibitor |
| caspase-3 inhibitor |
| caspase-4 inhibitor |
| caspase-5 inhibitor |
| caspase-6 inhibitor |
| caspase-7 inhibitor |
| caspase-8 inhibitor |
| caspase-9 inhibitor |
| caspase-activated apoptosis inducer |
smac activator mimetic (second mitochondria activator | caspases) |
anti-bacterial (enterococcus | casselflavus gram-, vancomycin resistant) |
abca-1 activator (atp-binding | cassette transporter) |
| castor bean poison |
crpc treatment ( | castration resistant prostate cancer) |
| catacholamine potentiator |
anti- | cataleptic |
anti-cataracts (anti- | cataractic) |
anti- | cataracts (anti-cataractic) |
anti-bacterial (moraxella | catarrhalis gram-) |
mitotic | catastrophant |
comt inhibitor ( | catechol-o-methyl-transferase, ec 2.1.1.6) |
b- | catenin agonist |
b- | catenin/tcf4 pathway inhibitor |
laxative ( | cathartic, prokinetic) |
| cathepsin-a inhibitor |
| cathepsin b & l inhibitor (ec 3.4.22.1) |
| cathepsin c inhibitor |
| cathepsin d inhibitor |
| cathepsin f inhibitor |
| cathepsin g inhibitor |
| cathepsin k inhibitor |
| cathepsin s inhibitor |
cannabinoid | cb1 agonist |
cannabinoid | cb1 antagonist |
cannabinoid | cb1 binder |
cannabinoid | cb1 inverse agonist |
cannabinoid | cb2 agonist |
cannabinoid | cb2 antagonist |
cannabinoid | cb2 binder |
cannabinoid | cb2 inverse agonist |
| cb2 inverse agonist (cannabinoid b2) |
| cbi-e (coactivator binding inhibitor estrogen) |
| cbi-vdr (coactivator binding inhibitor vitamin d) |
| cbl inhibitor (cystathionine-b-lyase) |
| cbr antagonist (central benzodiazepine) |
cholecystokinin antagonist ( | cck) |
cholecystokinin-1 agonist ( | cck-1, cck-a) |
cholecystokinin-1 antagonist ( | cck-1, cck-a) |
cholecystokinin-2 antagonist ( | cck-2, cck-b) |
cholecystokinin-1 agonist (cck-1, | cck-a) |
cholecystokinin-1 antagonist (cck-1, | cck-a) |
cholecystokinin-2 antagonist (cck-2, | cck-b) |
| ccr-9 antagonist (chemokine-9) |
| ccr1 antagonist (chemokine) |
| ccr2 antagonist (chemokine-2, cxcr2) |
| ccr3 chemokine-3 antagonist |
| ccr4 antagonist (chemokine-4) |
| ccr5 agonist (chemokine 5) |
| ccr5 antagonist (chemokine-5, immune cell receptor) |
| ccr8 antagonist (chemokine-8) |
| ccxr1 antagonist (chemokine-x1) |
c-kit inhibitor ( | cd 117, tyrosine kinase) |
anti-neoplastic (anti- | cd-3) |
clk inhibitor ( | cd2-like kinase) |
| cd38 inhibitor |
| cd4-mhc binding inhibitor (major histocompatability complex) |
| cdc-25b cell division cycle phosphatase inhibitor |
| cdc25a inhibitor (phosphatase) |
ack1 inhibitor (activated | cdc42 associated kinase) |
| cdc7 kinase inhibitor |
| cdk-5 inhibitor (cyclin-dependent kinase) |
cyclin-dependent kinase-7 inhibitor ( | cdk-7) |
cyclin-dependent kinase-1 inhibitor ( | cdk1) |
cyclin-dependent kinase-2 inhibitor ( | cdk2) |
cyclin-dependent kinase-4 inhibitor ( | cdk4) |
| cdk5 inhibitor (cyclin-dependent kinase-5) |
cyclin-dependent kinase-9 inhibitor ( | cdk9) |
| cdpk-1 inhibitor (calcium-dependent protein kinase) |
| ce inhibitor (carboxyl esterase, low ache & bche) |
| celiac treatment (gluten reaction) |
anti-neoplastic (lung small | cell) |
esc differentiation blocker (embryonic stem | cell) |
hsc transplant enhancer (human stem | cell) |
psc inducer (pluripotent stem | cell) |
mast | cell activation inhibitor |
vcam-1 inhibitor (vascular | cell adhesion molecule) |
| cell aging inhibitor |
| cell arrest at g2/m phase |
anti-neoplastic (skin basal | cell bcc) |
methuosis inducer ( | cell death) |
ledgf-p75 integrase blocker (lens epithelial- | cell derived) |
stem | cell differentiation director |
anti-mitotic (suppresses | cell division) |
cdc-25b | cell division cycle phosphatase inhibitor |
th17 inhibitor (t- | cell helper) |
huvec | cell inhibition |
stem/progenitor | cell inhibitor |
itk inhibitor (interleukin-2 inducible t- | cell kinase) |
mcl-1 inhibitor (myeloid | cell leukemia) |
anti-neoplastic (burkitt's b- | cell lymphoma) |
anti-neoplastic (ptcl, peripheral t- | cell lymphoma) |
anti-neoplastic (mantle | cell lymphoma) |
jcl inhibitor (jurkat | cell lysis) |
pancreatic | cell manipulator |
blood stem | cell mobilization agent |
anti-neoplastic (lung non-small | cell, nsclc) |
anti-neoplastic (active over nci | cell panel) |
t- | cell proliferation inhibitor |
mesangial | cell proliferaton inhibitor (mcp) |
ccr5 antagonist (chemokine-5, immune | cell receptor) |
mock-infected mt4 | cell toxicity |
sickle | cell treatment |
inhibitor | cell-wall synthesis |
low toxicity to mice or fibroblast | cells |
crth-2 antagonist (t-helper-2 | cells) |
btk inhibitor (bruton's tyrosine kinase, beta | cells) |
| cenp-e inhibitor (centromere-assoc. protein-e)(kinase-7) |
cbr antagonist ( | central benzodiazepine) |
cenp-e inhibitor ( | centromere-assoc. protein-e)(kinase-7) |
penicillin & | cephalosporin precursor |
ac inhibitor (acid | ceramidase) |
| ceramide synthase inhibitor |
anti-neoplastic (brain | cerebral) |
vasodilator ( | cerebral) |
ischemic stroke treatment (cardiac/ | cerebral) |
| cerebral circulation stimulant |
anti- | cerebral disease/injury/palsy |
anti- | cerebral edema |
anti- | cerebral insufficiency |
nootropic ( | cerebral stimulant) |
| cerebral thrombolytic |
anti- | cerebral vascular disease |
| cerebroprotective |
anti-fungal (saccharomyces | cerevisiae) |
| cervical relaxant |
anti-neoplastic (hela | cervical uterine endometrial) |
anti-addictive (nicotine, smoking | cessation) |
cholesterolester transfer protein inhibitor ( | cetp) |
| cfms kinase inhibitor |
| cftr blocker (cystic fibrosis transmembrane conductuctance regulator) |
| cftr corrector (cystic fibrosis transmembrane conductance regulator) |
| cftr potentiator (cycstic fibrosis transmembrane conductance regulator) |
| cfviia inhibitor (coagulation factor viia) |
| cgmp phosphodiesterase inhibitor |
| cgrp antagonist (calcitonin gene-related peptide) |
anti-plasmodial ( | chabaudi) |
anti-protozoal (trypanosoma cruzi or t.brucei, | chagas, sleeping sickness) |
cng antagonist (cyclic nucleotide-gated | channel) |
clc2 activator (chloride | channel) |
asic blocker (acid sensitive ion | channel) |
calcium | channel a2d modulator |
calcium | channel activator |
potassium | channel blocker |
sodium | channel blocker |
l-type calcium | channel blocker |
ikca calcium activated potassium | channel blocker |
gardos | channel blocker |
epithelial sodium | channel blocker |
t-type calcium | channel blocker |
ion | channel blocker |
herg | channel blocker (increase qt interval, cardiac risk) |
calcium | channel blocker (l-type) |
n-type voltage gated calcium | channel blocker (vgcc, vdcc) |
voltage gated sodium | channel blocker (vgsc) |
potassium | channel k-7 modulator/inhibitor (kcnq-2) |
sodium | channel modulator |
kir potassium | channel modulator (inwardly rectifying) |
k2p potassium | channel modulator (twin pore) |
ik/sk potassium | channel modulators |
sodium | channel nav1.3 modulator |
sodium | channel nav1.4 blocker |
sodium | channel nav1.7 modulator |
sodium | channel nav1.8 modulator |
sodium | channel opener |
potassium | channel opener |
kca1.1 potassium | channel opener (ca and voltage gated) |
potassium atp | channel opener (sarcolemmal) |
herg | channel optimized (qt interval decreased) |
a-glucosidase | chaperone |
pc (pharmacological | chaperone) |
pilus | chaperone blocker (pilicide) |
| chaperone of protein folding |
| chcr-1 inhibitor (chinese hamster carbonyl reductase) |
chk-1 inhibitor ( | checkpoint kinase-1) |
chk-2 inhibitor ( | checkpoint kinase-2) |
calcium selective | chelator |
metal | chelator |
| chelator |
iron | chelator (siderophore) |
high volume industrial | chem. epa (450,000 kg/yr) |
| chemical warfare agent |
anti-neoplastic ( | chemo-induced tumors) |
ccr1 antagonist ( | chemokine) |
cxcr3 agonist ( | chemokine) |
cxcr7 ligand ( | chemokine) |
ccr2 antagonist ( | chemokine-2, cxcr2) |
ccr3 | chemokine-3 antagonist |
ccr4 antagonist ( | chemokine-4) |
ccr5 agonist ( | chemokine 5) |
ccr5 antagonist ( | chemokine-5, immune cell receptor) |
ccr8 antagonist ( | chemokine-8) |
ccr-9 antagonist ( | chemokine-9) |
cxcr4 | chemokine antagonist |
hiv-1 | chemokine antagonist |
cxcr8 | chemokine antagonist |
cxcr-3 | chemokine (killer) antagonist |
ccxr1 antagonist ( | chemokine-x1) |
| chemosterilant |
| chemosterilant (avian) |
| chf (congestive heart failure) therapy |
dihydrofolate reductase inhibitor (dhrf, | chicken liver) |
chikv inhibitor ( | chikungunya virus) |
| chikv inhibitor (chikungunya virus) |
| chimp-human pharmacokinetics compared |
chcr-1 inhibitor ( | chinese hamster carbonyl reductase) |
| chitin-synthesis inhibitor |
amcase inhibitor (acidic mammalian | chitinase, ec 3.2.1.14) |
| chk-1 inhibitor (checkpoint kinase-1) |
| chk-2 inhibitor (checkpoint kinase-2) |
clc2 activator ( | chloride channel) |
| chlorismate synthase inhibitor (ec 4.6.1.4) |
anti-plasmodial (falciparum | chloroquine resistant) |
choleretic ( | cholagogue, bile stimulant) |
| cholecystographic |
diagnostic aid: | cholecystographic |
| cholecystokinin-1 agonist (cck-1, cck-a) |
| cholecystokinin-1 antagonist (cck-1, cck-a) |
| cholecystokinin-2 antagonist (cck-2, cck-b) |
| cholecystokinin antagonist (cck) |
anti- | cholelithogenic |
| cholelitholytic agent (gall stones) |
| cholera toxin inhibitor |
| choleretic (cholagogue, bile stimulant) |
anti- | cholesteremic |
| cholesterol ester reformation inhibitor |
| cholesterol esterase inhibitor |
| cholesterol synthesis inhibitor |
| cholesterolester transfer protein inhibitor (cetp) |
succinyl- | choline synergist |
ophthalmic | cholinergic |
anti- | cholinergic |
| cholinergic |
anti- | cholinergic (gastric) |
anti- | cholinergic (ophthalmic) |
butyryl | cholinesterase inhibitor |
| cholinesterase inhibitor (ec 3.1.1.8) |
| chondroprotectant (cartilage) |
| chorismate synthase inhibitor |
| chronic kidney disease treatment |
anti-neoplastic (cll | chronic lymphocytic leukemia) |
| chronic myeloid leukemia (cml) treatment |
anti-copd ( | chronic obstructive pulmonary disease) |
negative | chronotropic (decrease heart rate) |
positive | chronotropic (increase heart rate) |
familial | chylomicronemia treatment |
human | chymase inhibitor |
| chymotrypsin protease inhibitor |
vulnerary ( | cicatrizant, wound healer) |
| circadian period decrease |
| circadian period increase |
cerebral | circulation stimulant |
diagnostic aid: | circulation time |
acly inhibitor (atp- | citrate lyase) |
| citrus flavor |
anti-prion (tse, | cjd, scrapie, misfolded protein) |
| ck-1a enhancer (casein kinase) |
| ck-1d inhibitor (casein kinase) |
| ck1-inhibitor (casein kinase) |
protein kinase | ck2 inhibitor |
| ck2 inhibitor (casein kinase) |
saluretic (na+, | cl- excretion) |
bacterial sliding | clamp inhibitor |
| clc2 activator (chloride channel) |
rnase-h inhibitor ( | cleavage) |
| clk inhibitor (cd2-like kinase) |
anti-neoplastic ( | cll chronic lymphocytic leukemia) |
anti-bacterial ( | clostridium difficle gram+) |
anti- | clotting (anti-coagulant) |
| cmet tyrosine kinase inhibitor |
chronic myeloid leukemia ( | cml) treatment |
anti-viral ( | cmv, herpes-2 cytomegalo) |
| cng antagonist (cyclic nucleotide-gated channel) |
respiratory stimulant ( | cns) |
| cns active |
| cns depressant |
| cns dopamine blocker |
anti- | cns injury |
anti-neoplastic ( | cns, neuroblastoma) |
dopamine agonist ( | cns presynaptic) |
| cns stimulant |
| cns stimulant (veterinary) |
| cns toxicant |
fab-d inhibitor (malonyl | co-a acyl carrier) |
enzyme | co-factor |
acat inhibitor (acetyl- | coa-acyltransferase, ec 2.3.1.16) |
acc1 inhibitor (acetyl- | coa-carboxylase-1, lipid synthesis) |
acc2 inhibitor (acetyl | coa carboxylase-2, mitochondrial) |
acc inhibitor (acetyl- | coa carboxylase)(ec6.4.1.2) |
mcd inhibitor (malonyl- | coa decarboxylase, ec 4.1.1.9) |
scd-1 inhibitor (stearoyl- | coa-desaturase) |
hmg- | coa reductase inhibitor (hmgr, ec 1.1.1.34) |
carm-1 inhibitor ( | coactivator-assoc. arginine transferase) |
cbi-e ( | coactivator binding inhibitor estrogen) |
cbi-vdr ( | coactivator binding inhibitor vitamin d) |
thyroid | coactivator interaction inhibitor |
anti-clotting (anti- | coagulant) |
apc inhibitor (pro- | coagulant) |
cfviia inhibitor ( | coagulation factor viia) |
anti-addictive ( | cocaine, opiates, methamphetamine, etc.) |
anti-protozoal ( | coccidia) |
insecticide ( | cockroach) |
| cockroach repellant |
| coenzyme precursor |
| cognition dysfunction monitor |
| cognition enhancer |
contraceptive (post- | coital) |
anti-bacterial (escherichia | coli gram-) |
metap inhibitor (e. | coli metalloproteinase) |
anti-ulcerative | colitis |
| collagen inhibitor |
| collagenase inhibitor |
anti-neoplastic (hct | colon) |
fms inhibitor (macrophage | colony-stimulating factor, csf-1, ron) |
larvicide ( | colorado potato beetle) |
anti-neoplastic ( | colorectal) |
blue food | coloring |
in | combination therapy |
chimp-human pharmacokinetics | compared |
nmda antagonist (n-methyl-d-aspartate, | competitive) |
glutamate antagonist ( | competitive) |
p-cab (potassium- | competitive acid blocker) |
mglur1 antagonist | competitive (metabotropic glutamate) |
c3a agonist ( | complement 3a) |
c3a antagonist ( | complement 3a) |
| complement c5a antagonist |
cd4-mhc binding inhibitor (major histocompatability | complex) |
mitochondrial electron transport | complex i inhibitor |
mitochondrial electron transport | complex ii inhibitor |
succinate dehydrogenase ( | complex ii) inhibitor (ec 1.3.5.1) |
mitochondrial electron transport | complex iii (qi) inhibitor |
mitochondrial electron transport | complex iv inhibitor |
prrb-prra two- | component histidine kinase |
ocpd treatment (obsessive | compulsive personality) |
spect imaging (single photon emission | computed tomography) |
| comt inhibitor (catechol-o-methyl-transferase, ec 2.1.1.6) |
melanin | concentrating hormone inhibitor (mch-1) |
cftr potentiator (cycstic fibrosis transmembrane | conductance regulator) |
cftr corrector (cystic fibrosis transmembrane | conductance regulator) |
cftr blocker (cystic fibrosis transmembrane | conductuctance regulator) |
chf ( | congestive heart failure) therapy |
ubiquitin | conjugation inhibitor (e1/e2) |
ubiquitin | conjugation inhibitor (e3) |
anti-bacterial ( | conjunctivitis) |
car agonist ( | constituitive androstane receptor) |
p97 inhibitor (vcp, valosine | containing protein) |
| contraceptive |
| contraceptive (female) |
| contraceptive (male) |
| contraceptive (post-coital) |
smooth muscle | contractant |
negative inotrope (weakens muscle | contraction) |
miotic (pupil | contraction) |
positive inotrope (strengthen muscle | contraction) |
| controlled (soft) deactivation |
fertility | controller |
ace-2 inhibitor (angiotensin | converting) |
ace inhibitor (angiotensin- | converting enzyme) |
endothelin | converting enzyme inhibitor (ec-1) |
interleukin-1b | converting enzyme inhibitor (il-1b) |
| convulsant |
anti- | convulsant (anti-epileptic) |
anti- | copd (chronic obstructive pulmonary disease) |
larvicide (hylemya platura, seed | corn borer) |
diagnostic aid: | corneal indicator |
| corneal trauma indicator |
anti-viral (sars- | corona) |
vasodilator ( | coronary) |
luteolytic ( | corpus luteum) |
cftr | corrector (cystic fibrosis transmembrane conductance regulator) |
ics (inhaled | corticosteroid) |
| corticosteroid (topical) |
cytochrome p450 inhibitor (cyp-11b1, | corticosterone synthase) |
crf receptor antagonist ( | corticotropin releasing factor) |
| corticotropin-releasing hormone antagonist |
| counter-irritant |
| counter-irritant (topical) |
gpcr-35 agonist (g-protein- | coupled) |
gpcr-109a modulator (g-protein- | coupled) |
gpba-1 agonist (g-protein- | coupled bile acid) |
pcft inhibitor (proton- | coupled folate transporter) |
gpcr-109a agonist (g-protein | coupled, niacin-109a) |
gpcr119 agonist (g-protein | coupled receptor) |
tgr-5 agonist (g-protein | coupled receptor) |
gpcr-30 agonist (g-protein | coupled receptor) |
gpcr119 antagonist (g-protein | coupled receptor) |
gpcr-120 agonist (g-protein | coupled receptor) |
gpcr-139 agonist (g-protein | coupled receptor) |
gpr-119 agonist (g-protein | coupled receptor) |
gpcr-52 (g-protein | coupled receptor) |
gpcr-40 agonist (g-protein | coupled receptor, ffa-1) |
gpcr-40 antagonist (g-protein | coupled receptor, ffa-1) |
| covalent protein modifier (irreversible) |
anti-viral orthopox (vaccinia/ | cow, smallpox) |
| cox-1 & cox-2 inhibitor (cyclooxygenase) |
cox-2/ | cox-1 inhibition ratio |
| cox-1 inhibitor (cyclooxygenase, human) |
| cox-2/cox-1 inhibition ratio |
cox-1 & | cox-2 inhibitor (cyclooxygenase) |
| cox-2 inhibitor (cyclooxygenase) |
| cox-3 inhibitor (cyclooxygenase) |
anti-viral ( | coxsackie) |
| cpp inhibitor (cytolytic protein performin) |
| cpt-1a activator (carnitine palmitoyl transferase) |
| cpt-1a inhibitor (carnitine palmitoyl transferase) |
anti-addictive (substance abuse treatment, anti- | craving) |
| crf receptor antagonist (corticotropin releasing factor) |
ibd treatment (irritable bowel disease) | crohn's |
| crohn's disease treatment |
dna interstrand | cross linker |
| crpc treatment (castration resistant prostate cancer) |
| crth-2 agonist |
| crth-2 antagonist (t-helper-2 cells) |
dehydrosqualene synthase inhibitor ( | crtm, staphylococcus aureus) |
| cruzain inhibitor (ec.3.4.22.51) |
anti-protozoal (trypanosoma | cruzi or t.brucei, chagas, sleeping sickness) |
anti-fungal ( | cryptoformans neoformans) |
anti-protozoal ( | cryptosporidium parvum/ hominis) |
anti-inflammatory (cytokine suppressing, | csaid) |
fms inhibitor (macrophage colony-stimulating factor, | csf-1, ron) |
calcium-sensing receptor antagonist ( | csr, calcilytic) |
beta-lactamase | ctxm-a inhibitor |
| curare antidote |
ikur inhibitor (potassium ion | current, atrium) |
| cushings disease treatment |
fractalkine antagonist ( | cx3cr1) |
| cxcr-3 chemokine (killer) antagonist |
| cxcr1 antagonist |
ccr2 antagonist (chemokine-2, | cxcr2) |
| cxcr3 agonist (chemokine) |
| cxcr4 chemokine antagonist |
| cxcr7 ligand (chemokine) |
| cxcr8 chemokine antagonist |
| cyanide poisoning antidote |
| cyanobacterium extractant |
adenyl | cyclase activator (ec 4.6.1.1) |
guanyl | cyclase activator (ec 4.6.1.2) |
glutaminyl | cyclase inhibitor (ec 2.3.2.5) |
adenylate | cyclase inhibitor (ec 4.6.1.1) |
guanyl | cyclase inhibitor (ec 4.6.1.2) |
2,3-oxidosqualene | cyclase inhibitor (ec 5.4.99.7) |
cdc-25b cell division | cycle phosphatase inhibitor |
| cyclic amp inhibitor (camp) |
| cyclic amp phosphodiesterase inhibitor (camp) |
hcn-1 blocker (hyperpolarization-activated | cyclic nucleoside-gated) |
hcn-2 blocker (hyperpolarization-activated | cyclic nucleoside-gated) |
cng antagonist ( | cyclic nucleotide-gated channel) |
| cyclical mastalgia treatment |
cdk-5 inhibitor ( | cyclin-dependent kinase) |
| cyclin-dependent kinase-1 inhibitor (cdk1) |
| cyclin-dependent kinase-2 inhibitor (cdk2) |
| cyclin-dependent kinase-4 inhibitor (cdk4) |
cdk5 inhibitor ( | cyclin-dependent kinase-5) |
| cyclin-dependent kinase-7 inhibitor (cdk-7) |
| cyclin-dependent kinase-9 inhibitor (cdk9) |
gak inhibitor ( | cyclin-g associated kinase) |
cox-3 inhibitor ( | cyclooxygenase) |
cox-1 & cox-2 inhibitor ( | cyclooxygenase) |
cox-2 inhibitor ( | cyclooxygenase) |
cox-1 inhibitor ( | cyclooxygenase, human) |
| cyclophilin inhibitor |
cftr potentiator ( | cycstic fibrosis transmembrane conductance regulator) |
anti-plasmodial (plasmodium | cynomolgi) |
cytochrome p450 inhibitor ( | cyp-11b1, corticosterone synthase) |
cytochrome p450 inhibitor ( | cyp-11b2, aldosterone synthase) |
cytochrome p450 inhibitor ( | cyp-17) |
ai inhibitor (aromatase) ( | cyp-19) |
cytochrome p450 inhibitor ( | cyp-1a1) |
cytochrome p450 inhibitor ( | cyp-26a) |
cytochrome p450 inhibitor (cyp-2d6 or | cyp-2c19) |
cytochrome p450 inhibitor ( | cyp-2c8) |
cytochrome p450 inhibitor ( | cyp-2c9) |
cytochrome p450 inhibitor ( | cyp-2d6) |
cytochrome p450 inhibitor ( | cyp-2d6 or cyp-2c19) |
cytochrome p450 inhibitor ( | cyp-3a4, grapefruit effect) |
cytochrome p450 inhibitor ( | cyp-51) |
allene oxide synthase inhibitor ( | cyp-74) |
cytochrome p450 inhibitor ( | cyp1b1)(pah activator) |
cytochrome p450 inhibitor ( | cyp2w1) |
cysteinyl leukotriene antagonist ( | cys-lt1) |
| cysk1 inhibitor (pyridoxal phosphate-dependent-o-acetyl sulfhydrylase) |
cbl inhibitor ( | cystathionine-b-lyase) |
| cysteine protease inhibitor |
| cysteinyl leukotriene antagonist |
| cysteinyl leukotriene antagonist (cys-lt1) |
cftr corrector ( | cystic fibrosis transmembrane conductance regulator) |
cftr blocker ( | cystic fibrosis transmembrane conductuctance regulator) |
| cystic fibrosis treatment |
diagnostic aid: | cystoscopy |
| cytidine deaminase |
| cytochrome c inhibitor |
| cytochrome p450 inducer (drug interaction?) |
| cytochrome p450 inducer (ethoxyresorufin o-deethylase) |
| cytochrome p450 inhibitor (cyp-11b1, corticosterone synthase) |
| cytochrome p450 inhibitor (cyp-11b2, aldosterone synthase) |
| cytochrome p450 inhibitor (cyp-17) |
| cytochrome p450 inhibitor (cyp-1a1) |
| cytochrome p450 inhibitor (cyp-26a) |
| cytochrome p450 inhibitor (cyp-2c8) |
| cytochrome p450 inhibitor (cyp-2c9) |
| cytochrome p450 inhibitor (cyp-2d6) |
| cytochrome p450 inhibitor (cyp-2d6 or cyp-2c19) |
| cytochrome p450 inhibitor (cyp-3a4, grapefruit effect) |
| cytochrome p450 inhibitor (cyp-51) |
| cytochrome p450 inhibitor (cyp1b1)(pah activator) |
| cytochrome p450 inhibitor (cyp2w1) |
| cytochrome p450 inhibitor (drug interaction?) |
| cytochrome p680 photosynthesis inhibitor (hill reaction) |
anti-inflammatory ( | cytokine suppressing, csaid) |
cpp inhibitor ( | cytolytic protein performin) |
anti-viral (cmv, herpes-2 | cytomegalo) |
| cytoprotectant |
| cytotoxic (hypoxia-activated) |
| d-amino acid oxidase inhibitor(daao) |
dopamine | d1 agonist |
prostaglandin | d1 antagonist |
dopamine | d1 antagonist |
dopamine | d1 binder |
dopamine | d1-d5 antagonist |
prostaglandin | d2 agonist |
dopamine | d2 agonist |
prostaglandin | d2 antagonist |
dopamine | d2 antagonist |
dopamine | d2 binder |
dopamine | d2 partial agonist |
prostaglandin | d2 synthase inhibitor |
dopamine | d3 agonist |
dopamine | d3 antagonist |
dopamine | d3 binder |
dopamine | d4 agonist |
leukotriene | d4 antagonist |
dopamine | d4 antagonist |
dopamine | d4 binder |
dopamine d1- | d5 antagonist |
sterol | d8d7 isomerase binder |
d-amino acid oxidase inhibitor( | daao) |
| dagl-a inhibitor (diacylglycerol lipase-a) |
| dagr agonist (dissociated glucocorticoid receptor) |
gene repair of nonsense mutation | damage |
dopamine transport inhibitor ( | dat) |
sam- | dc inhibitor (s-adenosylmethionine decarboxylase) |
| dck inhibitor (deoxycytidine kinase) |
| dcx-1 opioid agonist |
| dcx-2 opioid agonist |
| ddl inhibitor (d-alanine-d-alanine ligase) |
activated by | ddn (deazaflavin-dependent nitroreductase) |
| ddp-9 inhibitor (dipeptidyl peptidase-9) |
| ddr inhibitor (discoidin domain) |
dead-box atpase | ddx3 |
anti-dyskinetic (giles | de la tourette's syndrome) |
histone | deacetylase-1 inhibitor (hdac-1) |
histone | deacetylase-10 inhibitor (hdac-10) |
histone | deacetylase-11 inhibitor (hdac-11) |
histone | deacetylase-2 inhibitor (hdac-2) |
histone | deacetylase-3 inhibitor (hdac-3) |
histone | deacetylase-4 inhibitor (hdac-4) |
histone | deacetylase-5 inhibitor (hdac-5) |
histone | deacetylase-6 inhibitor (hdac-6) |
histone | deacetylase-7 inhibitor (hdac-7) |
histone | deacetylase-8 inhibitor (hdac-8) |
histone | deacetylase-9 inhibitor (hdac-9) |
controlled (soft) | deactivation |
| dead-box atpase ddx3 |
cytidine | deaminase |
pad inhibitor (protein arginine | deaminase) |
adenosine monophosphate | deaminase (ampda, ec 3.5.4.6) |
adenosine | deaminase inhibitor (ec 3.5.4.4) |
methuosis inducer (cell | death) |
dr5 activator ( | death receptor) |
activated by ddn ( | deazaflavin-dependent nitroreductase) |
dpre1 inhibitor ( | decaprenylphosphoryl-b-d-ribose-2'-epimerase) |
sam-dc inhibitor (s-adenosylmethionine | decarboxylase) |
odcase inhibitor (orotidine 5'-monophosphate | decarboxylase, ec 4.1.1.23) |
mcd inhibitor (malonyl-coa | decarboxylase, ec 4.1.1.9) |
dopa | decarboxylase inhibitor |
| decarboxylase inhibitor |
histidine | decarboxylase inhibitor |
ornithine | decarboxylase inhibitor (ec 4.1.1.17) |
nasal | decongestant |
circadian period | decrease |
negative chronotropic ( | decrease heart rate) |
herg channel optimized (qt interval | decreased) |
cytochrome p450 inducer (ethoxyresorufin o- | deethylase) |
erod inducer (7-ethoxyresorufin-o- | deethylase) |
nutrition aid: vitamin b | deficiency |
folate | deficiency (anti-anemic) |
pten- | deficient cancer treatment |
anti-adhd (attention | deficit hyperactivity disorder) |
| defoliant |
peptide | deformylase inhibitor |
anti-amd (age related macular | degeneration) |
mnk/ar | degrader (mitogen-activated kinase & androgen receptor) |
ide inhibitor (insulin- | degrading enzyme) |
sulfur mustard | degredation product |
fab-z inhibitor (b-hydroxacyl-acp- | dehydrase) |
7dhcr inhibitor (7- | dehydrocholesterol reductase, ec 1.3.1.21) |
dpd inhibitor (dihydropyrimidine | dehydrogenase) |
pfldh inhibitor (p.falciparum lactate | dehydrogenase) |
aldh-2 inhibitor (aldehyde | dehydrogenase) |
6-pgdh inhibitor (6-phosphogluconate | dehydrogenase) |
15-pgdh inhibitor (15-hydroxyprostaglandin | dehydrogenase) |
g6pd inhibitor (glucose-6-phosphate | dehydrogenase) |
ldh-a inhibitor (lactate | dehydrogenase) |
idh-1 inhibitor (isocitrate | dehydrogenase) |
aldh-1a1 inhibitor (aldehyde | dehydrogenase) |
11b-hsd-1 inhibitor (11b-hydroxysteroid | dehydrogenase-1) |
17b-hsd1 inhibitor (17b-hydroxysteroid | dehydrogenase-1, ec 1.1.1.62) |
17b-hsd2 inhibitor (17b-hydroxysteroid | dehydrogenase-2) |
succinate | dehydrogenase (complex ii) inhibitor (ec 1.3.5.1) |
dhodh-pf inhibitor (dihydroorotate | dehydrogenase-falciparum) |
dhodh-hs inhibitor (dihydroorate | dehydrogenase-human) |
malate | dehydrogenase inhibitor (ec 1.1.1.37) |
inosine-5'-monophosphate | dehydrogenase inhibitor (impdh) |
pyruvate | dehydrogenase kinase inhibitor (pdhk) |
| dehydroquinase ii inhibitor (ec 4.2.1.10) |
| dehydrosqualene synthase inhibitor (crtm, staphylococcus aureus) |
thyroxine | deiodinase inhibitor |
oxytocin antagonist (tocolytic, | delays labor) |
| delete |
pi-3kd inhibitor (phosphoinositide kinase | delta) |
pde- | delta inhibitor (phosphodiesterase) |
| delta opioid agonist |
| delta opioid antagonist |
jmjd2 inhibitor (jumonji domain histone | demethylase) |
lsd-1 inhibitor (lysine specific | demethylase) |
kdm2/7 inhibitor (histone lysine | demethylase) |
steroid 14-a- | demethylase inhibitor |
lanosterol-14-a- | demethylase inhibitor |
alcohol | denaturant |
| dengue 2 ns2b protease inhibitor |
anti-viral (flavivirus, | dengue, west nile) |
| denki inhibitor (dual enkephalinase) |
ldlr agonist (low- | density lipoprotein) |
hdl-c high | density lipoprotein elevator |
analgesic ( | dental) |
bone loss inhibitor ( | dental) |
| dental caries (prophylactic) |
anti-bacterial ( | dental plaque) |
dck inhibitor ( | deoxycytidine kinase) |
ido inhibitor (indolamine-2,3- | deoxygenase, ec 1.13.11.52) |
| deoxyhypusine hydroxylase inhibitor (ec 1.14.99.29) |
dutp inhibitor ( | deoxyuridine triphosphatase) |
dxr inhibitor ( | deoxyxylulose-phosphate reductoisomerase, ispc) |
anti-neoplastic (breast, hormone- | dependent) |
tgf-b1 inhibitor (transforming growth factor, alk5 | dependent) |
camk-2 inhibitor (calcium/calmodulin | dependent) |
lpx-c inhibitor (zinc- | dependent acetylase) |
asbt inhibitor (apical sodium- | dependent bile acid transporter) |
sodium- | dependent glucose transporter-2 inhibitor (sglt2) |
cdk-5 inhibitor (cyclin- | dependent kinase) |
cyclin- | dependent kinase-1 inhibitor (cdk1) |
cyclin- | dependent kinase-2 inhibitor (cdk2) |
cyclin- | dependent kinase-4 inhibitor (cdk4) |
cdk5 inhibitor (cyclin- | dependent kinase-5) |
cyclin- | dependent kinase-7 inhibitor (cdk-7) |
cyclin- | dependent kinase-9 inhibitor (cdk9) |
cap- | dependent m-rna translation inhibitor |
activated by ddn (deazaflavin- | dependent nitroreductase) |
cysk1 inhibitor (pyridoxal phosphate- | dependent-o-acetyl sulfhydrylase) |
dna-pk inhibitor (dna- | dependent protein kinase) |
cdpk-1 inhibitor (calcium- | dependent protein kinase) |
recombinant- | dependent replication inhibition (rdr) |
rdrp inhibitor (rna- | dependent,rna-poylmerase, ec 2.7.7.48) |
thy-x inhibitor (fdts, flavin- | dependent thymidylate synthase) |
| depigmentor (melanine synthesis inhibitor) |
| depilatory (epilatory) |
cns | depressant |
cardiac | depressant |
anti- | depressant |
bipolar treatment (manic | depression) |
ledgf-p75 integrase blocker (lens epithelial-cell | derived) |
platelet- | derived growth factor inhibitor (pdgf) |
| dermatitis suppressant (herpetiformis or atopic) |
| dermatologic |
scd-1 inhibitor (stearoyl-coa- | desaturase) |
phytoene | desaturase inhibitor |
| designer drug |
microtubule | destabilizer |
| detergent |
explosive | detonator |
antidote ( | detoxicant) |
dub inhibitors ( | deubiquitinating enzymes, pan) |
| dgat-1 inhibitor (diacylglyceride acyltransferase) |
dihydrofolate reductase inhibitor ( | dhfr, bacillus anthracis) |
dihydrofolate reductase inhibitor ( | dhfr, candida) |
dihydrofolate reductase inhibitor ( | dhfr, ec 1.5.1.3) |
r67 | dhfr inhibitor (dihydrofolate reductase) |
dihydrofolate reductase inhibitor ( | dhfr, rat liver) |
| dhodh-hs inhibitor (dihydroorate dehydrogenase-human) |
| dhodh-pf inhibitor (dihydroorotate dehydrogenase-falciparum) |
| dhps inhibitor (dihydropteroate synthase) |
dihydrofolate reductase inhibitor ( | dhrf, chicken liver) |
anti- | diabetic |
hyperglycemic (pro- | diabetic) |
dk treatment ( | diabetic ketoacidosis) |
anti- | diabetic neuropathy |
anti- | diabetic (type-2, t2dm) |
dgat-1 inhibitor ( | diacylglyceride acyltransferase) |
| diacylglycerol kinase inhibitor (ec 2.7.1.107) |
dagl-a inhibitor ( | diacylglycerol lipase-a) |
| diagnostic aid |
| diagnostic aid: amyloidosis |
| diagnostic aid: carrier |
| diagnostic aid: cholecystographic |
| diagnostic aid: circulation time |
| diagnostic aid: corneal indicator |
| diagnostic aid: cystoscopy |
| diagnostic aid: gastric secretion |
| diagnostic aid: hepatic |
| diagnostic aid: hepatobiliary function |
| diagnostic aid: lymphangiography |
| diagnostic aid: myasthenia gravis |
| diagnostic aid: obstetrics |
| diagnostic aid: pancreas |
| diagnostic aid: pituitary function |
| diagnostic aid: renal function |
| diaphoretic (perspiration) |
anti- | diarrheal |
esc | differentiation blocker (embryonic stem cell) |
stem cell | differentiation director |
myd-88 inhibitor (myeloid | differentiation protein) |
idp inhibitor (inhibitor | differentiation protein) |
anti-bacterial (clostridium | difficle gram+) |
dpb treatment ( | diffuse panbronchiolitis) |
r67 dhfr inhibitor ( | dihydrofolate reductase) |
| dihydrofolate reductase inhibitor (dhfr, bacillus anthracis) |
| dihydrofolate reductase inhibitor (dhfr, candida) |
| dihydrofolate reductase inhibitor (dhfr, ec 1.5.1.3) |
| dihydrofolate reductase inhibitor (dhfr, rat liver) |
| dihydrofolate reductase inhibitor (dhrf, chicken liver) |
| dihydroneopterin aldolase inhibitor |
dhodh-hs inhibitor ( | dihydroorate dehydrogenase-human) |
dhodh-pf inhibitor ( | dihydroorotate dehydrogenase-falciparum) |
renal | dihydropeptidase inhibitor |
hppk inhibitor (6-hydroxymethyl-7,8- | dihydropetrin kinase) |
dhps inhibitor ( | dihydropteroate synthase) |
dpd inhibitor ( | dihydropyrimidine dehydrogenase) |
mydriatic ( | dilates pupils) |
hydrocholeretic (bile | dilution) |
hiv protease | dimerization inhibitor |
nad synthetase inhibitor (nicotinamide adenine | dinucleotide) |
4-hppd inhibitor (hydroxyphenyl pyruvate | dioxygenase) |
tdo inhibitor (tryptophan-2,3- | dioxygenase, ec 1.13.11.11) |
dpp2 inhibitor ( | dipeptidyl peptidase-2) |
| dipeptidyl peptidase 3 inhibitor |
dpp4 inhibitor ( | dipeptidyl peptidase 4, ec 3.4.14.5) |
dpp-8 inhibitor ( | dipeptidyl peptidase-8) |
ddp-9 inhibitor ( | dipeptidyl peptidase-9) |
upps inhibitor (undecaprenyl | diphosphate synthase) |
farnesyl | diphosphate synthetase inhibitor (fpps, ec 2.5.1.10) |
stem cell differentiation | director |
ddr inhibitor ( | discoidin domain) |
| discontinued (withdrawn) |
treatment of gaucher's | disease |
anti-paget's | disease |
anti-cerebral vascular | disease |
anti-wilson's | disease |
leprosy treatment (hansen's | disease) |
anti-gerd (gastroesophageal reflux | disease) |
nafld treatment (non-alcoholic fatty liver | disease) |
lsd treatment (lysosomal storage | disease) |
fd treatment (fabry | disease) |
anti-copd (chronic obstructive pulmonary | disease) |
als treatment (amyotrophic lateral sclerosis, lou gehrig's | disease) |
ibd treatment (irritable bowel | disease) crohn's |
anti-cerebral | disease/injury/palsy |
crohn's | disease treatment |
huntington | disease treatment |
chronic kidney | disease treatment |
polycystic kidney | disease treatment |
meniere's | disease treatment |
pompe | disease treatment |
cushings | disease treatment |
tsd/sd treatment (tay-sachs, sandhoff | diseases) |
vaginal | disinfectant |
| disinfectant (topical) |
| dislipidemia treatment |
mutant sod-1 anti-aggregant (superoxide | dismutase) |
sod inhibitor (superoxide | dismutase, ec 1.15.1.1) |
anti-adhd (attention deficit hyperactivity | disorder) |
treatment of sex-hormone | disorders |
anti-venous | disorders |
anti-vascular | disorders |
anti-upper intestinal | disorders |
anti-hepatic | disorders (liver) |
golgi | disruption |
vda vascular | disruptive agent |
protein-protein | disruptor |
endocrine | disruptor |
c-myc-max heterodimer | disruptor |
mdm2-p53 | disruptors |
dagr agonist ( | dissociated glucocorticoid receptor) |
| diuretic |
anti- | diuretic (polyuria) |
| diuretic (potassium-sparing) |
anti-mitotic (suppresses cell | division) |
cdc-25b cell | division cycle phosphatase inhibitor |
| dk treatment (diabetic ketoacidosis) |
| dlk,map3k12 inhibitor (dual leucine zippper kinase) |
| dna alkylator |
poly d(a-t) | dna binder |
poly d(c-g) | dna binder |
| dna binder (non-intercalating) |
anti-androgen ( | dna binding site) |
dna-pk inhibitor ( | dna-dependent protein kinase) |
| dna directed rna polymerase inhibitor |
| dna gyrase inhibitor |
| dna helicase inhibitor |
| dna intercaltor |
| dna interstrand cross linker |
hlig-i inhibitor (human | dna ligase-i) |
dnmt inhibitor ( | dna methyltransferase) |
mgmt inhibitor (methylguanine- | dna methyltransferase) |
| dna minor groove binder |
tdp1 inhibitor (tyrosyl- | dna phosphodiesterase) |
tdp2 inhibitor (tyrosyl- | dna-phosphodiesterase-2) |
| dna photocleaver |
| dna-pk inhibitor (dna-dependent protein kinase) |
| dna polymerase inhibitor |
| dna primase inhibitor |
| dna synthesis inhibitor |
anti- | dna viral |
| dnmt inhibitor (dna methyltransferase) |
ddr inhibitor (discoidin | domain) |
jmjd2 inhibitor (jumonji | domain histone demethylase) |
nitroxyl | donor |
nitric oxide | donor |
h2s | donor (hydrogen sulfide releasing) |
| dopa decarboxylase inhibitor |
triple reuptake inhibitor (serotonin, norepinephrine, | dopamine) |
| dopamine-2 agonist, b-arrestin biased |
| dopamine agonist |
| dopamine agonist (cns presynaptic) |
| dopamine antagonist |
| dopamine auto-receptor agonist |
| dopamine b-hydroxylase inhibitor |
cns | dopamine blocker |
| dopamine d1 agonist |
| dopamine d1 antagonist |
| dopamine d1 binder |
| dopamine d1-d5 antagonist |
| dopamine d2 agonist |
| dopamine d2 antagonist |
| dopamine d2 binder |
| dopamine d2 partial agonist |
| dopamine d3 agonist |
| dopamine d3 antagonist |
| dopamine d3 binder |
| dopamine d4 agonist |
| dopamine d4 antagonist |
| dopamine d4 binder |
ndri inhibitor (norepinephrine | dopamine reuptake) |
| dopamine reuptake inhibitor |
| dopamine transport inhibitor (dat) |
| dopamine transporter binder |
| dopaminergic |
| dopaminergic (peripheral) |
| dopaminergic stabilizer |
| dormant hiv inhibitor |
anti-bacterial (tuberculosis, | dormant,non-replicating) |
hmt- | dot1l inhibitor (histone methyl transferase) |
serd (estrogen receptor | down-regulator) |
| down's syndrome therapy |
prostaglandin | dp antagonist (pgd2) |
| dpb treatment (diffuse panbronchiolitis) |
| dpd inhibitor (dihydropyrimidine dehydrogenase) |
| dpp-8 inhibitor (dipeptidyl peptidase-8) |
| dpp2 inhibitor (dipeptidyl peptidase-2) |
| dpp4 inhibitor (dipeptidyl peptidase 4, ec 3.4.14.5) |
| dpre1 inhibitor (decaprenylphosphoryl-b-d-ribose-2'-epimerase) |
| dr5 activator (death receptor) |
poison (hemlock water | dropwort) |
| drought tolerance promoter |
prohibited (regulated) | drug |
designer | drug |
cytochrome p450 inhibitor ( | drug interaction?) |
cytochrome p450 inducer ( | drug interaction?) |
| drug metabolism inhibitor |
| drug precursor |
multi- | drug resistance inhibitor/extruder (mdr1, mrp1) |
| dry eye treatment |
anti-xerostomia ( | dry mouth) |
denki inhibitor ( | dual enkephalinase) |
dlk,map3k12 inhibitor ( | dual leucine zippper kinase) |
dyrk-1a inhibitor ( | dual-specificity tyrosine kinase) |
dyrk-1b ( | dual-specificity tyrosine kinase, mirk) |
| dub inhibitors (deubiquitinating enzymes, pan) |
muscle relaxant (short | duration) |
analgesic (short | duration) |
kif5b-ret inhibitor (kinase fusion, rearranged | during transport) |
| dutp inhibitor (deoxyuridine triphosphatase) |
| dxr inhibitor (deoxyxylulose-phosphate reductoisomerase, ispc) |
mitochondrial | dye |
| dyrk-1a inhibitor (dual-specificity tyrosine kinase) |
| dyrk-1b (dual-specificity tyrosine kinase, mirk) |
ed therapy (erectile | dysfunction) |
fsd therapy (female sexual | dysfunction) |
cognition | dysfunction monitor |
anti- | dyskinetic |
anti- | dyskinetic (giles de la tourette's syndrome) |
anti-hyperlipidemic (hypolipidemic | dyslipidemic) |
| dysmenorrhea treatment |
| dyspareunia |
antacid, anti- | dyspepsia |
treatment for muscular | dystrophy |
urinary incontinence ( | dysuria, overactive bladder, oab) |
metap inhibitor ( | e. coli metalloproteinase) |
prostaglandin | e1 agonist |
prostaglandin | e1 antagonist |
ubiquitin conjugation inhibitor ( | e1/e2) |
mu opioid agonist (mor-1 6tm/ | e11) |
ubiquitin conjugation inhibitor (e1/ | e2) |
prostaglandin | e2 agonist |
prostaglandin | e2 antagonist |
ovarian | e2 secretion inhibitor |
mpges-1 inhibitor (microsomal prostaglandin | e2 synthase) |
ubiquitin conjugation inhibitor ( | e3) |
prostaglandin | e3 agonist |
prostaglandin | e3 antagonist |
prostaglandin | e4 agonist |
prostaglandin | e4 antagonist |
exitory amino acid receptor agonist ( | eaa) |
| eaat-1 inhibitor (excitory amino acid transport-1) |
| eaat-2 inhibitor (excitory amino acid transport-2) |
| ebi-2 antagonist (epstein-barr virus-induced) |
anti-filovirus | ebola/marburg |
endothelin converting enzyme inhibitor ( | ec-1) |
aldh-1 inhibitor (aldose reductase, | ec 1.1.1.21) |
hmg-coa reductase inhibitor (hmgr, | ec 1.1.1.34) |
malate dehydrogenase inhibitor ( | ec 1.1.1.37) |
17b-hsd1 inhibitor (17b-hydroxysteroid dehydrogenase-1, | ec 1.1.1.62) |
nqo2 inhibitor (nad quinone oxidoreductase, | ec 1.10.99.2) |
mpo inhibitor (myeloperoxidase, | ec 1.11.2.2) |
tdo inhibitor (tryptophan-2,3-dioxygenase, | ec 1.13.11.11) |
5-lipoxygenase inhibitor (flap, | ec 1.13.11.12) |
ido inhibitor (indolamine-2,3-deoxygenase, | ec 1.13.11.52) |
nitric oxide synthase inhibitor (nos, | ec 1.14.13.39) |
tyrosinase inhibitor (rtk, | ec 1.14.18.1) |
deoxyhypusine hydroxylase inhibitor ( | ec 1.14.99.29) |
sod inhibitor (superoxide dismutase, | ec 1.15.1.1) |
7dhcr inhibitor (7-dehydrocholesterol reductase, | ec 1.3.1.21) |
succinate dehydrogenase (complex ii) inhibitor ( | ec 1.3.5.1) |
mao-b inhibitor (monamine oxidase, | ec 1.4.3.4) |
mao inhibitor ( | ec 1.4.3.4) |
ssao inhibitor (semicarbazide-sensitive amino oxidase, | ec 1.4.3.6) |
dihydrofolate reductase inhibitor (dhfr, | ec 1.5.1.3) |
nqo1 inhibitor (nad quinone oxidoreductase, | ec 1.6.99.2) |
thioredoxin reductase inhibitor (trxr, | ec 1.8.1.9) |
phenylethanolamine methyl-transferase inhibitor (pnmt, | ec 2.1.1.28) |
thymidylate synthetase inhibitor ( | ec 2.1.1.45) |
comt inhibitor (catechol-o-methyl-transferase, | ec 2.1.1.6) |
acat inhibitor (acetyl-coa-acyltransferase, | ec 2.3.1.16) |
glutaminyl cyclase inhibitor ( | ec 2.3.2.5) |
glycogen phosphorylase inhibitor ( | ec 2.4.1.1) |
purine nucleoside phosphorylase inhibitor (pnp, | ec 2.4.2.1) |
poly adp-ribose polymerase-1 inhibitor (parp-1, | ec 2.4.2.30) |
farnesyl diphosphate synthetase inhibitor (fpps, | ec 2.5.1.10) |
glutathione-s-transferase inhibitor (gst, | ec 2.5.1.18) |
kat-2 inhibitor (kynurenine aminotransferase, | ec 2.6.1.7) |
diacylglycerol kinase inhibitor ( | ec 2.7.1.107) |
adenosine kinase inhibitor ( | ec 2.7.1.20) |
thymidine kinase inhibitor ( | ec 2.7.1.21) |
pgk phosphoglycerate kinase inhibitor ( | ec 2.7.2.3) |
tmk inhibitor (thymidylate kinase, | ec 2.7.4.9) |
rdrp inhibitor (rna-dependent,rna-poylmerase, | ec 2.7.7.48) |
phospholipase a2 inhibitor ( | ec 3.1.1.4) |
acetylcholinesterase inhibitor (ache, | ec 3.1.1.7) |
cholinesterase inhibitor ( | ec 3.1.1.8) |
alkaline phosphatase inhibitor ( | ec 3.1.3.1) |
fructose-1,6-bisphosphatase inhibitor (fbpase, | ec 3.1.3.11) |
pde inhibitor (phosphodiesterase, | ec 3.1.4) |
amcase inhibitor (acidic mammalian chitinase, | ec 3.2.1.14) |
alpha-glucosidase inhibitor ( | ec 3.2.1.20) |
beta galactosidase inhibitor ( | ec 3.2.1.23) |
gcase (glucocerebrosidase reactivator, | ec 3.2.1.45) |
glucocerebroside inhibitor ( | ec 3.2.1.45) |
dpp4 inhibitor (dipeptidyl peptidase 4, | ec 3.4.14.5) |
prcp inhibitor (prolylcarboxypeptidase, | ec 3.4.16.2) |
prep inhibitor (prolyl oligopeptidase, | ec 3.4.21.26) |
neutrophil elastase inhibitor ( | ec 3.4.21.37) |
cathepsin b & l inhibitor ( | ec 3.4.22.1) |
beta lactamase inhibitor ( | ec 3.5.2.6) |
adenosine deaminase inhibitor ( | ec 3.5.4.4) |
adenosine monophosphate deaminase (ampda, | ec 3.5.4.6) |
kynurenine hydroxylase inhibitor ( | ec 3.7.1.3) |
ornithine decarboxylase inhibitor ( | ec 4.1.1.17) |
odcase inhibitor (orotidine 5'-monophosphate decarboxylase, | ec 4.1.1.23) |
mcd inhibitor (malonyl-coa decarboxylase, | ec 4.1.1.9) |
carbonic anhydrase-9 inhibitor (membrane-assoc., | ec 4.2.1.1) |
carbonic anhydrase-beta inhibitor (b-ca, | ec 4.2.1.1) |
dehydroquinase ii inhibitor ( | ec 4.2.1.10) |
adenyl cyclase activator ( | ec 4.6.1.1) |
adenylate cyclase inhibitor ( | ec 4.6.1.1) |
guanyl cyclase activator ( | ec 4.6.1.2) |
guanyl cyclase inhibitor ( | ec 4.6.1.2) |
chlorismate synthase inhibitor ( | ec 4.6.1.4) |
udp-galactose-4'-epimerase ( | ec 5.1.3.2) |
thromboxane synthetase inhibitor ( | ec 5.3.99.5) |
2,3-oxidosqualene cyclase inhibitor ( | ec 5.4.99.7) |
gs inhibitor (glutamine synthase | ec 6.3.1.2) |
biotin carboxylase inhibitor ( | ec 6.3.4.14) |
adss inhibitor (adenylosuccinate synthetase, | ec 6.3.4.4) |
cruzain inhibitor ( | ec.3.4.22.51) |
kmo inhibitor (kynurenine-3- monooxygenase)( | ec1.14.13.9) |
acc inhibitor (acetyl-coa carboxylase)( | ec6.4.1.2) |
| ecb (endogenous cannabinoid) |
human enterovirus inhibitor (hev-71/ | echo) |
| ectoparasiticide |
| ectoparasiticide (veterinary) |
anti- | eczema |
| ed therapy (erectile dysfunction) |
anti-cerebral | edema |
anti- | edemic |
anti-bacterial ( | edwardsiella tarda gram+) |
| eef2-kinase inhibitor (eukaryotic elongation factor) |
eps high (extrapyramidal | effect) |
eps relatively low (extrapyramidal | effect) |
cytochrome p450 inhibitor (cyp-3a4, grapefruit | effect) |
allosteric hemoglobin | effector |
p-gp | efflux high (p-glycoprotein) |
p-gp | efflux optimized (p-glycoprotein) |
| efflux pump inhibitor |
treatment pleural | effusion |
| eg5 inhibitor (mitotic kinesin) |
| egfr inhibitor (epidermal growth factor) |
| eif4e/eif4g protein interaction inhibitor |
| eif4e inhibitor (eukaryotic initiation factor, hri) |
eif4e/ | eif4g protein interaction inhibitor |
pe treatment (premature | ejaculation) |
anti-neoplastic (lymphoma | el-4) |
human neutrophil | elastase inhibitor |
human leukocyte | elastase inhibitor |
human pancreatic | elastase inhibitor |
| elastase inhibitor |
neutrophil | elastase inhibitor (ec 3.4.21.37) |
| electrolyte for flow battery |
| electrolyte replenisher adjuvant |
mitochondrial | electron transport complex i inhibitor |
mitochondrial | electron transport complex ii inhibitor |
mitochondrial | electron transport complex iii (qi) inhibitor |
mitochondrial | electron transport complex iv inhibitor |
srebp inhibitor (sterol regulatory | element binding protein) |
hdl-c high density lipoprotein | elevator |
| elimination rate (metabolism excretion) |
elovl-6 inhibitor (fatty acid | elongase-6, lce, face) |
eef2-kinase inhibitor (eukaryotic | elongation factor) |
| elovl-6 inhibitor (fatty acid elongase-6, lce, face) |
esc differentiation blocker ( | embryonic stem cell) |
herbicide (pre- | emergence) |
herbicide (post- | emergence) |
| emetic |
anti- | emetic (anti-nauseant) |
| emge (epigenetic modulator gene expression) |
spect imaging (single photon | emission computed tomography) |
pet imaging (positron | emission tomography) |
cardiac pet imaging (positron | emission tomography) |
| emollient |
| emphysema treatment |
rage inhibitor (receptor advanced glycation | end products) |
age inhibitor (advanced glycation | end products) |
| endocrine disruptor |
| endocytosis inhibitor |
ecb ( | endogenous cannabinoid) |
anti-neoplastic (hela cervical uterine | endometrial) |
| endometriosis treatment |
ape-1 inhibitor (apurinic/apyrimidinic | endonuclease-1) |
flap | endonuclease-1 inhibitor (fen1) |
| endopeptidase inhibitor |
erap-1 inhibitor ( | endoplasmic reticulum aminopeptidase) |
erap-2 inhibitor ( | endoplasmic reticulum aminopeptidase) |
perk inhibitor ( | endoplasmic reticulum kinase) |
| endosomal/lysosomal labile iron probe |
vegf-3 inhibitor (vascular | endothelial) |
vegf-2 inhibitor (vascular | endothelial g.f., kdr, fr) |
| endothelial lipase inhibitor |
| endothelin-a antagonist (et-a) |
| endothelin-b antagonist (et-b) |
| endothelin converting enzyme inhibitor (ec-1) |
| enkephalin analog |
denki inhibitor (dual | enkephalinase) |
| enkephalinase inhibitor |
| enolpyruvateshikamate-3-phosphate synthase inhibitor (epsps) |
fab-i inhibitor ( | enoyl-acp-reductase) |
| enoyl-acp reductase inhibitor |
anti-amebic ( | entamoeba histolytica) |
anti-bacterial ( | enterococcus casselflavus gram-, vancomycin resistant) |
anti-bacterial ( | enterococcus faecalis gram+) |
anti-bacterial (vancomycin-resistant | enterococcus faecalis, vre) |
human | enterovirus inhibitor (hev-71/echo) |
anti- | enuresis (bed-wetting) |
aph3'-iiia inhibitor (aminoglycoside modifying | enzyme) |
ide inhibitor (insulin-degrading | enzyme) |
ire-1 inhibitor (inositol-requiring | enzyme) |
ace inhibitor (angiotensin-converting | enzyme) |
| enzyme co-factor |
hepatic | enzyme inducer |
endothelin converting | enzyme inhibitor (ec-1) |
interleukin-1b converting | enzyme inhibitor (il-1b) |
dub inhibitors (deubiquitinating | enzymes, pan) |
| eosinophil inhibitor |
vla4 antagonist (very late antigen, | eosinophil integrin) |
mur-b inhibitor (udp- | ep-glu-nac reductase) |
high volume industrial chem. | epa (450,000 kg/yr) |
| epac-2 antagonist (exchange protein camp activated) |
| eph-b3 inhibitor (erythropoietin-producing hepatocarcinoma receptor) |
| eph-b4 inhibitor |
anti-neoplastic ( | epidermal) |
her-2 inhibitor (human | epidermal growth) |
egfr inhibitor ( | epidermal growth factor) |
anti-fungal ( | epidermophyton floccosum) |
emge ( | epigenetic modulator gene expression) |
depilatory ( | epilatory) |
anti-convulsant (anti- | epileptic) |
dpre1 inhibitor (decaprenylphosphoryl-b-d-ribose-2'- | epimerase) |
udp-galactose-4'- | epimerase (ec 5.1.3.2) |
ledgf-p75 integrase blocker (lens | epithelial-cell derived) |
| epithelial sodium channel blocker |
squalene | epoxidase inhibitor |
aldrin | epoxidation inhibitor |
| epoxide hydrolase inhibitor |
| eps high (extrapyramidal effect) |
| eps inducer (extrapyramidal symptoms) |
| eps relatively low (extrapyramidal effect) |
ikke inhibitor (i-kappa-kinase | epsilon) |
pkc-e inhibitor (protein kinase-c- | epsilon) |
enolpyruvateshikamate-3-phosphate synthase inhibitor ( | epsps) |
ebi-2 antagonist ( | epstein-barr virus-induced) |
| erap-1 inhibitor (endoplasmic reticulum aminopeptidase) |
| erap-2 inhibitor (endoplasmic reticulum aminopeptidase) |
| erb-tyrosine kinase inhibitor |
ed therapy ( | erectile dysfunction) |
insecticide (spodoptura | eridania, southern army worm) |
| erk-1/erk-2 inhibitor (extracellular signal-regulated kinase) |
erk-1/ | erk-2 inhibitor (extracellular signal-regulated kinase) |
| erk-5 inhibitor (extracellular signal-regulated kinase, mapk-7) |
| erod inducer (7-ethoxyresorufin-o-deethylase) |
| err-a antagonist (estrogen related receptor) |
| err-a inverse agonist (estrogen-related receptor-a) |
sle treatment (systemic lupus | erythematous) |
nrf-2 activator (nuclear factor | erythroid) |
anti-neoplastic ( | erythroleukemia) |
eph-b3 inhibitor ( | erythropoietin-producing hepatocarcinoma receptor) |
| es treatment (ewing's sarcoma) |
| esc differentiation blocker (embryonic stem cell) |
anti-bacterial ( | escherichia coli gram-) |
treatment of | eskape pathogens |
anti-neoplastic ( | esophagus) |
fruit | essences |
| essential fatty acid |
cholesterol | ester reformation inhibitor |
aryl | esterase-a |
aryl | esterase-b |
cholesterol | esterase inhibitor |
juvenile hormone | esterase inhibitor |
neuropathy target | esterase inhibitor (nte) |
ce inhibitor (carboxyl | esterase, low ache & bche) |
| estrogen |
cbi-e (coactivator binding inhibitor | estrogen) |
| estrogen a agonist |
| estrogen a antagonist |
| estrogen a receptor binder |
| estrogen b receptor binder/agonist |
serd ( | estrogen receptor down-regulator) |
anti-estrogen (serm, selective | estrogen receptor modulator) |
err-a antagonist ( | estrogen related receptor) |
err-a inverse agonist ( | estrogen-related receptor-a) |
anti- | estrogen (serm, selective estrogen receptor modulator) |
| estrogenic hrt (hormone replacement therapy) |
| estrone sulfatase inhibitor |
| estrus synchronizer |
endothelin-a antagonist ( | et-a) |
endothelin-b antagonist ( | et-b) |
anti-addictive (cocaine, opiates, methamphetamine, | etc.) |
ethr inhibitor (incr. | ethionamide action) |
cytochrome p450 inducer ( | ethoxyresorufin o-deethylase) |
erod inducer (7- | ethoxyresorufin-o-deethylase) |
| ethr inhibitor (incr. ethionamide action) |
| ethylene synthesis inhibitor (ripening delayer) |
anti-narcoleptic ( | eugeroic) |
eef2-kinase inhibitor ( | eukaryotic elongation factor) |
eif4e inhibitor ( | eukaryotic initiation factor, hri) |
| euphoretic |
es treatment ( | ewing's sarcoma) |
sodium-hydrogen | exchange inhibitor (nhe-1) |
epac-2 antagonist ( | exchange protein camp activated) |
eaat-1 inhibitor ( | excitory amino acid transport-1) |
eaat-2 inhibitor ( | excitory amino acid transport-2) |
natriuretic (sodium | excretion) |
saluretic (na+, cl- | excretion) |
elimination rate (metabolism | excretion) |
inhibits | excretion of penicillin |
uricosuric (uric acid | excretor, gout treatment) |
| exhibits atropisomerism |
| exitory amino acid receptor agonist (eaa) |
| expectorant |
| explosive detonator |
emge (epigenetic modulator gene | expression) |
erk-1/erk-2 inhibitor ( | extracellular signal-regulated kinase) |
erk-5 inhibitor ( | extracellular signal-regulated kinase, mapk-7) |
plant | extract |
cyanobacterium | extractant |
eps high ( | extrapyramidal effect) |
eps relatively low ( | extrapyramidal effect) |
eps inducer ( | extrapyramidal symptoms) |
multi-drug resistance inhibitor/ | extruder (mdr1, mrp1) |
dry | eye treatment |
| ezh-2 inhibitor (enhancer zeste homolog) |
pgf2a allosteric modulator (prostaglandin- | f2a) |
prostaglandin | f2a agonist |
prostaglandin | f2a antagonist |
| faah inhibitor (fatty acid amide hydrolase) |
| fab-b/f inhibitor (b-ketoacetyl-acp synthase 1/2) |
| fab-d inhibitor (malonyl co-a acyl carrier) |
| fab-g inhibitor (b-ketoacyl-acp-reductase) |
| fab-h inhibitor (b-ketoacetyl acp synthase-3) |
| fab-i inhibitor (enoyl-acp-reductase) |
| fab-k inhibitor |
| fab-z inhibitor (b-hydroxacyl-acp-dehydrase) |
fd treatment ( | fabry disease) |
elovl-6 inhibitor (fatty acid elongase-6, lce, | face) |
treatment | facial hirsutism |
nutritional | factor |
enzyme co- | factor |
crf receptor antagonist (corticotropin releasing | factor) |
somatostatin antagonist (srif release-inhibiting | factor) |
hif-1 inhibitor (hypoxia inducible | factor) |
mif (macrophage migration inhibitory | factor) |
igf-1 inhibitor (insulin-like growth | factor) |
eef2-kinase inhibitor (eukaryotic elongation | factor) |
tgf-b2 inhibitor (transforming growth | factor) |
arf-1 inhibitor (adp-ribosylation | factor) |
ngf agonist (nerve growth | factor) |
hgf inhibitor (hepatocyte growth | factor) |
egfr inhibitor (epidermal growth | factor) |
1hur inhibitor (ribosylation | factor-1) |
| factor 2a antagonist |
| factor 7a antagonist |
nerve growth | factor activator |
tgf-b1 inhibitor (transforming growth | factor, alk5 dependent) |
tumor necrosis | factor blocker (tnf-a, tace, adam-17) |
fms inhibitor (macrophage colony-stimulating | factor, csf-1, ron) |
nrf-2 activator (nuclear | factor erythroid) |
eif4e inhibitor (eukaryotic initiation | factor, hri) |
nerve growth | factor inhibitor |
anti-bacterial (anthrax lethal | factor inhibitor) |
fibroblast growth | factor inhibitor (fgf) |
platelet-derived growth | factor inhibitor (pdgf) |
| factor ix-a inhibitor |
nuclear | factor kappa b inhibitor (nf-k-b) |
tissue | factor vii-a inhibitor |
cfviia inhibitor (coagulation | factor viia) |
| factor x-a antagonist (fxa) |
| factor xia antagonist (fxia) |
anti-bacterial (enterococcus | faecalis gram+) |
anti-bacterial (vancomycin-resistant enterococcus | faecalis, vre) |
| fak inhibitor (focal adhesion kinase) |
| falcipain-2 inhibitor |
| falcipain-3 inhibitor |
| falcipain inhibitor |
anti-plasmodial ( | falciparum) |
dhodh-pf inhibitor (dihydroorotate dehydrogenase- | falciparum) |
anti-plasmodial ( | falciparum chloroquine resistant) |
| familial chylomicronemia treatment |
| fap inhibitor (fibroblast activator protein) |
| farnesoid x agonist (fxr) |
| farnesoid-x antagonist (fxr) |
| farnesyl diphosphate synthetase inhibitor (fpps, ec 2.5.1.10) |
ftase ( | farnesyl transferase inhibitor) |
| fas-ii inhibitor (fatty acid synthase) |
flukicide ( | fasciolicide) |
| fasn-te inhibitor (fatty acid synthase-thioesterase) |
essential | fatty acid |
vlcfa synthesis inhibitor (very long chain | fatty acid) |
ffa-2 antagonist (free | fatty acid-2)(gpr3) |
faah inhibitor ( | fatty acid amide hydrolase) |
elovl-6 inhibitor ( | fatty acid elongase-6, lce, face) |
pfkasiii inhibitor ( | fatty acid synthase) |
fas-ii inhibitor ( | fatty acid synthase) |
fasn-te inhibitor ( | fatty acid synthase-thioesterase) |
| fatty acid transport inhibitor |
nafld treatment (non-alcoholic | fatty liver disease) |
fto inhibitor ( | fatty mass & obesity assoc. protein) |
fructose-1,6-bisphosphatase inhibitor ( | fbpase, ec 3.1.3.11) |
| fd treatment (fabry disease) |
thy-x inhibitor ( | fdts, flavin-dependent thymidylate synthase) |
anti-pyretic hypothermic (anti- | febric) |
anti-oxidant (animal | feed) |
reproductive toxicity (ca prop. 65, | female) |
contraceptive ( | female) |
fsd therapy ( | female sexual dysfunction) |
flap endonuclease-1 inhibitor ( | fen1) |
| fertility controller |
plant | fertility regulator |
npff ligand (neuropeptide | ff) |
gpcr-40 agonist (g-protein coupled receptor, | ffa-1) |
gpcr-40 antagonist (g-protein coupled receptor, | ffa-1) |
| ffa-2 antagonist (free fatty acid-2)(gpr3) |
fibroblast growth factor inhibitor ( | fgf) |
tau | fibrilization inhibitor (polymerization, aggregation) |
anti-arrhythmic (anti- | fibrillatory, anti-afib) |
| fibrinogen antagonist |
thrombin-activatable | fibrinolysis inhibitor (tafia) |
| fibrinolytic |
anti- | fibrinolytic |
fap inhibitor ( | fibroblast activator protein) |
low toxicity to mice or | fibroblast cells |
| fibroblast growth factor inhibitor (fgf) |
fop ( | fibrodysplasia ossificans progressiva) |
anti-neoplastic ( | fibrosarcoma) |
ipf treatment (ideopathic pulmonary | fibrosis) |
cftr potentiator (cycstic | fibrosis transmembrane conductance regulator) |
cftr corrector (cystic | fibrosis transmembrane conductance regulator) |
cftr blocker (cystic | fibrosis transmembrane conductuctance regulator) |
cystic | fibrosis treatment |
| filaricide (worms) |
ftsz inhibition ( | filimentation temp.-sensitive protein z) |
anti- | filovirus ebola/marburg |
gfr tracer (glomerular | filtration rate) |
fimh antagonist ( | fimbrae-mediated bacterial adhesion) |
| fimh antagonist (fimbrae-mediated bacterial adhesion) |
marine toxin/metabolite (algal/sponge/ | fish) |
piscicide ( | fish) |
anti-fungal (anti-parasitic, | fish) |
anesthetic (transport of | fish) |
perfume | fixative |
peptidyl prolyl isomerase inhibitor ( | fkbp) |
| fkbp51 ligand |
5-lipoxygenase inhibitor ( | flap, ec 1.13.11.12) |
| flap endonuclease-1 inhibitor (fen1) |
carminative (relieves | flatulence) |
thy-x inhibitor (fdts, | flavin-dependent thymidylate synthase) |
anti-viral ( | flavivirus, dengue, west nile) |
| flavodoxin inhibitor |
citrus | flavor |
bitter | flavor |
bitter | flavor masker |
| flavoring |
imitation grape | flavoring |
brandy | flavoring |
artificial rum | flavoring |
ancient | flavoring |
insecticide ( | fleas) |
anti-fungal (epidermophyton | floccosum) |
electrolyte for | flow battery |
| flt-3 inhibitor (tyrosine kinase) |
anti-schistosomal ( | flukicide) |
| flukicide (fasciolicide) |
| flukicide (veterinary) |
| fluorescent label |
| fms inhibitor (macrophage colony-stimulating factor, csf-1, ron) |
fak inhibitor ( | focal adhesion kinase) |
anti- | folate |
| folate deficiency (anti-anemic) |
fr-a inhibitor ( | folate receptor-alpha) |
fr-b inhibitor ( | folate receptor-beta) |
pcft inhibitor (proton-coupled | folate transporter) |
chaperone of protein | folding |
fsh agonist ( | follicle stimulating hormone) |
fsh antagonist ( | follicle stimulating hormone) |
anti-fungal ( | fonsecaea pedrosoi) |
anti-oxidant ( | food) |
| food additive (veterinary) |
blue | food coloring |
| fop (fibrodysplasia ossificans progressiva) |
increased bone | formation (anabolic) |
anti-bacterial (biofilm | forming) |
garft inhibitor (glycinamide ribonucleotide | formyl transferase) |
anti- | fouling paint |
farnesyl diphosphate synthetase inhibitor ( | fpps, ec 2.5.1.10) |
vegf-2 inhibitor (vascular endothelial g.f., kdr, | fr) |
| fr-a inhibitor (folate receptor-alpha) |
| fr-b inhibitor (folate receptor-beta) |
| fractalkine antagonist (cx3cr1) |
| fragile-x syndrome treatment |
perfume or | fragrance ingredient/intermediate |
anti-bacterial ( | francisella tularensis, bio-warfare agt.) |
| fraxin/ubiquitin interaction inhibition |
ffa-2 antagonist ( | free fatty acid-2)(gpr3) |
| free radical generator |
| free radical scavenger |
| friedreich's ataxia treatment |
sfrp-1 inhibitor (secreted | frizzled-related protein) |
poison (toad/ | frog) |
| frog neurotoxin |
| fructose-1,6-bisphosphatase inhibitor (fbpase, ec 3.1.3.11) |
| fruit essences |
| fruit ripener |
| fruit & vegetable setting agent |
| fsd therapy (female sexual dysfunction) |
| fsh agonist (follicle stimulating hormone) |
| fsh antagonist (follicle stimulating hormone) |
| ftase (farnesyl transferase inhibitor) |
| fto inhibitor (fatty mass & obesity assoc. protein) |
| ftsz inhibition (filimentation temp.-sensitive protein z) |
qfr inhibitor (quinol/ | fumarate reductase) |
| fumigant |
soil | fumigant |
anti-fungal (aspergillus | fumigatus) |
alkaloid-like (plant/ | fungal) |
anti- | fungal (anti-mycotic) |
anti- | fungal (anti-parasitic, fish) |
anti- | fungal (aspergillus fumigatus) |
anti- | fungal (aspergillus niger) |
anti- | fungal (barley mildew) |
anti- | fungal (botrydiplodia theobrome) |
anti- | fungal (candida albicans) |
anti- | fungal (candida glabrata, torulopsis) |
anti- | fungal (candida krusei) |
anti- | fungal (candida parapsilosis) |
anti- | fungal (candida stellaloidea) |
anti- | fungal (candida tropicalis) |
anti- | fungal (cryptoformans neoformans) |
anti- | fungal (epidermophyton floccosum) |
anti- | fungal (fonsecaea pedrosoi) |
anti- | fungal (fusarium oxysporum) |
anti- | fungal (microsporum canis) |
anti- | fungal (powdery mildew) |
anti- | fungal (pyricularia oryzae) |
anti- | fungal (rhizoctonia bataticola) |
anti- | fungal (saccharomyces cerevisiae) |
anti- | fungal (sporothrix schenckii) |
anti- | fungal (trichophyton mentagrophytes) |
anti- | fungal (trichophyton rubrum) |
anti- | fungal (trichophyton spp., ringworm, jock-itch) |
anti- | fungal (wheat rust) |
| fungicide |
| fungicide (agricultural) |
| fungicide (systemic) |
| fungicide (topical) |
| fungistat |
anti-fungal ( | fusarium oxysporum) |
rsv anti-viral (respiratory syncytial | fusion) |
kif5b-ret inhibitor (kinase | fusion, rearranged during transport) |
factor x-a antagonist ( | fxa) |
factor xia antagonist ( | fxia) |
farnesoid x agonist ( | fxr) |
farnesoid-x antagonist ( | fxr) |
| g-protein activator |
| g-secretase inhibitor |
| g-secretase modulator |
vegf-2 inhibitor (vascular endothelial | g.f., kdr, fr) |
cell arrest at | g2/m phase |
trmd inhibitor (t-rna-n1- | g37 methyltransferase) |
gadph binder (glyceraldehyde-3-phosphate, | g3dph) |
| g6pd inhibitor (glucose-6-phosphate dehydrogenase) |
lysine methyl-transferase | g9a inhibitor |
| gaba-4 antagonist (gamma amino butyric acid) |
| gaba-a agonist (gamma amino butyric acid) |
| gaba-a antagonist (gamma amino butyric acid) |
| gaba-a modulator (gamma amino butyric acid) |
| gaba-a3 agonist (gamma amino butyric acid) |
| gaba agonist (gamma amino butyric acid) |
| gaba-b agonist |
| gaba-b antagonist (gamma amino butyric acid) |
| gaba-c agonist (gamma amino butyric acid) |
| gaba-c antagonist (gamma amino butyric acid) |
| gaba inverse agonist (gamma amino butyric acid) |
| gaba mimetic (gamma amino butyric acid) |
| gaba reuptake inhibitor (gamma amino butyric acid) |
| gaba-t inhibitor (gaba transaminase) |
gaba-t inhibitor ( | gaba transaminase) |
| gadph binder (glyceraldehyde-3-phosphate, g3dph) |
| gak inhibitor (cyclin-g associated kinase) |
| gal-3 antagonist (galanin-3) |
udp- | galactose-4'-epimerase (ec 5.1.3.2) |
beta | galactosidase inhibitor (ec 3.2.1.23) |
| galactosyltransferase inhibitor |
gal-3 antagonist ( | galanin-3) |
| galectin-3 inhibitor |
anti-spasmodic ( | gall bladder) |
cholelitholytic agent ( | gall stones) |
pi-3kg inhibitor (phosphoinositide kinase | gamma) |
rorgt antagonist (nuclear hormone receptor | gamma) |
gaba-4 antagonist ( | gamma amino butyric acid) |
gaba mimetic ( | gamma amino butyric acid) |
gaba-a modulator ( | gamma amino butyric acid) |
gaba-c agonist ( | gamma amino butyric acid) |
gaba-a3 agonist ( | gamma amino butyric acid) |
gaba-c antagonist ( | gamma amino butyric acid) |
gaba agonist ( | gamma amino butyric acid) |
gaba-a agonist ( | gamma amino butyric acid) |
gaba reuptake inhibitor ( | gamma amino butyric acid) |
gaba inverse agonist ( | gamma amino butyric acid) |
gaba-b antagonist ( | gamma amino butyric acid) |
gaba-a antagonist ( | gamma amino butyric acid) |
| ganglionic blocker (ganglioplegic) |
ganglionic blocker ( | ganglioplegic) |
| gap junction modifier |
| gardos channel blocker |
| garft inhibitor (glycinamide ribonucleotide formyl transferase) |
nerve | gas prophylactic |
organophosphate nerve | gas reactivator (ache, bche) |
lennox- | gastaut syndrome treatment |
anti-cholinergic ( | gastric) |
anti-spasmodic ( | gastric) |
| gastric acidifier |
gastroprotective ( | gastric anti-inflammatory) |
| gastric anti-secretory |
diagnostic aid: | gastric secretion |
| gastrin antagonist (bombesin bb) |
anti-neoplastic ( | gastro-intestinal, gist) |
gastroprokinetic ( | gastro-intestinal stimulant) |
acute | gastroenteritis treatment |
anti-gerd ( | gastroesophagael reflux) |
anti-gerd ( | gastroesophageal reflux disease) |
| gastrointestinal toxicant |
| gastroprokinetic (gastro-intestinal stimulant) |
| gastroprotective (gastric anti-inflammatory) |
treatment of | gaucher's disease |
| gcase (glucocerebrosidase reactivator, ec 3.2.1.45) |
glutamate carboxypeptidase ii inhibitor ( | gcp-ii) |
| gcs inhibitor (glucosylceramide synthase) |
| gdept (gene directed prodrug therapy) |
als treatment (amyotrophic lateral sclerosis, lou | gehrig's disease) |
mmp-2 inhibitor (matrix metalloproteinase-2, | gelatinase-a) |
mmp-9 inhibitor (matrix metalloproteinase-9, | gelatinase-b) |
| gelling agent |
smn2 | gene activator/modulator |
| gene delivery vector |
gdept ( | gene directed prodrug therapy) |
emge (epigenetic modulator | gene expression) |
agr inhibitor (accessory | gene regulator) |
cgrp antagonist (calcitonin | gene-related peptide) |
| gene repair of nonsense mutation damage |
inhibitor of | gene transcription |
anesthetic ( | general) |
free radical | generator |
intracellular superoxide | generator |
mrg-x1 antagonist (mas-related | genes) |
anti-viral (herpes | genitalis) |
| geranylgeranyl transferase inhibitor |
anti- | gerd (gastroesophagael reflux) |
anti- | gerd (gastroesophageal reflux disease) |
seed | germinator |
abortifacient (anti- | gestagen) |
| gfr tracer (glomerular filtration rate) |
| ghrelin agonist (grln, partial) |
ghsr-1a antagonist/inverse agonist ( | ghrelin receptor) |
| ghsr-1a antagonist/inverse agonist (ghrelin receptor) |
anti-protozoal ( | giardia) |
anti-dyskinetic ( | giles de la tourette's syndrome) |
anti-neoplastic (gastro-intestinal, | gist) |
| gkrp modulator (glucokinase regulatory protein) |
molluscicide (biomphalaria | glabrata) |
anti-fungal (candida | glabrata, torulopsis) |
anti- | glaucoma |
o- | glc-ncase inhibitor (o-linked glucose-n-acetyl) |
anti-neoplastic ( | glioma) |
gfr tracer ( | glomerular filtration rate) |
anti- | glomerulonephritis |
| glp-1 agonist (glucagon-like peptide) |
| gls inhibitor (glutaminase) |
| glu-n1/2a nmda receptor inhibitor |
nmda ligand ( | glu-n1/2b selective) |
mur-b inhibitor (udp-ep- | glu-nac reductase) |
| glucagon antagonist |
glp-1 agonist ( | glucagon-like peptide) |
| glucagon stimulant |
1,3-b-d- | glucan synthase inhibitor |
gcase ( | glucocerebrosidase reactivator, ec 3.2.1.45) |
| glucocerebroside inhibitor (ec 3.2.1.45) |
anti- | glucocorticoid |
| glucocorticoid (agonist-modulator) |
dagr agonist (dissociated | glucocorticoid receptor) |
sgk-1 inhibitor (serum | glucocorticoid-regulated kinase) |
| glucocorticoid (topical) |
| glucokinase agonist |
gkrp modulator ( | glucokinase regulatory protein) |
| glucolipid synthase inhibitor |
| glucosamine-6-phosphate synthase inhibitor |
hepatic | glucose-6-phosphatase inhibitor |
g6pd inhibitor ( | glucose-6-phosphate dehydrogenase) |
o-glc-ncase inhibitor (o-linked | glucose-n-acetyl) |
hsp-78d inhibitor (grp-78 | glucose regulated protein) |
glut-1 inhibitor ( | glucose transport) |
sodium-dependent | glucose transporter-2 inhibitor (sglt2) |
a- | glucosidase chaperone |
beta- | glucosidase inhibitor |
alpha- | glucosidase inhibitor (ec 3.2.1.20) |
gcs inhibitor ( | glucosylceramide synthase) |
b- | glucuronidase inhibitor |
| gluk-1 agonist (glutamate kainate) |
| gluk-1 antagonist (glutamate kainate) |
| glun2c/d antagonist (glutamate) |
| glun2c modulator (glutamate binding) |
| glur-2 partial agonist (glutamate kainate) |
| glur5 kainate antagonist |
| glut-1 inhibitor (glucose transport) |
mglur1 imager (metabotropic | glutamate) |
mglur5 agonist (metabotropic | glutamate) |
mglur2 agonist (metabotropic | glutamate) |
mglur3 agonist (metabotropic | glutamate) |
mglur5 antagonist (metabotropic | glutamate) |
mglur1 antagonist competitive (metabotropic | glutamate) |
mglur7 antagonist (meabotropic | glutamate) |
mglur4 agonist (meabotropic | glutamate) |
mglur3 antagonist (metabotropic | glutamate) |
mglur2 modulator (metabotropic | glutamate) |
glun2c/d antagonist ( | glutamate) |
iglu-a2 modulator (ionotropic | glutamate) |
iglur-5 binder (ionotropic | glutamate-5) |
| glutamate antagonist |
| glutamate antagonist (competitive) |
glun2c modulator ( | glutamate binding) |
| glutamate carboxypeptidase ii inhibitor (gcp-ii) |
gluk-1 agonist ( | glutamate kainate) |
gluk-1 antagonist ( | glutamate kainate) |
glur-2 partial agonist ( | glutamate kainate) |
n-acetyl-aspartyl- | glutamate peptidase inhibitor (naag) |
| glutamate racemase (muri) |
mglur agonist (metabotropic | glutamate receptor) |
mglur antagonist (metabotropic | glutamate receptor) |
| glutamatergic |
mur-d ligase inhibitor ( | glutamic acid) |
gls inhibitor ( | glutaminase) |
gs inhibitor ( | glutamine synthase ec 6.3.1.2) |
| glutaminyl cyclase inhibitor (ec 2.3.2.5) |
gsh synthase inducer ( | glutathione) |
| glutathione-s-transferase inducer (gst) |
| glutathione-s-transferase inhibitor (gst, ec 2.5.1.18) |
celiac treatment ( | gluten reaction) |
rage inhibitor (receptor advanced | glycation end products) |
age inhibitor (advanced | glycation end products) |
gadph binder ( | glyceraldehyde-3-phosphate, g3dph) |
hlda inhibitor ( | glycero-manno-heptose-7-phosphate kinase) |
hlde inhibitor ( | glycero-manno-heptose-7-phosphate kinase) |
garft inhibitor ( | glycinamide ribonucleotide formyl transferase) |
| glycine receptor antagonist |
glyt-1 inhibitor ( | glycine transport) |
| glycogen phosphorylase inhibitor (ec 2.4.1.1) |
| glycogen synthase kinase-3-beta inhibitor (gsk-3beta) |
| glycogen synthase kinase-a inhibitor (gsk-3a) |
nad | glycohydrase inhibitor |
parg inhibitor (poly-adp-ribose | glycohydrolase) |
nad | glycohydrolase inhibitor |
antidote | glycol methanol poisoning |
hiv-gp41 inhibitor ( | glycoprotein) |
pgp overexpression inhibitor (plasma membrane | glycoprotein) |
p-gp efflux high (p- | glycoprotein) |
p-gp efflux optimized (p- | glycoprotein) |
p- | glycoprotein inhibitor (p-gp) |
| glycoprotein receptor antagonist |
| glycosidase inhibitor |
cardiac | glycoside |
| glycosuric (veterinary) |
| glyt-1 inhibitor (glycine transport) |
| gmp guanosine monophosphate synthase inhibitor |
lhrh/ | gnrh antagonist (luteinizing/gonadotropin-releasing hormone) |
| golgi disruption |
| gonad stimulator |
lhrh/gnrh antagonist (luteinizing/ | gonadotropin-releasing hormone) |
anti-protozoal (toxoplasma | gondii) |
anti-bacterial ( | gonococcus) |
uricosuric (uric acid excretor, | gout treatment) |
p-glycoprotein inhibitor (p- | gp) |
p- | gp efflux high (p-glycoprotein) |
p- | gp efflux optimized (p-glycoprotein) |
| gp iib/iiia inhibitor (gycoprotein) |
hiv- | gp41 inhibitor (glycoprotein) |
| gpba-1 agonist (g-protein-coupled bile acid) |
| gpcr-109a agonist (g-protein coupled, niacin-109a) |
| gpcr-109a modulator (g-protein-coupled) |
| gpcr-120 agonist (g-protein coupled receptor) |
| gpcr-139 agonist (g-protein coupled receptor) |
| gpcr-30 agonist (g-protein coupled receptor) |
| gpcr-30 antagonist |
| gpcr-35 agonist (g-protein-coupled) |
| gpcr-40 agonist (g-protein coupled receptor, ffa-1) |
| gpcr-40 antagonist (g-protein coupled receptor, ffa-1) |
| gpcr-52 (g-protein coupled receptor) |
| gpcr119 agonist (g-protein coupled receptor) |
| gpcr119 antagonist (g-protein coupled receptor) |
| gpr-103 antagonist (g-protein receptor) |
| gpr-119 agonist (g-protein coupled receptor) |
ffa-2 antagonist (free fatty acid-2)( | gpr3) |
imitation | grape flavoring |
cytochrome p450 inhibitor (cyp-3a4, | grapefruit effect) |
turf growth regulator ( | grass) |
| grass growth inhibitor |
diagnostic aid: myasthenia | gravis |
ghrelin agonist ( | grln, partial) |
dna minor | groove binder |
her-2 inhibitor (human epidermal | growth) |
igf-1 inhibitor (insulin-like | growth factor) |
tgf-b2 inhibitor (transforming | growth factor) |
ngf agonist (nerve | growth factor) |
hgf inhibitor (hepatocyte | growth factor) |
egfr inhibitor (epidermal | growth factor) |
nerve | growth factor activator |
tgf-b1 inhibitor (transforming | growth factor, alk5 dependent) |
nerve | growth factor inhibitor |
fibroblast | growth factor inhibitor (fgf) |
platelet-derived | growth factor inhibitor (pdgf) |
| growth hormone inhibitor (secretagogue) |
| growth hormone stimulant |
plant | growth inhibitor |
prostate | growth inhibitor |
grass | growth inhibitor |
animal | growth promoter |
| growth regulator |
plant | growth regulator |
insect | growth regulator |
turf | growth regulator (grass) |
plant | growth stimulant |
hsp-78d inhibitor ( | grp-78 glucose regulated protein) |
| gs inhibitor (glutamine synthase ec 6.3.1.2) |
| gsh synthase inducer (glutathione) |
glycogen synthase kinase-a inhibitor ( | gsk-3a) |
glycogen synthase kinase-3-beta inhibitor ( | gsk-3beta) |
glutathione-s-transferase inducer ( | gst) |
glutathione-s-transferase inhibitor ( | gst, ec 2.5.1.18) |
guanosine triphosphatase inhibitor ( | gtp-ase) |
rac-1 inhibitor (rho- | gtp-ase) |
tgt inhibitor (t-rna | guanine transglycolase) |
gmp | guanosine monophosphate synthase inhibitor |
| guanosine triphosphatase inhibitor (gtp-ase) |
| guanyl cyclase activator (ec 4.6.1.2) |
| guanyl cyclase inhibitor (ec 4.6.1.2) |
gp iib/iiia inhibitor ( | gycoprotein) |
bacterial | gyrase inhibitor |
dna | gyrase inhibitor |
| h1 histamine agonist |
| h1 histamine antagonist |
| h1 histamine binder |
prostaglandin | h2 antagonist |
| h2 histamine agonist |
| h2 histamine antagonist |
| h2s donor (hydrogen sulfide releasing) |
| h3 histamine agonist |
| h3 histamine antagonist/inverse agonist |
| h3 histamine binder |
| h4 histamine agonist |
| h4 histamine antagonist |
| h4 histamine ligand |
na-h5n1 inhibitor (neuramidase | h5n1) |
na- | h5n1 inhibitor (neuramidase h5n1) |
anti-bacterial (streptococcus | haemolyticus gram+) |
anti-bacterial ( | haemophilus influenzae gram-) |
anti-alopecia ( | hair restorer) |
| half-life in animal/plasma |
anti- | hallucinogen |
psychodysleptic ( | hallucinogenic) |
activation by | halogen bonding |
chcr-1 inhibitor (chinese | hamster carbonyl reductase) |
leprosy treatment ( | hansen's disease) |
sclerosing agent ( | hardening) |
histone acetyltransferase inhibitor ( | hat) |
| hbsag inhibitor (hepatitis-b surface antigen) |
| hbvp inhibitor (hepatitis-b viral polymerase) |
| hcn-1 blocker (hyperpolarization-activated cyclic nucleoside-gated) |
| hcn-2 blocker (hyperpolarization-activated cyclic nucleoside-gated) |
anti-viral (bvdv, | hcp) |
anti-neoplastic ( | hct colon) |
anti-viral (hepatitis c, | hcv) |
hepatitis c protease inhibitor ( | hcv) |
hepatitis c polymerase inhibitor ( | hcv) |
| hcv entry inhibitor (hepatitis-c) |
| hcv entry inhibitor (hepatitis c) |
| hcv ires inhibitor (internal ribosome entry site, hepatitis c) |
| hcv-ns3 protease inhibitor (hepatitis c) |
| hcv-ns4a inhibitor (hepatitis c) |
| hcv-ns4b inhibitor (hepatitis c) |
| hcv-ns5a inhibitor (hepatitis c) |
| hcv-ns5b rna polymerase inhibitor (hepatitis c) |
| hcv-p7 inhibitor (hepatitis c) |
histone deacetylase-1 inhibitor ( | hdac-1) |
histone deacetylase-10 inhibitor ( | hdac-10) |
histone deacetylase-11 inhibitor ( | hdac-11) |
histone deacetylase-2 inhibitor ( | hdac-2) |
histone deacetylase-3 inhibitor ( | hdac-3) |
histone deacetylase-4 inhibitor ( | hdac-4) |
histone deacetylase-5 inhibitor ( | hdac-5) |
histone deacetylase-6 inhibitor ( | hdac-6) |
histone deacetylase-7 inhibitor ( | hdac-7) |
histone deacetylase-8 inhibitor ( | hdac-8) |
histone deacetylase-9 inhibitor ( | hdac-9) |
| hdl-c high density lipoprotein elevator |
vulnerary (cicatrizant, wound | healer) |
chf (congestive | heart failure) therapy |
positive chronotropic (increase | heart rate) |
negative chronotropic (decrease | heart rate) |
hsp-90 inhibitor ( | heat shock protein) |
hsp-70 inhibitor ( | heat shock protein) |
hsp-27 inhibitor ( | heat shock protein) |
nek2/ | hec1 inhibitor |
| hedgehog signaling antagonist (hh, smo) |
anti-neoplastic ( | hela cervical uterine endometrial) |
viral | helicase inhibitor |
rna | helicase inhibitor |
dna | helicase inhibitor |
anti-bacterial ( | helicobacter pylori gram-) |
anthelmintic (anti- | helmintic) |
th17 inhibitor (t-cell | helper) |
crth-2 antagonist (t- | helper-2 cells) |
hematinic ( | hemaglobin promoter) |
| hematinic (hemaglobin promoter) |
| hematopoietic vitamin |
| heme oxygenase-1 inhibitor |
poison ( | hemlock) |
poison ( | hemlock water dropwort) |
allosteric | hemoglobin effector |
anti- | hemolytic |
| hemophilia therapy |
| hemorrhagenic |
capillary protectant (anti- | hemorrhagic) |
| hemostatic |
| hemozoin ligand |
anti- | heparin |
diagnostic aid: | hepatic |
anti- | hepatic disorders (liver) |
| hepatic enzyme inducer |
| hepatic glucose-6-phosphatase inhibitor |
anti-neoplastic ( | hepatic, liver) |
| hepatic steatosis treatment |
anti-viral ( | hepatitis) |
svps inhibitor (subviral particle secretion, | hepatitis-b) |
hbsag inhibitor ( | hepatitis-b surface antigen) |
bv-ca inhibitor ( | hepatitis b viral capsid assembly) |
hbvp inhibitor ( | hepatitis-b viral polymerase) |
hcv entry inhibitor ( | hepatitis-c) |
hcv-ns3 protease inhibitor ( | hepatitis c) |
hcv-ns5b rna polymerase inhibitor ( | hepatitis c) |
hcv ires inhibitor (internal ribosome entry site, | hepatitis c) |
hcv-ns4b inhibitor ( | hepatitis c) |
hcv-ns5a inhibitor ( | hepatitis c) |
hcv entry inhibitor ( | hepatitis c) |
hcv-p7 inhibitor ( | hepatitis c) |
hcv-ns4a inhibitor ( | hepatitis c) |
anti-viral ( | hepatitis c, hcv) |
| hepatitis c polymerase inhibitor (hcv) |
| hepatitis c protease inhibitor (hcv) |
| hepato-biliary regulator |
diagnostic aid: | hepatobiliary function |
eph-b3 inhibitor (erythropoietin-producing | hepatocarcinoma receptor) |
hgf inhibitor ( | hepatocyte growth factor) |
mediates uptake blood to liver ( | hepatocytes) |
| hepatoprotectant |
| hepatotherapeutic |
| hepatotoxicity |
anti- | hepatoxic |
hlda inhibitor (glycero-manno- | heptose-7-phosphate kinase) |
hlde inhibitor (glycero-manno- | heptose-7-phosphate kinase) |
| her-2 inhibitor (human epidermal growth) |
| herbicide |
| herbicide (post-emergence) |
| herbicide (pre-emergence) |
| herg channel blocker (increase qt interval, cardiac risk) |
| herg channel optimized (qt interval decreased) |
anti-viral (cmv, | herpes-2 cytomegalo) |
anti-viral ( | herpes genitalis) |
hsv-1 imaging ( | herpes simplex) |
anti-viral (hsv-1 | herpes simplex) |
dermatitis suppressant ( | herpetiformis or atopic) |
20- | hete synthase inhibitor (hydroxyeicosatetraenoic acid) |
c-myc-max | heterodimer disruptor |
human enterovirus inhibitor ( | hev-71/echo) |
| hgf inhibitor (hepatocyte growth factor) |
map4k4 inhibitor (mitogen-activated kinase, | hgk) |
hedgehog signaling antagonist ( | hh, smo) |
anti-perspirant (anti- | hidrotic) |
| hif-1 inhibitor (hypoxia inducible factor) |
hdl-c | high density lipoprotein elevator |
eps | high (extrapyramidal effect) |
p-gp efflux | high (p-glycoprotein) |
| high volume industrial chem. epa (450,000 kg/yr) |
cytochrome p680 photosynthesis inhibitor ( | hill reaction) |
treatment facial | hirsutism |
h1 | histamine agonist |
h3 | histamine agonist |
h4 | histamine agonist |
h2 | histamine agonist |
h2 | histamine antagonist |
h4 | histamine antagonist |
h1 | histamine antagonist |
h3 | histamine antagonist/inverse agonist |
h3 | histamine binder |
h1 | histamine binder |
h4 | histamine ligand |
| histamine n-methyl-transferase inhibitor |
anti- | histamine (non-sedating) |
anti- | histaminic |
| histidine decarboxylase inhibitor |
prrb-prra two-component | histidine kinase |
cd4-mhc binding inhibitor (major | histocompatability complex) |
anti-amebic (entamoeba | histolytica) |
anti-protozoal ( | histomonas) |
kat3 inhibitor ( | histone acetyltransferase) |
| histone acetyltransferase inhibitor (hat) |
| histone deacetylase-1 inhibitor (hdac-1) |
| histone deacetylase-10 inhibitor (hdac-10) |
| histone deacetylase-11 inhibitor (hdac-11) |
| histone deacetylase-2 inhibitor (hdac-2) |
| histone deacetylase-3 inhibitor (hdac-3) |
| histone deacetylase-4 inhibitor (hdac-4) |
| histone deacetylase-5 inhibitor (hdac-5) |
| histone deacetylase-6 inhibitor (hdac-6) |
| histone deacetylase-7 inhibitor (hdac-7) |
| histone deacetylase-8 inhibitor (hdac-8) |
| histone deacetylase-9 inhibitor (hdac-9) |
jmjd2 inhibitor (jumonji domain | histone demethylase) |
kdm2/7 inhibitor ( | histone lysine demethylase) |
hmt-dot1l inhibitor ( | histone methyl transferase) |
anti-viral ( | hiv) |
| hiv-1 chemokine antagonist |
| hiv-1 maturation inhibitor |
| hiv-1ca inhibitor (capsid assembly) |
anti-viral ( | hiv, attachment/ entry inhibitor) |
| hiv-gp41 inhibitor (glycoprotein) |
dormant | hiv inhibitor |
| hiv integrase inhibitor |
anti-neoplastic ( | hiv lymphoid) |
| hiv-nucleocapsid binder (nc) |
| hiv protease dimerization inhibitor |
| hiv protease inhibitor |
sl3-rna | hiv replication inhibitor |
anti-viral ( | hiv, reverse transcriptase) |
anti-viral ( | hiv, tat) |
anti-neoplastic ( | hl-60 leukemia) |
| hlda inhibitor (glycero-manno-heptose-7-phosphate kinase) |
| hlde inhibitor (glycero-manno-heptose-7-phosphate kinase) |
| hlig-i inhibitor (human dna ligase-i) |
| hmg-coa reductase inhibitor (hmgr, ec 1.1.1.34) |
hmg-coa reductase inhibitor ( | hmgr, ec 1.1.1.34) |
| hmt-dot1l inhibitor (histone methyl transferase) |
anti-neoplastic (non- | hodgkin lymphoma) |
anti-protozoal (cryptosporidium parvum/ | hominis) |
ezh-2 inhibitor (enhancer zeste | homolog) |
mechanistic | hop |
thyroid | hormone |
pineal | hormone |
lh agonist (luteinizing | hormone) |
pth-1 antagonist (parathyroid | hormone) |
fsh agonist (follicle stimulating | hormone) |
fsh antagonist (follicle stimulating | hormone) |
acth inhibitor (adrenocorticotropic | hormone) |
lhrh/gnrh antagonist (luteinizing/gonadotropin-releasing | hormone) |
thyrotropin-releasing | hormone agonist (trh) |
corticotropin-releasing | hormone antagonist |
anti-neoplastic (breast, | hormone-dependent) |
treatment of sex- | hormone disorders |
juvenile | hormone esterase inhibitor |
melanin concentrating | hormone inhibitor (mch-1) |
growth | hormone inhibitor (secretagogue) |
rorgt antagonist (nuclear | hormone receptor gamma) |
estrogenic hrt ( | hormone replacement therapy) |
| hormone sensitive lipase inhibitor (hsl) |
growth | hormone stimulant |
insecticide ( | housefly) |
4- | hppd inhibitor (hydroxyphenyl pyruvate dioxygenase) |
| hppk inhibitor (6-hydroxymethyl-7,8-dihydropetrin kinase) |
anti- | hpv (human papilloma virus) |
eif4e inhibitor (eukaryotic initiation factor, | hri) |
estrogenic | hrt (hormone replacement therapy) |
dhodh- | hs inhibitor (dihydroorate dehydrogenase-human) |
| hsc transplant enhancer (human stem cell) |
11b- | hsd-1 inhibitor (11b-hydroxysteroid dehydrogenase-1) |
17b- | hsd1 inhibitor (17b-hydroxysteroid dehydrogenase-1, ec 1.1.1.62) |
17b- | hsd2 inhibitor (17b-hydroxysteroid dehydrogenase-2) |
hormone sensitive lipase inhibitor ( | hsl) |
| hsp-27 inhibitor (heat shock protein) |
| hsp-70 inhibitor (heat shock protein) |
| hsp-78d inhibitor (grp-78 glucose regulated protein) |
| hsp-90 c-terminal inhibitor |
| hsp-90 inhibitor (heat shock protein) |
anti-viral ( | hsv-1 herpes simplex) |
anti-viral ( | hsv-1 & hsv-2) |
| hsv-1 imaging (herpes simplex) |
anti-viral (hsv-1 & | hsv-2) |
5- | ht serotonin antagonist |
5- | ht serotonin reuptake inhibitor (ssri) |
5- | ht serotonin transport inhibitor (sert) |
5- | ht serotonin uptake inhibitor |
5- | ht1-a,b,d autoreceptor antagonist |
5- | ht1a serotonin agonist |
5- | ht1a serotonin antagonist |
5- | ht1a serotonin binder |
5- | ht1b serotonin agonist |
5- | ht1b serotonin antagonist |
5- | ht1b serotonin inverse agonist |
5- | ht1bd serotonin agonist |
5- | ht1d serotonin agonist |
5- | ht1d serotonin antagonist |
5- | ht1f serotonin agonist |
5- | ht2 serotonin agonist |
5- | ht2 serotonin antagonist |
5- | ht2a serotonin agonist |
5- | ht2a serotonin antagonist |
5- | ht2b serotonin agonist |
5- | ht2b serotonin antagonist |
5- | ht2c serotonin agonist |
5- | ht2c serotonin antagonist |
5- | ht3 serotonin agonist |
5- | ht3 serotonin antagonist |
5- | ht3 serotonin ligand |
5- | ht4 serotonin agonist |
5- | ht4 serotonin antagonist |
5- | ht5a serotonin antagonist |
5- | ht6 serotonin agonist |
5- | ht6 serotonin antagonist |
5- | ht7 serotonin agonist |
5- | ht7 serotonin antagonist |
5- | htp serotonin uptake inhibitor |
cox-1 inhibitor (cyclooxygenase, | human) |
dhodh-hs inhibitor (dihydroorate dehydrogenase- | human) |
| human carcinogen (iarc) |
| human chymase inhibitor |
hlig-i inhibitor ( | human dna ligase-i) |
| human enterovirus inhibitor (hev-71/echo) |
her-2 inhibitor ( | human epidermal growth) |
| human immunoproteasome inhibitor (b1i selective) |
| human leukocyte elastase inhibitor |
| human neutrophil elastase inhibitor |
| human pancreatic elastase inhibitor |
| human pancreatic trypsin inhibitor |
anti-hpv ( | human papilloma virus) |
chimp- | human pharmacokinetics compared |
anti-viral ( | human rhinovirus) |
hsc transplant enhancer ( | human stem cell) |
telomerase inhibitor | human (trap assay) |
huratat-1 inhibitor ( | human uric acid transporter) |
| huntington disease treatment |
poly-q anti-aggregant (anti- | huntington's) |
| huratat-1 inhibitor (human uric acid transporter) |
| huvec cell inhibition |
| hyaluronidase inhibitor |
aryl | hydrocarbon hydrolase inducer |
aryl | hydrocarbon hydroxylase inhibitor (ahh) |
ahr antagonist (aryl | hydrocarbon receptor) |
ahr agonist (aryl | hydrocarbon receptor) |
sahr modulator (selective aromatic | hydrocarbon receptor) |
| hydrocholeretic (bile dilution) |
sodium- | hydrogen exchange inhibitor (nhe-1) |
| hydrogen peroxide probe |
h2s donor ( | hydrogen sulfide releasing) |
faah inhibitor (fatty acid amide | hydrolase) |
aryl hydrocarbon | hydrolase inducer |
leukotriene a4 | hydrolase inhibitor |
epoxide | hydrolase inhibitor |
fab-z inhibitor (b- | hydroxacyl-acp-dehydrase) |
20-hete synthase inhibitor ( | hydroxyeicosatetraenoic acid) |
tph-1 inhibitor (tryptophan | hydroxylase) |
phd2 inhibitor (prolyl | hydroxylase-2) |
dopamine b- | hydroxylase inhibitor |
tyrosine | hydroxylase inhibitor |
aryl hydrocarbon | hydroxylase inhibitor (ahh) |
deoxyhypusine | hydroxylase inhibitor (ec 1.14.99.29) |
kynurenine | hydroxylase inhibitor (ec 3.7.1.3) |
hppk inhibitor (6- | hydroxymethyl-7,8-dihydropetrin kinase) |
shmt inhibitor (serine | hydroxymethyltransferase |
4-hppd inhibitor ( | hydroxyphenyl pyruvate dioxygenase) |
15-pgdh inhibitor (15- | hydroxyprostaglandin dehydrogenase) |
11b-hsd-1 inhibitor (11b- | hydroxysteroid dehydrogenase-1) |
17b-hsd1 inhibitor (17b- | hydroxysteroid dehydrogenase-1, ec 1.1.1.62) |
17b-hsd2 inhibitor (17b- | hydroxysteroid dehydrogenase-2) |
larvicide ( | hylemya platura, seed corn borer) |
anti-adhd (attention deficit | hyperactivity disorder) |
apo-induced | hyperactivity inhibitor |
anti- | hypercholesterolemic |
| hyperglycemic (pro-diabetic) |
anti- | hyperlipidemic (hypolipidemic dyslipidemic) |
anti- | hyperlipoproteinemic |
anti- | hyperpigmentation |
bph treatment (benign prostatic | hyperplasia) |
hcn-1 blocker ( | hyperpolarization-activated cyclic nucleoside-gated) |
hcn-2 blocker ( | hyperpolarization-activated cyclic nucleoside-gated) |
keratolytic (suppreses keratinocyte | hyperproliferation) |
anti- | hypertensive |
| hypertensive (pulmonary) |
anti- | hypertensive (pulmonary, pah) |
anti- | hyperthyroid |
anti-prostatic | hypertrophy |
cardiac | hypertrophy treatment |
| hypnotic |
| hypoammoniuric (anti-ammoniuric) |
| hypocalciuric |
| hypocholesterolemic |
| hypoglycemic |
| hypoglycemic (oral) |
anti-hyperlipidemic ( | hypolipidemic dyslipidemic) |
| hyponatremia treatment (low sodium) |
pituitary inhibitor ( | hypophysis) |
ophthalmic | hypotensive |
vasoconstrictor (vasopressor, anti- | hypotensive) |
anti-pyretic | hypothermic (anti-febric) |
cytotoxic ( | hypoxia-activated) |
| hypoxia activated prodrug |
| hypoxia imaging |
hif-1 inhibitor ( | hypoxia inducible factor) |
anti- | hypoxic (anti-anoxic) |
imidazoline-2 ligand ( | i2) |
prostaglandin | i2 agonist |
prostaglandin | i2 antagonist |
bir2 selective (second baculovirus | iap repeat) |
human carcinogen ( | iarc) |
| ibat inhibitor (ileal bile acid transporter) |
| ibd treatment (irritable bowel disease) crohn's |
| icmt inhibitor (isoprenylcysteine carboxyl transferase) |
| ics (inhaled corticosteroid) |
| ide inhibitor (insulin-degrading enzyme) |
ipf treatment ( | ideopathic pulmonary fibrosis) |
| idh-1 inhibitor (isocitrate dehydrogenase) |
| ido inhibitor (indolamine-2,3-deoxygenase, ec 1.13.11.52) |
| idp inhibitor (inhibitor differentiation protein) |
| igf-1 inhibitor (insulin-like growth factor) |
| iglu-a2 modulator (ionotropic glutamate) |
| iglur-5 binder (ionotropic glutamate-5) |
glutamate carboxypeptidase ii inhibitor (gcp- | ii) |
angiotensin | ii agonist |
urotensin | ii antagonist |
angiotensin | ii antagonist |
angiotensin | ii binder |
arginase | ii inhibitor |
mitochondrial electron transport complex | ii inhibitor |
topoisomerase | ii inhibitor |
succinate dehydrogenase (complex | ii) inhibitor (ec 1.3.5.1) |
dehydroquinase | ii inhibitor (ec 4.2.1.10) |
fas- | ii inhibitor (fatty acid synthase) |
glutamate carboxypeptidase | ii inhibitor (gcp-ii) |
plasmepsin | ii inhibitor (malarial) |
gp | iib/iiia inhibitor (gycoprotein) |
mitochondrial electron transport complex | iii (qi) inhibitor |
aph3'- | iiia inhibitor (aminoglycoside modifying enzyme) |
gp iib/ | iiia inhibitor (gycoprotein) |
| ik/sk potassium channel modulators |
| ikca calcium activated potassium channel blocker |
| ikkb-1 inhibitor (i-kappa-kinase-beta) |
| ikkb-2 inhibitor (i-kappa kinase beta) |
| ikke inhibitor (i-kappa-kinase epsilon) |
| ikur inhibitor (potassium ion current, atrium) |
interleukin-13 blocker ( | il-13) |
interleukin-1b converting enzyme inhibitor ( | il-1b) |
interleukin-2 blocker ( | il-2) |
interleukin-5 blocker ( | il-5) |
interleukin-6 blocker ( | il-6) |
ibat inhibitor ( | ileal bile acid transporter) |
mglur1 | imager (metabotropic glutamate) |
myocardial | imaging |
beta-amyloid | imaging |
spin label | imaging |
melanoma | imaging |
hypoxia | imaging |
brain | imaging |
hsv-1 | imaging (herpes simplex) |
pet | imaging (positron emission tomography) |
cardiac pet | imaging (positron emission tomography) |
spect | imaging (single photon emission computed tomography) |
| imidazoline-2 ligand (i2) |
ir-1 ligand ( | imidazoline receptor-1) |
| imitation grape flavoring |
ccr5 antagonist (chemokine-5, | immune cell receptor) |
| immunomodulator (autoimmune therapy) |
human | immunoproteasome inhibitor (b1i selective) |
| immunostimulant |
| immunosuppressant (prevents implant rejection) |
inosine-5'-monophosphate dehydrogenase inhibitor ( | impdh) |
immunosuppressant (prevents | implant rejection) |
atp-ase inhibitor ( | incl. vacuolar, v-atp-ase) |
urinary | incontinence (dysuria, overactive bladder, oab) |
ethr inhibitor ( | incr. ethionamide action) |
circadian period | increase |
positive chronotropic ( | increase heart rate) |
herg channel blocker ( | increase qt interval, cardiac risk) |
| increased bone formation (anabolic) |
ido inhibitor ( | indolamine-2,3-deoxygenase, ec 1.13.11.52) |
ebi-2 antagonist (epstein-barr virus- | induced) |
soicr suppressor (store-overloaded- | induced calcium release) |
apo- | induced hyperactivity inhibitor |
anti-neoplastic (chemo- | induced tumors) |
hif-1 inhibitor (hypoxia | inducible factor) |
| inducible nitric oxide synthase inhibitor (inos) |
itk inhibitor (interleukin-2 | inducible t-cell kinase) |
seizure | inducing |
high volume | industrial chem. epa (450,000 kg/yr) |
treatment for myocardial | infarction or perfusion injury |
mock- | infected mt4 cell toxicity |
anti-septic (anti- | infective) |
anti- | inflammatory |
gastroprotective (gastric anti- | inflammatory) |
anti- | inflammatory (cytokine suppressing, csaid) |
anti- | inflammatory non-steroidal (nsaid) |
anti- | inflammatory (ophthalmic-topical) |
anti- | inflammatory (respiratory) |
anti- | inflammatory (topical) |
anti- | inflammatory (veterinary) |
anti-viral ( | influenza) |
anti-bacterial (haemophilus | influenzae gram-) |
perfume or fragrance | ingredient/intermediate |
analgesic ( | inhalation) |
anesthetic ( | inhalation) |
ics ( | inhaled corticosteroid) |
somatostatin antagonist (srif release- | inhibiting factor) |
tnks-1 | inhibitior (tankyrase-1) |
meallo-beta-lactamase | inhibitors |
dub | inhibitors (deubiquitinating enzymes, pan) |
mif (macrophage migration | inhibitory factor) |
| inhibits excretion of penicillin |
eif4e inhibitor (eukaryotic | initiation factor, hri) |
translation | initiation inhibitor |
anti-cns | injury |
treatment for myocardial infarction or perfusion | injury |
anti-cerebral disease/ | injury/palsy |
inducible nitric oxide synthase inhibitor ( | inos) |
| inosine-5'-monophosphate dehydrogenase inhibitor (impdh) |
| inositol monophosphatase inhibitor |
ire-1 inhibitor ( | inositol-requiring enzyme) |
ip3 | inositol triphosphate agonist |
positive | inotrope (strengthen muscle contraction) |
negative | inotrope (weakens muscle contraction) |
| insect growth regulator |
| insect neurotoxin |
| insect pheromone |
| insect repellant |
| insecticide |
| insecticide (aphid) |
| insecticide (bedbugs) |
| insecticide (cockroach) |
| insecticide (fleas) |
| insecticide (housefly) |
| insecticide (mosquito adult) |
| insecticide (mosquito larvae) |
| insecticide (potential) |
| insecticide (red mites) |
| insecticide (spodoptura eridania, southern army worm) |
| insecticide synergist |
| insecticide (systemic) |
| insecticide (thrip) |
| insecticide (turf) |
| insecticide (veterinary) |
sleep promoter (anti- | insomnia) |
anti-cerebral | insufficiency |
ide inhibitor ( | insulin-degrading enzyme) |
igf-1 inhibitor ( | insulin-like growth factor) |
| insulin mimic (modulator) |
irtk activator ( | insulin receptor tyrosine kinase) |
irap inhibitor ( | insulin-regulated aminopeptidase) |
pancreatic | insulin secretion inhibitor |
| insulin sensitizer |
| insulinotropic |
ledgf-p75 | integrase blocker (lens epithelial-cell derived) |
hiv | integrase inhibitor |
vla4 antagonist (very late antigen, eosinophil | integrin) |
| integrin antagonist |
| integrin antagonist (a4b1~a4b7) |
| integrin antagonist (a5b1) |
| integrin antagonist (a5b3) |
| integrin antagonist (aiibb3) |
| integrin antagonist (avb3) |
| integrin antagonist (avb5) |
| integrin antagonist (avb6) |
mml1-menin | interaction blocker |
fraxin/ubiquitin | interaction inhibition |
thyroid coactivator | interaction inhibitor |
eif4e/eif4g protein | interaction inhibitor |
cytochrome p450 inhibitor (drug | interaction?) |
cytochrome p450 inducer (drug | interaction?) |
dna binder (non- | intercalating) |
dna | intercaltor |
| interferon inducer |
| interleukin-13 blocker (il-13) |
| interleukin-1b converting enzyme inhibitor (il-1b) |
| interleukin-2 blocker (il-2) |
itk inhibitor ( | interleukin-2 inducible t-cell kinase) |
| interleukin-5 blocker (il-5) |
| interleukin-6 blocker (il-6) |
| interleukin-8 blocker |
irak-4 inhibitor ( | interleukin receptor associated kinase) |
perfume or fragrance ingredient/ | intermediate |
hcv ires inhibitor ( | internal ribosome entry site, hepatitis c) |
dna | interstrand cross linker |
anti-bacterial ( | intestinal) |
anti-septic ( | intestinal) |
amebicide ( | intestinal) |
anti-upper | intestinal disorders |
anti-neoplastic (gastro- | intestinal, gist) |
gastroprokinetic (gastro- | intestinal stimulant) |
| intracellular superoxide generator |
anesthetic ( | intravenous) |
ph indicator, non- | invasive |
kir potassium channel modulator ( | inwardly rectifying) |
| iodine source |
asic blocker (acid sensitive | ion channel) |
| ion channel blocker |
ikur inhibitor (potassium | ion current, atrium) |
selective | ionophore |
iglu-a2 modulator ( | ionotropic glutamate) |
iglur-5 binder ( | ionotropic glutamate-5) |
| ip3 inositol triphosphate agonist |
| ipf treatment (ideopathic pulmonary fibrosis) |
| ir-1 ligand (imidazoline receptor-1) |
| irak-4 inhibitor (interleukin receptor associated kinase) |
| irap inhibitor (insulin-regulated aminopeptidase) |
| ire-1 inhibitor (inositol-requiring enzyme) |
hcv | ires inhibitor (internal ribosome entry site, hepatitis c) |
| iron chelator (siderophore) |
endosomal/lysosomal labile | iron probe |
covalent protein modifier ( | irreversible) |
ibd treatment ( | irritable bowel disease) crohn's |
counter- | irritant |
terpine (often toxic/ | irritant) |
counter- | irritant (topical) |
| irtk activator (insulin receptor tyrosine kinase) |
| ischemic stroke treatment (cardiac/cerebral) |
| ishemia/reperfusion treatment |
idh-1 inhibitor ( | isocitrate dehydrogenase) |
ksi inhibitor (ketosteroid | isomerase) |
sterol d8d7 | isomerase binder |
peptidyl prolyl | isomerase inhibitor (fkbp) |
retinoid | isomerohydrolase inhibitor |
icmt inhibitor ( | isoprenylcysteine carboxyl transferase) |
dxr inhibitor (deoxyxylulose-phosphate reductoisomerase, | ispc) |
carcinogen cal.prop.65 or | isscan |
anti-fungal (trichophyton spp., ringworm, jock- | itch) |
| itk inhibitor (interleukin-2 inducible t-cell kinase) |
topoisomerase | iv inhibitor |
mitochondrial electron transport complex | iv inhibitor |
factor | ix-a inhibitor |
| jak-1 inhibitor (janus kinase-1) |
| jak-2 inhibitor (janus kinase-2) |
| jak-3 inhibitor (janus kinase 3) |
jak-1 inhibitor ( | janus kinase-1) |
jak-2 inhibitor ( | janus kinase-2) |
jak-3 inhibitor ( | janus kinase 3) |
| jcl inhibitor (jurkat cell lysis) |
| jmjd2 inhibitor (jumonji domain histone demethylase) |
| jnk-3 inhibitor (c-jun-n-terminal kinase) |
| jnk inhibitor (c-jun n-terminal kinase) |
anti-fungal (trichophyton spp., ringworm, | jock-itch) |
jmjd2 inhibitor ( | jumonji domain histone demethylase) |
jnk inhibitor (c- | jun n-terminal kinase) |
jnk-3 inhibitor (c- | jun-n-terminal kinase) |
gap | junction modifier |
jcl inhibitor ( | jurkat cell lysis) |
anti-neoplastic ( | jurkat leukemia) |
| juvenile hormone esterase inhibitor |
| k-secretase inhibitor |
| k2-b opioid agonist |
| k2p potassium channel modulator (twin pore) |
gluk-1 agonist (glutamate | kainate) |
gluk-1 antagonist (glutamate | kainate) |
glur-2 partial agonist (glutamate | kainate) |
| kainate agonist |
| kainate antagonist |
glur5 | kainate antagonist |
plasma | kallikrein inhibitor |
anti-bacterial (mycobacterium | kansasii gram+) |
nuclear factor | kappa b inhibitor (nf-k-b) |
ikkb-1 inhibitor (i- | kappa-kinase-beta) |
ikkb-2 inhibitor (i- | kappa kinase beta) |
ikke inhibitor (i- | kappa-kinase epsilon) |
| kappa opioid agonist (sedating) |
| kappa opioid antagonist |
analgesic ( | kappa selective) |
| kat-2 inhibitor (kynurenine aminotransferase, ec 2.6.1.7) |
| kat3 inhibitor (histone acetyltransferase) |
| kca1.1 potassium channel opener (ca and voltage gated) |
potassium channel k-7 modulator/inhibitor ( | kcnq-2) |
| kdm2/7 inhibitor (histone lysine demethylase) |
vegf-2 inhibitor (vascular endothelial g.f., | kdr, fr) |
nrf2 activator ( | keap-1 modifier) |
keratolytic (suppreses | keratinocyte hyperproliferation) |
anti-psoriatic ( | keratolytic) |
anti-pruritic ( | keratolytic) |
| keratolytic (suppreses keratinocyte hyperproliferation) |
anti-actinic | keratosis |
akr1c3 inhibitor (aldo- | keto reductase) |
fab-b/f inhibitor (b- | ketoacetyl-acp synthase 1/2) |
fab-h inhibitor (b- | ketoacetyl acp synthase-3) |
dk treatment (diabetic | ketoacidosis) |
fab-g inhibitor (b- | ketoacyl-acp-reductase) |
| ketohexokinase inhibitor |
ksi inhibitor ( | ketosteroid isomerase) |
high volume industrial chem. epa (450,000 | kg/yr) |
anti-neoplastic (renal / | kidney) |
chronic | kidney disease treatment |
polycystic | kidney disease treatment |
| kidney failure protectant |
| kif5b-ret inhibitor (kinase fusion, rearranged during transport) |
cxcr-3 chemokine ( | killer) antagonist |
prrb-prra two-component histidine | kinase |
lck sh2 inhibitor (lymphocyte-specific protein tyrosine | kinase) |
erk-1/erk-2 inhibitor (extracellular signal-regulated | kinase) |
dna-pk inhibitor (dna-dependent protein | kinase) |
alk inhibition (anaplastic lymphoma | kinase) |
flt-3 inhibitor (tyrosine | kinase) |
tyk-2 inhibitor (tyrosine | kinase) |
jnk inhibitor (c-jun n-terminal | kinase) |
tmpk inhibitor (thymidine monophosphate | kinase) |
syk inhibitor (spleen tyrosine | kinase) |
pk inhibitor (pyruvate | kinase) |
pk activator (pyruvate | kinase) |
ck1-inhibitor (casein | kinase) |
irtk activator (insulin receptor tyrosine | kinase) |
ampk activator (adenosine monophosphate activated | kinase) |
sphk-1 inhibitor (sphingosine | kinase) |
vzv-tk inhibitor (varicella-zoster thymidine | kinase) |
c-kit inhibitor (cd 117, tyrosine | kinase) |
cdk-5 inhibitor (cyclin-dependent | kinase) |
plk-1 inhibitor (polo-like | kinase) |
fak inhibitor (focal adhesion | kinase) |
mnk-1 inhibitor (mitogen-activated | kinase) |
itk inhibitor (interleukin-2 inducible t-cell | kinase) |
ask-1 inhibitor (apoptosis-regulating | kinase) |
dyrk-1a inhibitor (dual-specificity tyrosine | kinase) |
sgk-1 inhibitor (serum glucocorticoid-regulated | kinase) |
irak-4 inhibitor (interleukin receptor associated | kinase) |
clk inhibitor (cd2-like | kinase) |
cdpk-1 inhibitor (calcium-dependent protein | kinase) |
ack1 inhibitor (activated cdc42 associated | kinase) |
pak-4 inhibitor (p21-activated | kinase) |
trk-a inhibitor (tropomyosin-related | kinase) |
lrrk2 inhibitor (leucine-rich repeat | kinase) |
1heh inhibitor (nicotinamide ribose | kinase) |
pyk2 inhibitor (proline-rich tyrosine | kinase) |
perk inhibitor (endoplasmic reticulum | kinase) |
trk-b inhibitor (tropomyocin-related | kinase) |
hlda inhibitor (glycero-manno-heptose-7-phosphate | kinase) |
hlde inhibitor (glycero-manno-heptose-7-phosphate | kinase) |
ck-1a enhancer (casein | kinase) |
pkk-4 inhibitor (polo-like | kinase) |
mer-rtk inhibitor (receptor tyrosine | kinase) |
ark-5 inhibitor (ampk-related | kinase) |
pi4kiiia inhibitor (phosphatidylinositol | kinase) |
ck-1d inhibitor (casein | kinase) |
trk-b agonist (tyrosine | kinase) |
apkc modulator (atypical protein | kinase) |
sphk-2 inhibitor (sphingosine | kinase) |
dck inhibitor (deoxycytidine | kinase) |
hppk inhibitor (6-hydroxymethyl-7,8-dihydropetrin | kinase) |
jnk-3 inhibitor (c-jun-n-terminal | kinase) |
map4k2 inhibitor (mitogen-activated protein | kinase) |
ck2 inhibitor (casein | kinase) |
dlk,map3k12 inhibitor (dual leucine zippper | kinase) |
pank-3 inhibitor (pantothenate | kinase) |
pank-3 activator (pantothenate | kinase) |
pank-1b inhibitor (pantothenate | kinase) |
limk-1 inhibitor (lim | kinase) |
gak inhibitor (cyclin-g associated | kinase) |
pfbkfb3 inhibitor (metabolic | kinase) |
rock-1 inhibitor (rho | kinase-1) |
chk-1 inhibitor (checkpoint | kinase-1) |
mlk-1 inhibitor (mixed-lineage | kinase-1) |
jak-1 inhibitor (janus | kinase-1) |
cyclin-dependent | kinase-1 inhibitor (cdk1) |
mlk-2 inhibitor (mixed-lineage | kinase-2) |
rock-2 inhibitor (rho | kinase-2) |
jak-2 inhibitor (janus | kinase-2) |
chk-2 inhibitor (checkpoint | kinase-2) |
cyclin-dependent | kinase-2 inhibitor (cdk2) |
jak-3 inhibitor (janus | kinase 3) |
mlk-3 inhibitor (mixed-lineage | kinase-3) |
glycogen synthase | kinase-3-beta inhibitor (gsk-3beta) |
cyclin-dependent | kinase-4 inhibitor (cdk4) |
cdk5 inhibitor (cyclin-dependent | kinase-5) |
cenp-e inhibitor (centromere-assoc. protein-e)( | kinase-7) |
cyclin-dependent | kinase-7 inhibitor (cdk-7) |
cyclin-dependent | kinase-9 inhibitor (cdk9) |
tyrosine | kinase-a inhibitor |
glycogen synthase | kinase-a inhibitor (gsk-3a) |
protein | kinase a inhibitor (pka) |
pi-3ka inhibitor (phosphoinositide | kinase alpha) |
mnk/ar degrader (mitogen-activated | kinase & androgen receptor) |
protein | kinase b inhibitor (akt) |
protein | kinase b inhibitor (akt-1) |
protein | kinase b inhibitor (akt-2) |
protein | kinase b inhibitor (akt-3) |
ikkb-1 inhibitor (i-kappa- | kinase-beta) |
ikkb-2 inhibitor (i-kappa | kinase beta) |
pi-3kb inhibitor (phosphoinositide | kinase beta) |
btk inhibitor (bruton's tyrosine | kinase, beta cells) |
pkc-theta inhibitor (protein | kinase-c) |
protein | kinase c activator |
pkc-e inhibitor (protein | kinase-c-epsilon) |
protein | kinase c inhibitor |
pkcz inhibitor (protein | kinase-c zeta) |
protein | kinase-c1 modulator |
protein | kinase ck2 inhibitor |
protein | kinase d inhibitor |
pi-3kd inhibitor (phosphoinositide | kinase delta) |
tmk inhibitor (thymidylate | kinase, ec 2.7.4.9) |
ikke inhibitor (i-kappa- | kinase epsilon) |
kif5b-ret inhibitor ( | kinase fusion, rearranged during transport) |
protein | kinase g inhibitor |
pi-3kg inhibitor (phosphoinositide | kinase gamma) |
map4k4 inhibitor (mitogen-activated | kinase, hgk) |
c-src | kinase inhibitor |
erb-tyrosine | kinase inhibitor |
c-src tyrosine | kinase inhibitor |
aurora-b | kinase inhibitor |
cmet tyrosine | kinase inhibitor |
cdc7 | kinase inhibitor |
aurora-a | kinase inhibitor |
cfms | kinase inhibitor |
c-raf | kinase inhibitor |
pim-2 | kinase inhibitor |
ul-97 | kinase inhibitor |
bcr-abl and t315i-mutant | kinase inhibitor |
aurora-c | kinase inhibitor |
ret | kinase inhibitor |
pim-3 | kinase inhibitor |
abl protein | kinase inhibitor (bcr-abl) |
b-raf | kinase inhibitor (braf) |
diacylglycerol | kinase inhibitor (ec 2.7.1.107) |
adenosine | kinase inhibitor (ec 2.7.1.20) |
thymidine | kinase inhibitor (ec 2.7.1.21) |
pgk phosphoglycerate | kinase inhibitor (ec 2.7.2.3) |
eef2- | kinase inhibitor (eukaryotic elongation factor) |
lymphocyte-specific | kinase inhibitor (lck) |
mst-1 | kinase inhibitor (mammalian sterile-20) |
mitogen stress response | kinase inhibitor(msk-1) |
mitogen-activated protein | kinase inhibitor (p38-map) |
pyruvate dehydrogenase | kinase inhibitor (pdhk) |
pim-1 | kinase inhibitor (proto-oncogene) |
protein tyrosine | kinase inhibitor (ptk) |
protein | kinase inhibitor (rsk2) |
mitochondrial thymidine | kinase inhibitor (tk-2) |
erk-5 inhibitor (extracellular signal-regulated | kinase, mapk-7) |
dyrk-1b (dual-specificity tyrosine | kinase, mirk) |
mkp-1 inhibitor (mitogen activated protein | kinase phosphatase) |
pi-3kc inhibitor (phosphoinositide | kinase) (vps-34) |
prolificate for agc | kinases |
eg5 inhibitor (mitotic | kinesin) |
| kinesin spindle protein inhibitor (ksp) |
| kir potassium channel modulator (inwardly rectifying) |
c- | kit inhibitor (cd 117, tyrosine kinase) |
anti-bacterial ( | klebsiella pneumoniae gram-) |
| kmo inhibitor (kynurenine-3- monooxygenase)(ec1.14.13.9) |
| kmo inhibitor (kynurenine-3 oxygenase) |
| knockdown agent |
anti-fungal (candida | krusei) |
| ksi inhibitor (ketosteroid isomerase) |
kinesin spindle protein inhibitor ( | ksp) |
| kv 1.3 inhibitor |
kmo inhibitor ( | kynurenine-3- monooxygenase)(ec1.14.13.9) |
kmo inhibitor ( | kynurenine-3 oxygenase) |
kat-2 inhibitor ( | kynurenine aminotransferase, ec 2.6.1.7) |
| kynurenine hydroxylase inhibitor (ec 3.7.1.3) |
| l-type calcium channel blocker |
uch- | l1 inhibitor (ubiquitin-specific protease) |
anti-dyskinetic (giles de | la tourette's syndrome) |
endosomal/lysosomal | labile iron probe |
oxytocin antagonist (tocolytic, delays | labor) |
anti-neutropenia ( | lack of neutrophils) |
| lacrimator |
beta- | lactamase ctxm-a inhibitor |
beta | lactamase inhibitor (ec 3.5.2.6) |
meallo-beta- | lactamase inhibitors |
beta- | lactamase resistant |
pfldh inhibitor (p.falciparum | lactate dehydrogenase) |
ldh-a inhibitor ( | lactate dehydrogenase) |
| lamprey pheromone |
| lampricide |
| lanosterol-14-a-demethylase inhibitor |
mmpl-3 inhibitor (mycobacterial membrane | large) |
insecticide (mosquito | larvae) |
| larvicide |
| larvicide (colorado potato beetle) |
| larvicide (hylemya platura, seed corn borer) |
| larvicide (rice borer) |
vla4 antagonist (very | late antigen, eosinophil integrin) |
als treatment (amyotrophic | lateral sclerosis, lou gehrig's disease) |
| laxative (cathartic, prokinetic) |
elovl-6 inhibitor (fatty acid elongase-6, | lce, face) |
lymphocyte-specific kinase inhibitor ( | lck) |
| lck sh2 inhibitor (lymphocyte-specific protein tyrosine kinase) |
| ldh-a inhibitor (lactate dehydrogenase) |
| ldlr agonist (low-density lipoprotein) |
| ledgf-p75 integrase blocker (lens epithelial-cell derived) |
restless | leg treatment |
anti-protozoal ( | leishmaniasis) |
slos treatment (smith- | lemli-opitz syndrome) |
| lennox-gastaut syndrome treatment |
ledgf-p75 integrase blocker ( | lens epithelial-cell derived) |
| leprosy treatment (hansen's disease) |
| lesch-nyhan treatment |
anti-bacterial (anthrax | lethal factor inhibitor) |
aminopeptidase inhibitor (alanyl and/or | leucine) |
lrrk2 inhibitor ( | leucine-rich repeat kinase) |
dlk,map3k12 inhibitor (dual | leucine zippper kinase) |
| leucyl t-rna synthesis inhibitor |
anti-neoplastic (p388 | leukemia) |
anti-neoplastic (hl-60 | leukemia) |
anti-neoplastic (acute monocytic | leukemia) |
anti-neoplastic (jurkat | leukemia) |
anti-neoplastic (cll chronic lymphocytic | leukemia) |
apl treatment (acute promyelocytic | leukemia) |
mcl-1 inhibitor (myeloid cell | leukemia) |
anti-neoplastic (acute lymphoblastic | leukemia, all) |
anti-neoplastic (acute myelogenous | leukemia, aml) |
chronic myeloid | leukemia (cml) treatment |
anti-neoplastic ( | leukemia l-1210) |
mll inhibition (mixed lineage | leukemias) |
anti- | leukemic |
carcinogen ( | leukemic) |
anti- | leukemic (lymphoblasts) |
human | leukocyte elastase inhibitor |
lymphocyte/ | leukocyte function assoc. antigen antagonist (lfa-1) |
| leukopoietic stimulant |
| leukotriene a4 hydrolase inhibitor |
cysteinyl | leukotriene antagonist |
| leukotriene antagonist |
ltd4-lte4 | leukotriene antagonist |
ltd-4 | leukotriene antagonist |
cysteinyl | leukotriene antagonist (cys-lt1) |
| leukotriene b4 agonist |
| leukotriene b4 antagonist |
| leukotriene b4 synthesis inhibitor (ltb4) |
| leukotriene c4 antagonist |
| leukotriene d4 antagonist |
| leukotriene inhibitor |
lymphocyte/leukocyte function assoc. antigen antagonist ( | lfa-1) |
| lh agonist (luteinizing hormone) |
| lhrh/gnrh antagonist (luteinizing/gonadotropin-releasing hormone) |
pediculicide ( | lice) |
half- | life in animal/plasma |
radiodiagnostic/ | ligand |
sigma 2 | ligand |
sigma-1 | ligand |
5-ht3 serotonin | ligand |
h4 histamine | ligand |
fkbp51 | ligand |
hemozoin | ligand |
brd | ligand (bromodomain acetyl-lysine) |
cxcr7 | ligand (chemokine) |
nmda | ligand (glu-n1/2b selective) |
imidazoline-2 | ligand (i2) |
ir-1 | ligand (imidazoline receptor-1) |
npff | ligand (neuropeptide ff) |
rar-b2 | ligand (retinoic acid receptor b2) |
vacht | ligand (vesicular acetylcholine transporter) |
ddl inhibitor (d-alanine-d-alanine | ligase) |
hlig-i inhibitor (human dna | ligase-i) |
mur-d | ligase inhibitor (glutamic acid) |
non-mutagenic ( | likely) |
limk-1 inhibitor ( | lim kinase) |
| limk-1 inhibitor (lim kinase) |
mlk-1 inhibitor (mixed- | lineage kinase-1) |
mlk-2 inhibitor (mixed- | lineage kinase-2) |
mlk-3 inhibitor (mixed- | lineage kinase-3) |
mll inhibition (mixed | lineage leukemias) |
anti-bacterial (s. aureus, mrsa, methicillin & | linezolid resistant) |
o-glc-ncase inhibitor (o- | linked glucose-n-acetyl) |
xiap antagonist (x- | linked inhibitor apoptosis protein) |
dna interstrand cross | linker |
magl inhibitor (monoacylglycerol | lipase) |
dagl-a inhibitor (diacylglycerol | lipase-a) |
endothelial | lipase inhibitor |
microbial | lipase inhibitor |
pancreatic | lipase inhibitor |
hormone sensitive | lipase inhibitor (hsl) |
monoacylglycerol | lipase inhibitor (mgl) |
anti-oxidant ( | lipid) |
| lipid peroxidation inhibitor |
acc1 inhibitor (acetyl-coa-carboxylase-1, | lipid synthesis) |
| lipid synthesis inhibitor |
annexin binder ( | lipocortin) |
ldlr agonist (low-density | lipoprotein) |
| lipoprotein assembly inhibitor |
hdl-c high density | lipoprotein elevator |
| liposome potentiator |
12- | lipoxygenase inhibitor |
15- | lipoxygenase inhibitor |
5- | lipoxygenase inhibitor (flap, ec 1.13.11.12) |
toxin, | liver |
anti-neoplastic (hepatic, | liver) |
carcinogen (mouse | liver) |
anti-hepatic disorders ( | liver) |
dihydrofolate reductase inhibitor (dhrf, chicken | liver) |
dihydrofolate reductase inhibitor (dhfr, rat | liver) |
nafld treatment (non-alcoholic fatty | liver disease) |
mediates uptake blood to | liver (hepatocytes) |
anti-malarial ( | liver stage) |
lxr-a agonist ( | liver-x receptor) |
lxr-b agonist ( | liver-x receptor-b) |
| lmw-ptp inhibitor (low mw protein tyrosine phosphatase) |
anesthetic ( | local) |
anti-asthmatic ( | local) |
mineralocorticoid (na retention, k | loss) |
bone | loss inhibitor (dental) |
als treatment (amyotrophic lateral sclerosis, | lou gehrig's disease) |
ce inhibitor (carboxyl esterase, | low ache & bche) |
ldlr agonist ( | low-density lipoprotein) |
eps relatively | low (extrapyramidal effect) |
lmw-ptp inhibitor ( | low mw protein tyrosine phosphatase) |
hyponatremia treatment ( | low sodium) |
| low toxicity to mice or fibroblast cells |
| lpa-1 antagonist (lysophosphatidic acid) |
| lpx-c inhibitor (zinc-dependent acetylase) |
| lrrk2 inhibitor |
| lrrk2 inhibitor (leucine-rich repeat kinase) |
| lsd-1 inhibitor (lysine specific demethylase) |
| lsd treatment (lysosomal storage disease) |
cysteinyl leukotriene antagonist (cys- | lt1) |
leukotriene b4 synthesis inhibitor ( | ltb4) |
| ltd-4 leukotriene antagonist |
| ltd4-lte4 leukotriene antagonist |
ltd4- | lte4 leukotriene antagonist |
| luciferase inhibitor |
anti-neoplastic ( | lung non-small cell, nsclc) |
anti-neoplastic ( | lung small cell) |
sle treatment (systemic | lupus erythematous) |
lhrh/gnrh antagonist ( | luteinizing/gonadotropin-releasing hormone) |
lh agonist ( | luteinizing hormone) |
| luteolytic (corpus luteum) |
luteolytic (corpus | luteum) |
| lux-s inhibitor (s-ribosylhomocysteinase) |
| lxr-a agonist (liver-x receptor) |
| lxr-b agonist (liver-x receptor-b) |
acly inhibitor (atp-citrate | lyase) |
cbl inhibitor (cystathionine-b- | lyase) |
diagnostic aid: | lymphangiography |
anti-neoplastic (acute | lymphoblastic leukemia, all) |
anti-leukemic ( | lymphoblasts) |
| lymphocyte/leukocyte function assoc. antigen antagonist (lfa-1) |
| lymphocyte-specific kinase inhibitor (lck) |
lck sh2 inhibitor ( | lymphocyte-specific protein tyrosine kinase) |
anti-neoplastic (cll chronic | lymphocytic leukemia) |
anti-neoplastic (hiv | lymphoid) |
ptpn-22 inhibitor ( | lymphoid tyrosine phosphatase, lyp) |
anti-neoplastic (burkitt's b-cell | lymphoma) |
anti-neoplastic (non-hodgkin | lymphoma) |
anti-neoplastic (ptcl, peripheral t-cell | lymphoma) |
anti-neoplastic (mantle cell | lymphoma) |
anti-neoplastic ( | lymphoma el-4) |
alk inhibition (anaplastic | lymphoma kinase) |
ptpn-22 inhibitor (lymphoid tyrosine phosphatase, | lyp) |
mlr inhibitor (mixed | lyphocyte reaction) |
| lysergic acid antagonist |
brd ligand (bromodomain acetyl- | lysine) |
mbt antagonist (methyl- | lysine binding protein) |
kdm2/7 inhibitor (histone | lysine demethylase) |
| lysine methyl-transferase g9a inhibitor |
lsd-1 inhibitor ( | lysine specific demethylase) |
jcl inhibitor (jurkat cell | lysis) |
lpa-1 antagonist ( | lysophosphatidic acid) |
endosomal/ | lysosomal labile iron probe |
lsd treatment ( | lysosomal storage disease) |
pfa- | m1 inhibitor (malarial metalloaminopeptidase) |
| m1 muscarinic agonist |
| m1 muscarinic antagonist |
muscarinic | m2 binder |
| m2 muscarinic agonist |
| m2 muscarinic antagonist |
| m2 muscarinic antagonist (cardioselective) |
| m3 muscarinic agonist |
| m3 muscarinic antagonist |
| m4 muscarinic agonist |
| m4 muscarinic antagonist |
| m5 muscarinic antagonist |
| mach4 agonist (muscarinic-4 acetylcholine) |
muscarinic-3 acetylcholine antagonist ( | machr-3) |
fms inhibitor ( | macrophage colony-stimulating factor, csf-1, ron) |
mif ( | macrophage migration inhibitory factor) |
anti-amd (age related | macular degeneration) |
| magl inhibitor (monoacylglycerol lipase) |
anti-viral (polio t1 | maheney) |
tranquilizer ( | major) |
cd4-mhc binding inhibitor ( | major histocompatability complex) |
| malaria prophylactic |
anti- | malarial |
plasmepsin-1 inhibitor ( | malarial) |
plasmepsin ii inhibitor ( | malarial) |
anti- | malarial (liver stage) |
pfa-m1 inhibitor ( | malarial metalloaminopeptidase) |
| malate dehydrogenase inhibitor (ec 1.1.1.37) |
reproductive toxicity (ca prop. 65, | male) |
contraceptive ( | male) |
fab-d inhibitor ( | malonyl co-a acyl carrier) |
mcd inhibitor ( | malonyl-coa decarboxylase, ec 4.1.1.9) |
mtor c1/c2 inhibitor ( | mamalian target of rapamycin) |
amcase inhibitor (acidic | mammalian chitinase, ec 3.2.1.14) |
mst-1 kinase inhibitor ( | mammalian sterile-20) |
mtor inhibitor ( | mammalian target of rapamycin) |
maspin inducer ( | mammary serine protease) |
bipolar treatment ( | manic depression) |
pancreatic cell | manipulator |
hlda inhibitor (glycero- | manno-heptose-7-phosphate kinase) |
hlde inhibitor (glycero- | manno-heptose-7-phosphate kinase) |
anti-neoplastic ( | mantle cell lymphoma) |
| mao-a inhibitor (monamine oxidase) |
| mao-b inhibitor (monamine oxidase, ec 1.4.3.4) |
| mao inhibitor (ec 1.4.3.4) |
mitogen-activated protein kinase inhibitor (p38- | map) |
dlk, | map3k12 inhibitor (dual leucine zippper kinase) |
| map4k2 inhibitor (mitogen-activated protein kinase) |
| map4k4 inhibitor (mitogen-activated kinase, hgk) |
erk-5 inhibitor (extracellular signal-regulated kinase, | mapk-7) |
anti-filovirus ebola/ | marburg |
alkaloid-like ( | marine/animal) |
| marine toxin/metabolite (algal/sponge/fish) |
mrg-x1 antagonist ( | mas-related genes) |
bitter flavor | masker |
| maspin inducer (mammary serine protease) |
fto inhibitor (fatty | mass & obesity assoc. protein) |
| mast cell activation inhibitor |
cyclical | mastalgia treatment |
| matriptase-2 inhibitor |
| matriptase inhibitor |
mmp-1 inhibitor ( | matrix metalloproteinase-1) |
mmp-10 inhibitor ( | matrix metalloproteinase-10) |
mmp-11 inhibitor ( | matrix metalloproteinase-11) |
mmp-12 inhibitor ( | matrix metalloproteinase-12) |
mmp-13 inhibitor ( | matrix metalloproteinase-13) |
mmp-14 inhibitor ( | matrix metalloproteinase-14) |
mmp-15 inhibitor ( | matrix metalloproteinase-15) |
mmp-16 inhibitor ( | matrix metalloproteinase-16) |
mmp-17 inhibitor ( | matrix metalloproteinase-17) |
mmp-2 inhibitor ( | matrix metalloproteinase-2, gelatinase-a) |
mmp-20 inhibitor ( | matrix metalloproteinase-20) |
mmp-26 inhibitor ( | matrix metalloproteinase-26) |
mmp-3 inhibitor ( | matrix metalloproteinase-3) |
mmp-7 inhibitor ( | matrix metalloproteinase-7) |
mmp-8 inhibitor ( | matrix metalloproteinase-8) |
mmp-9 inhibitor ( | matrix metalloproteinase-9, gelatinase-b) |
hiv-1 | maturation inhibitor |
c-myc- | max heterodimer disruptor |
anti-neoplastic | mb (medulloblastoma) |
| mbt antagonist (methyl-lysine binding protein) |
melanocortin-4 agonist ( | mc-4) |
melanocortin-4 antagonist ( | mc-4) |
| mcd inhibitor (malonyl-coa decarboxylase, ec 4.1.1.9) |
melanin concentrating hormone inhibitor ( | mch-1) |
| mcl-1 inhibitor (myeloid cell leukemia) |
mesangial cell proliferaton inhibitor ( | mcp) |
| mct-1 blocker (monocarboxylate transporter-1) |
adam-10 inhibitor (adamalysin, | mdc) |
| mdm2-p53 disruptors |
anti-bacterial (mycobacterium tuberculosis, | mdr) |
anti-bacterial synergist ( | mdr) |
anti-neoplastic (placlitaxel/ | mdr resistant) |
multi-drug resistance inhibitor/extruder ( | mdr1, mrp1) |
| mds treatment (myelodisplastic syndrome) |
mglur7 antagonist ( | meabotropic glutamate) |
mglur4 agonist ( | meabotropic glutamate) |
| meallo-beta-lactamase inhibitors |
anti-viral | measles (paramyxovirus) |
| mechanistic hop |
fimh antagonist (fimbrae- | mediated bacterial adhesion) |
| mediates uptake blood to liver (hepatocytes) |
anti-neoplastic mb ( | medulloblastoma) |
| mek1/2 inhibitor |
| melanin concentrating hormone inhibitor (mch-1) |
depigmentor ( | melanine synthesis inhibitor) |
| melanocortin-1 antagonist |
| melanocortin-4 agonist (mc-4) |
| melanocortin-4 antagonist (mc-4) |
anti-neoplastic ( | melanoma) |
| melanoma imaging |
trpm8 antagonist (transient receptor potential | melastatin) |
| melatonin-1 agonist (mt-1) |
| melatonin-1 antagonist (mt-1) |
| melatonin-2 agonist (mt-2) |
| melatonin-2 antagonist (mt-2) |
| melatonin-4 agonist |
| melatonin binder |
prostate specific | membrane antigen inhibitor (psma) |
carbonic anhydrase-9 inhibitor ( | membrane-assoc., ec 4.2.1.1) |
pgp overexpression inhibitor (plasma | membrane glycoprotein) |
mmpl-3 inhibitor (mycobacterial | membrane large) |
| memory enhancer |
| meniere's disease treatment |
mml1- | menin interaction blocker |
anti-bacterial (neisseria | meningitidis gram-) |
anti- | menopause |
anti-fungal (trichophyton | mentagrophytes) |
psychotropic ( | mental modifier) |
| mer-rtk inhibitor (receptor tyrosine kinase) |
| mesangial cell proliferaton inhibitor (mcp) |
anti-neoplastic (pleural | mesothelioma) |
pfbkfb3 inhibitor ( | metabolic kinase) |
| metabolic syndrome treatment |
elimination rate ( | metabolism excretion) |
drug | metabolism inhibitor |
active | metabolite |
anti- | metabolite |
significant | metabolite |
marine toxin/ | metabolite (algal/sponge/fish) |
mglur1 imager ( | metabotropic glutamate) |
mglur5 agonist ( | metabotropic glutamate) |
mglur2 agonist ( | metabotropic glutamate) |
mglur3 agonist ( | metabotropic glutamate) |
mglur5 antagonist ( | metabotropic glutamate) |
mglur1 antagonist competitive ( | metabotropic glutamate) |
mglur3 antagonist ( | metabotropic glutamate) |
mglur2 modulator ( | metabotropic glutamate) |
mglur agonist ( | metabotropic glutamate receptor) |
mglur antagonist ( | metabotropic glutamate receptor) |
p2y-11 receptor agonist (purine | metabromic) |
| metacestocide (tape worm) |
| metal chelator |
pfa-m1 inhibitor (malarial | metalloaminopeptidase) |
| metalloelastase inhibitor |
metap inhibitor (e. coli | metalloproteinase) |
mmp-1 inhibitor (matrix | metalloproteinase-1) |
mmp-10 inhibitor (matrix | metalloproteinase-10) |
mmp-11 inhibitor (matrix | metalloproteinase-11) |
mmp-12 inhibitor (matrix | metalloproteinase-12) |
mmp-13 inhibitor (matrix | metalloproteinase-13) |
mmp-14 inhibitor (matrix | metalloproteinase-14) |
mmp-15 inhibitor (matrix | metalloproteinase-15) |
mmp-16 inhibitor (matrix | metalloproteinase-16) |
mmp-17 inhibitor (matrix | metalloproteinase-17) |
mmp-2 inhibitor (matrix | metalloproteinase-2, gelatinase-a) |
mmp-20 inhibitor (matrix | metalloproteinase-20) |
mmp-26 inhibitor (matrix | metalloproteinase-26) |
mmp-3 inhibitor (matrix | metalloproteinase-3) |
mmp-7 inhibitor (matrix | metalloproteinase-7) |
mmp-8 inhibitor (matrix | metalloproteinase-8) |
mmp-9 inhibitor (matrix | metalloproteinase-9, gelatinase-b) |
| metallothionein synthesis inhibitor |
| metap-1 inhibitor (methionine aminopeptidase) |
| metap-2 inhibitor (methionine aminopeptidase) |
| metap inhibitor (e. coli metalloproteinase) |
| metastasis inhibitor |
anti-addictive (cocaine, opiates, | methamphetamine, etc.) |
antidote glycol | methanol poisoning |
anti- | methemoglobinemic |
anti-bacterial (s. aureus, mrsa, | methicillin & linezolid resistant) |
metap-2 inhibitor ( | methionine aminopeptidase) |
metap-1 inhibitor ( | methionine aminopeptidase) |
| methionine antagonist |
| methionyl t-rna synthetase inhibitor |
| methuosis inducer (cell death) |
nmda agonist (n- | methyl-d-aspartate) |
nmda blocker (n- | methyl-d-aspartate) |
nmda antagonist (n- | methyl-d-aspartate) |
nmda antagonist (n- | methyl-d-aspartate, competitive) |
mbt antagonist ( | methyl-lysine binding protein) |
prmt-1 inhibitor (protein arginine | methyl-transferase) |
hmt-dot1l inhibitor (histone | methyl transferase) |
comt inhibitor (catechol-o- | methyl-transferase, ec 2.1.1.6) |
lysine | methyl-transferase g9a inhibitor |
histamine n- | methyl-transferase inhibitor |
phenylethanolamine | methyl-transferase inhibitor (pnmt, ec 2.1.1.28) |
pme-1 inhibitor (protein phosphatase | methylesterase) |
mgmt inhibitor ( | methylguanine-dna methyltransferase) |
dnmt inhibitor (dna | methyltransferase) |
prmt-3 inhibitor (protein | methyltransferase) |
trmd inhibitor (t-rna-n1-g37 | methyltransferase) |
mgmt inhibitor (methylguanine-dna | methyltransferase) |
monoacylglycerol lipase inhibitor ( | mgl) |
| mglur agonist (metabotropic glutamate receptor) |
| mglur antagonist (metabotropic glutamate receptor) |
| mglur1 antagonist competitive (metabotropic glutamate) |
| mglur1 imager (metabotropic glutamate) |
| mglur2 agonist (metabotropic glutamate) |
| mglur2 modulator (metabotropic glutamate) |
| mglur3 agonist (metabotropic glutamate) |
| mglur3 antagonist (metabotropic glutamate) |
| mglur4 agonist (meabotropic glutamate) |
| mglur5 agonist (metabotropic glutamate) |
| mglur5 antagonist (metabotropic glutamate) |
| mglur7 antagonist (meabotropic glutamate) |
| mgmt inhibitor (methylguanine-dna methyltransferase) |
cd4- | mhc binding inhibitor (major histocompatability complex) |
low toxicity to | mice or fibroblast cells |
mptp-b inhibitor ( | microbacterium tyrosine phosphatase) |
anti- | microbial |
| microbial lipase inhibitor |
anti- | microbial topical |
anti- | microbial (veterinary) |
anti-bacterial ( | micrococcus aureus gram+) |
mpges-1 inhibitor ( | microsomal prostaglandin e2 synthase) |
| microsomal triglyceride transfer protein (mtp) inhibitor |
anti-fungal ( | microsporum canis) |
| microtox super-active |
| microtox tested (toxicity) |
| microtubule destabilizer |
| microtubule stabilizer (binder, tubulin inhibitor) |
| mif (macrophage migration inhibitory factor) |
anti- | migrane |
neutrophil | migration blocker |
mif (macrophage | migration inhibitory factor) |
anti-fungal (barley | mildew) |
anti-fungal (powdery | mildew) |
oxygen | mimetic |
beta turn | mimetic |
gaba | mimetic (gamma amino butyric acid) |
smac activator | mimetic (second mitochondria activator caspases) |
insulin | mimic (modulator) |
no attenuated | mimic (nitric oxide) |
| mineralocorticoid (aldosterone) antagonist |
| mineralocorticoid (na retention, k loss) |
tranquilizer ( | minor) |
dna | minor groove binder |
| miotic (pupil contraction) |
dyrk-1b (dual-specificity tyrosine kinase, | mirk) |
anti-prion (tse, cjd, scrapie, | misfolded protein) |
acaricide (ticks | mites) |
insecticide (red | mites) |
smac activator mimetic (second | mitochondria activator caspases) |
| mitochondria stabilizer |
acc2 inhibitor (acetyl coa carboxylase-2, | mitochondrial) |
| mitochondrial dye |
| mitochondrial electron transport complex i inhibitor |
| mitochondrial electron transport complex ii inhibitor |
| mitochondrial electron transport complex iii (qi) inhibitor |
| mitochondrial electron transport complex iv inhibitor |
mptp inhibitor ( | mitochondrial permeability transition pore) |
| mitochondrial thymidine kinase inhibitor (tk-2) |
| mitochondrial toxicant |
mnk-1 inhibitor ( | mitogen-activated kinase) |
mnk/ar degrader ( | mitogen-activated kinase & androgen receptor) |
map4k4 inhibitor ( | mitogen-activated kinase, hgk) |
map4k2 inhibitor ( | mitogen-activated protein kinase) |
| mitogen-activated protein kinase inhibitor (p38-map) |
mkp-1 inhibitor ( | mitogen activated protein kinase phosphatase) |
| mitogen stress response kinase inhibitor(msk-1) |
| mitogenic (mitosis) |
mitogenic ( | mitosis) |
| mitotic catastrophant |
eg5 inhibitor ( | mitotic kinesin) |
anti- | mitotic (suppresses cell division) |
mlk-1 inhibitor ( | mixed-lineage kinase-1) |
mlk-2 inhibitor ( | mixed-lineage kinase-2) |
mlk-3 inhibitor ( | mixed-lineage kinase-3) |
mll inhibition ( | mixed lineage leukemias) |
mlr inhibitor ( | mixed lyphocyte reaction) |
| mkp-1 inhibitor (mitogen activated protein kinase phosphatase) |
| mlk-1 inhibitor (mixed-lineage kinase-1) |
| mlk-2 inhibitor (mixed-lineage kinase-2) |
| mlk-3 inhibitor (mixed-lineage kinase-3) |
| mll inhibition (mixed lineage leukemias) |
| mlr inhibitor (mixed lyphocyte reaction) |
| mml1-menin interaction blocker |
| mmp-1 inhibitor (matrix metalloproteinase-1) |
| mmp-10 inhibitor (matrix metalloproteinase-10) |
| mmp-11 inhibitor (matrix metalloproteinase-11) |
| mmp-12 inhibitor (matrix metalloproteinase-12) |
| mmp-13 inhibitor (matrix metalloproteinase-13) |
| mmp-14 inhibitor (matrix metalloproteinase-14) |
| mmp-15 inhibitor (matrix metalloproteinase-15) |
| mmp-16 inhibitor (matrix metalloproteinase-16) |
| mmp-17 inhibitor (matrix metalloproteinase-17) |
| mmp-2 inhibitor (matrix metalloproteinase-2, gelatinase-a) |
| mmp-20 inhibitor (matrix metalloproteinase-20) |
| mmp-26 inhibitor (matrix metalloproteinase-26) |
| mmp-3 inhibitor (matrix metalloproteinase-3) |
| mmp-7 inhibitor (matrix metalloproteinase-7) |
| mmp-8 inhibitor (matrix metalloproteinase-8) |
| mmp-9 inhibitor (matrix metalloproteinase-9, gelatinase-b) |
| mmpl-3 inhibitor (mycobacterial membrane large) |
| mnk-1 inhibitor (mitogen-activated kinase) |
| mnk/ar degrader (mitogen-activated kinase & androgen receptor) |
blood stem cell | mobilization agent |
| mock-infected mt4 cell toxicity |
aph3'-iiia inhibitor (aminoglycoside | modifying enzyme) |
ik/sk potassium channel | modulators |
vcam-1 inhibitor (vascular cell adhesion | molecule) |
| moleuclar tong |
| molluscicide |
| molluscicide (biomphalaria glabrata) |
mao-a inhibitor ( | monamine oxidase) |
mao-b inhibitor ( | monamine oxidase, ec 1.4.3.4) |
cognition dysfunction | monitor |
magl inhibitor ( | monoacylglycerol lipase) |
| monoacylglycerol lipase inhibitor (mgl) |
vmat-2 inhibitor (vesicular | monoamine transporter) |
mct-1 blocker ( | monocarboxylate transporter-1) |
anti-neoplastic (acute | monocytic leukemia) |
kmo inhibitor (kynurenine-3- | monooxygenase)(ec1.14.13.9) |
inositol | monophosphatase inhibitor |
ampk activator (adenosine | monophosphate activated kinase) |
adenosine | monophosphate deaminase (ampda, ec 3.5.4.6) |
odcase inhibitor (orotidine 5'- | monophosphate decarboxylase, ec 4.1.1.23) |
inosine-5'- | monophosphate dehydrogenase inhibitor (impdh) |
tmpk inhibitor (thymidine | monophosphate kinase) |
gmp guanosine | monophosphate synthase inhibitor |
mps-1 inhibitor ( | monopolar spindle, ttk) |
| mood regulator |
mu opioid agonist ( | mor-1 6tm/e11) |
anti-bacterial ( | moraxella catarrhalis gram-) |
| morphine antagonist |
bmp-2 stimulator (bone | morphogenic protein) |
bmp-6 inhibitor (bone | morphogenic protein) |
insecticide ( | mosquito adult) |
insecticide ( | mosquito larvae) |
| motilin agonist |
| motilin antagonist |
carcinogen (rat, | mouse) |
carcinogen ( | mouse liver) |
anti-xerostomia (dry | mouth) |
| mpges-1 inhibitor (microsomal prostaglandin e2 synthase) |
| mpo inhibitor (myeloperoxidase, ec 1.11.2.2) |
parkinsonism inducer (as | mpp+) |
| mps-1 inhibitor (monopolar spindle, ttk) |
| mptp-b inhibitor (microbacterium tyrosine phosphatase) |
| mptp inhibitor (mitochondrial permeability transition pore) |
| mrg-x1 antagonist (mas-related genes) |
| mri probe |
multi-drug resistance inhibitor/extruder (mdr1, | mrp1) |
anti-bacterial (s. aureus, | mrsa, methicillin & linezolid resistant) |
| ms (multiple sclerosis) treatment |
mitogen stress response kinase inhibitor( | msk-1) |
| mst-1 kinase inhibitor (mammalian sterile-20) |
melatonin-1 agonist ( | mt-1) |
melatonin-1 antagonist ( | mt-1) |
melatonin-2 antagonist ( | mt-2) |
melatonin-2 agonist ( | mt-2) |
mock-infected | mt4 cell toxicity |
sah- | mta nucleosidase inhibitor |
| mtor activator |
| mtor c1/c2 inhibitor (mamalian target of rapamycin) |
| mtor inhibitor (mammalian target of rapamycin) |
microsomal triglyceride transfer protein ( | mtp) inhibitor |
calpain | mu (i) inhibitor |
| mu opioid agonist |
| mu opioid agonist (mor-1 6tm/e11) |
| mu opioid antagonist |
| mu opioid binder |
| mucolytic |
| mucosal protectant |
| multi-drug resistance inhibitor/extruder (mdr1, mrp1) |
anti-neoplastic ( | multiple myeloma) |
ms ( | multiple sclerosis) treatment |
| mur-a inhibitor (bacterial transferase) |
| mur-b inhibitor (udp-ep-glu-nac reductase) |
| mur-d ligase inhibitor (glutamic acid) |
glutamate racemase ( | muri) |
| muscarinic |
| muscarinic-3 acetylcholine antagonist (machr-3) |
mach4 agonist ( | muscarinic-4 acetylcholine) |
| muscarinic acetylcholine-5 agonist (achr-5) |
m3 | muscarinic agonist |
m4 | muscarinic agonist |
m1 | muscarinic agonist |
m2 | muscarinic agonist |
| muscarinic agonist |
m4 | muscarinic antagonist |
m5 | muscarinic antagonist |
m1 | muscarinic antagonist |
| muscarinic antagonist |
m2 | muscarinic antagonist |
m3 | muscarinic antagonist |
m2 | muscarinic antagonist (cardioselective) |
| muscarinic m2 binder |
| muscle atrophy treatment |
smooth | muscle contractant |
negative inotrope (weakens | muscle contraction) |
positive inotrope (strengthen | muscle contraction) |
skeletal | muscle relaxant |
| muscle relaxant |
smooth | muscle relaxant |
| muscle relaxant (short duration) |
| muscle relaxant (veterinary) |
uterotonic (uterus | muscle tone) |
treatment for | muscular dystrophy |
| musk odorant |
sulfur | mustard degredation product |
| mutagen (ames test carcinogen suspect) |
ames test negative (non- | mutagenic) |
non- | mutagenic (likely) |
anti-bacterial (streptococcus | mutans gram+) |
bcr-abl and t315i- | mutant kinase inhibitor |
| mutant sod-1 anti-aggregant (superoxide dismutase) |
gene repair of nonsense | mutation damage |
lmw-ptp inhibitor (low | mw protein tyrosine phosphatase) |
diagnostic aid: | myasthenia gravis |
anti- | myasthenic |
c- | myc-max heterodimer disruptor |
anti-bacterial ( | mycobacteria) |
mmpl-3 inhibitor ( | mycobacterial membrane large) |
anti-bacterial ( | mycobacterium avium gram+) |
anti-bacterial ( | mycobacterium kansasii gram+) |
anti-bacterial ( | mycobacterium tuberculosis) |
anti-bacterial ( | mycobacterium tuberculosis, mdr) |
anti-fungal (anti- | mycotic) |
| mycotoxin |
| myd-88 inhibitor (myeloid differentiation protein) |
| mydriatic (dilates pupils) |
mds treatment ( | myelodisplastic syndrome) |
| myelofibrosis treatment |
anti-neoplastic (myeloma | myelogenous) |
anti-neoplastic (acute | myelogenous leukemia, aml) |
mcl-1 inhibitor ( | myeloid cell leukemia) |
myd-88 inhibitor ( | myeloid differentiation protein) |
chronic | myeloid leukemia (cml) treatment |
anti-neoplastic (multiple | myeloma) |
anti-neoplastic ( | myeloma myelogenous) |
mpo inhibitor ( | myeloperoxidase, ec 1.11.2.2) |
| myocardial imaging |
treatment for | myocardial infarction or perfusion injury |
anabolic ( | myotrophic) |
n- | myristoyl transferase inhibitor (nmt) |
| n-acetyl-aspartyl-glutamate peptidase inhibitor (naag) |
| n-myristoyl transferase inhibitor (nmt) |
| n-type voltage gated calcium channel blocker (vgcc, vdcc) |
glu- | n1/2a nmda receptor inhibitor |
nmda ligand (glu- | n1/2b selective) |
trmd inhibitor (t-rna- | n1-g37 methyltransferase) |
| na-h5n1 inhibitor (neuramidase h5n1) |
neuraminidase | na inhibitor |
mineralocorticoid ( | na retention, k loss) |
saluretic ( | na+, cl- excretion) |
| naaa inhibitor (n-acylethanolamine acid amidase) |
n-acetyl-aspartyl-glutamate peptidase inhibitor ( | naag) |
neuropeptidase | naaladase inhibitor |
mur-b inhibitor (udp-ep-glu- | nac reductase) |
nicotinic acetylcholine agonist ( | nachr) |
nicotinic acetylcholine antagonist ( | nachr) |
nicotinic-acetylcholine binder, partial agonist ( | nachr) |
nicotinic acetylcholine inhibitor ( | nachr-7) |
nicotinic acetylcholine-7 agonist ( | nachr-7) |
nicotinic acetylcholine antagonist ( | nachr-a2b2) |
nicotinic acetylcholine agonist ( | nachr a3/b2) |
nicotinic acetylcholine a3b4 antagonist ( | nachr a3b4) |
nicotinic acetylcholine partial agonist ( | nachr-a4/b2) |
| nad glycohydrase inhibitor |
| nad glycohydrolase inhibitor |
nqo2 inhibitor ( | nad quinone oxidoreductase, ec 1.10.99.2) |
nqo1 inhibitor ( | nad quinone oxidoreductase, ec 1.6.99.2) |
| nad synthetase inhibitor (nicotinamide adenine dinucleotide) |
nox-1 inhibitor ( | nadph oxidase-1) |
nox-4 inhibitor ( | nadph oxidase-4) |
| nafld treatment (non-alcoholic fatty liver disease) |
allosteric inhibitor ( | nam) |
| nampt inhibitor (nicotinamide phosphororibosyltransferase) |
anti- | narcoleptic (eugeroic) |
| narcotic |
anti-addictive ( | narcotic antagonist) |
anti-addictive (alcohol/ | narcotic antagonist) |
anti-addictive (alcohol/ | narcotic aversion therapy) |
| narcotic (short acting) |
vasodilator ( | nasal) |
| nasal decongestant |
anti-neoplastic ( | nasopharynx) |
| natriuretic (sodium excretion) |
triterpene | natural product |
anti-emetic (anti- | nauseant) |
sodium channel | nav1.3 modulator |
sodium channel | nav1.4 blocker |
sodium channel | nav1.7 modulator |
sodium channel | nav1.8 modulator |
hiv-nucleocapsid binder ( | nc) |
o-glc- | ncase inhibitor (o-linked glucose-n-acetyl) |
anti-neoplastic (active over | nci cell panel) |
| ncx reverse inhibitor (sodium/calcium) |
| ndri inhibitor (norepinephrine dopamine reuptake) |
| necroptosis inducer |
| necroptosis inhibitor |
tumor | necrosis factor blocker (tnf-a, tace, adam-17) |
tnbc treatment (triple- | negative breast cancer) |
| negative chronotropic (decrease heart rate) |
| negative inotrope (weakens muscle contraction) |
ames test | negative (non-mutagenic) |
anti-bacterial ( | neisseria meningitidis gram-) |
| nek2/hec1 inhibitor |
| nematocide |
anthelmintic ( | nematode) |
anti-fungal (cryptoformans | neoformans) |
anti- | neoplastic |
anti- | neoplastic (active over nci cell panel) |
anti- | neoplastic (acute lymphoblastic leukemia, all) |
anti- | neoplastic (acute monocytic leukemia) |
anti- | neoplastic (acute myelogenous leukemia, aml) |
anti- | neoplastic (adenocarcinoma) |
anti- | neoplastic (adjuvant) |
anti- | neoplastic (anti-cd-3) |
anti- | neoplastic (ascites abdominal) |
anti- | neoplastic (bladder) |
anti- | neoplastic (brain cerebral) |
anti- | neoplastic (breast) |
anti- | neoplastic (breast, hormone-dependent) |
anti- | neoplastic (burkitt's b-cell lymphoma) |
anti- | neoplastic (chemo-induced tumors) |
anti- | neoplastic (cll chronic lymphocytic leukemia) |
anti- | neoplastic (cns, neuroblastoma) |
anti- | neoplastic (colorectal) |
anti- | neoplastic (epidermal) |
anti- | neoplastic (erythroleukemia) |
anti- | neoplastic (esophagus) |
anti- | neoplastic (fibrosarcoma) |
anti- | neoplastic (gastro-intestinal, gist) |
anti- | neoplastic (glioma) |
anti- | neoplastic (hct colon) |
anti- | neoplastic (hela cervical uterine endometrial) |
anti- | neoplastic (hepatic, liver) |
anti- | neoplastic (hiv lymphoid) |
anti- | neoplastic (hl-60 leukemia) |
anti- | neoplastic (jurkat leukemia) |
anti- | neoplastic (l-5178) |
anti- | neoplastic (leukemia l-1210) |
anti- | neoplastic (lung non-small cell, nsclc) |
anti- | neoplastic (lung small cell) |
anti- | neoplastic (lymphoma el-4) |
anti- | neoplastic (mantle cell lymphoma) |
anti- | neoplastic mb (medulloblastoma) |
anti- | neoplastic (melanoma) |
anti- | neoplastic (multiple myeloma) |
anti- | neoplastic (myeloma myelogenous) |
anti- | neoplastic (nasopharynx) |
anti- | neoplastic (non-hodgkin lymphoma) |
anti- | neoplastic (osteosarcoma, bone) |
anti- | neoplastic (ovarian) |
anti- | neoplastic (ovarian a2780r) |
anti- | neoplastic (p388 leukemia) |
anti- | neoplastic (pancreatic) |
anti- | neoplastic, peritoneal |
anti- | neoplastic (placlitaxel/mdr resistant) |
anti- | neoplastic (plasmocytoma) |
anti- | neoplastic (pleural mesothelioma) |
anti- | neoplastic (potentiator) |
anti- | neoplastic (prostate) |
anti- | neoplastic (ptcl, peripheral t-cell lymphoma) |
anti- | neoplastic (renal / kidney) |
anti- | neoplastic (sarcoma 180) |
anti- | neoplastic (skin basal cell bcc) |
anti- | neoplastic (solid tumors) |
anti- | neoplastic (squamous) |
anti- | neoplastic (taxane refractory) |
anti- | neoplastic (teratocarcinoma) |
anti- | neoplastic (testicular) |
anti- | neoplastic (thyroid) |
anti- | neoplastic (topical) |
anti- | neoplastic (walker 256) |
anti- | nephritic |
| nerve gas prophylactic |
organophosphate | nerve gas reactivator (ache, bche) |
ngf agonist ( | nerve growth factor) |
| nerve growth factor activator |
| nerve growth factor inhibitor |
noradrenaline/norepinephrine transport inhibitor ( | net) |
anesthetic ( | neuralgia) |
anti- | neuralgic |
na-h5n1 inhibitor ( | neuramidase h5n1) |
| neuraminidase na inhibitor |
anti- | neuritic |
| neuritogenic |
anti-neoplastic (cns, | neuroblastoma) |
nft binder ( | neurofibriallary tangle) |
| neurogenic |
| neuroinflammation treatment |
nk2 | neurokinin agonist |
nk1 | neurokinin antagonist |
nk4 | neurokinin antagonist |
nk2 | neurokinin antagonist |
nk3 | neurokinin antagonist |
anti-psychotic ( | neuroleptic) |
nmur-2 agonist ( | neuromedin) |
nmur-1 agonist ( | neuromedin) |
| neuromedin b antagonist |
| neuromodulator |
| neuromuscular blocker |
| neuromuscular toxicant |
| neuronal nitric oxide synthase inhibitor (nnos) |
anti-diabetic | neuropathy |
| neuropathy target esterase inhibitor (nte) |
peripheral | neuropathy treatment |
| neuropeptidase naaladase inhibitor |
nff1-agonist ( | neuropeptide) |
nff1-antagonist ( | neuropeptide) |
nff2-antagonist ( | neuropeptide) |
npff ligand ( | neuropeptide ff) |
npsr antagonist ( | neuropeptide-s receptor) |
npy-1 antagonist ( | neuropeptide-y1) |
npy-5 antagonist ( | neuropeptide-y5) |
| neuroprotectant |
nts-2 agonist ( | neurotensin) |
| neurotensin antagonist |
cardiotoxic and/or | neurotoxic |
| neurotoxin |
insect | neurotoxin |
frog | neurotoxin |
bonta inhibitor (botulinum | neurotoxin-a) |
| neurotransmitter |
tnk-1 antagonist (tachykinin | neurotransmitter-1) |
tnk2 antagonist (tachykinin | neurotransmitter-2) |
tnk-3 antagonist (tachykinin | neurotransmitter-3) |
tnk-3 agonist (tachykinin | neurotransmitter-3) |
| neurotrophic |
anti-viral ( | neurotropic, alpha) |
nvp-3cl inhibitor ( | neurovirus peptidase) |
boron | neutron capture therapy (bnct) |
anti- | neutropenia (lack of neutrophils) |
| neutrophil activator |
human | neutrophil elastase inhibitor |
| neutrophil elastase inhibitor (ec 3.4.21.37) |
| neutrophil migration blocker |
anti-neutropenia (lack of | neutrophils) |
nuclear factor kappa b inhibitor ( | nf-k-b) |
| nff1-agonist (neuropeptide) |
| nff1-antagonist (neuropeptide) |
| nff2-antagonist (neuropeptide) |
| nft binder (neurofibriallary tangle) |
| ngf agonist (nerve growth factor) |
sodium-hydrogen exchange inhibitor ( | nhe-1) |
gpcr-109a agonist (g-protein coupled, | niacin-109a) |
| niacin-109a receptor agonist |
nad synthetase inhibitor ( | nicotinamide adenine dinucleotide) |
nampt inhibitor ( | nicotinamide phosphororibosyltransferase) |
1heh inhibitor ( | nicotinamide ribose kinase) |
anti-addictive ( | nicotine, smoking cessation) |
| nicotinic a4b2 agonist |
| nicotinic acetylcholine-7 agonist (nachr-7) |
| nicotinic acetylcholine a3b4 antagonist (nachr a3b4) |
| nicotinic acetylcholine agonist (nachr) |
| nicotinic acetylcholine agonist (nachr a3/b2) |
| nicotinic acetylcholine antagonist (nachr) |
| nicotinic acetylcholine antagonist (nachr-a2b2) |
| nicotinic-acetylcholine binder, partial agonist (nachr) |
| nicotinic acetylcholine inhibitor (nachr-7) |
| nicotinic acetylcholine partial agonist (nachr-a4/b2) |
| nicotinic antagonist |
anti-fungal (aspergillus | niger) |
anti-viral (west | nile) |
anti-viral (flavivirus, dengue, west | nile) |
no attenuated mimic ( | nitric oxide) |
| nitric oxide donor |
| nitric oxide scavenger |
inducible | nitric oxide synthase inhibitor (inos) |
neuronal | nitric oxide synthase inhibitor (nnos) |
| nitric oxide synthase inhibitor (nos, ec 1.14.13.39) |
| nitrification inhibitor |
| nitrification inhibitor (soil) |
activated by ddn (deazaflavin-dependent | nitroreductase) |
| nitroxyl donor |
| nk1 neurokinin antagonist |
| nk2 neurokinin agonist |
| nk2 neurokinin antagonist |
| nk3 neurokinin antagonist |
| nk4 neurokinin antagonist |
| nmda agonist (n-methyl-d-aspartate) |
| nmda antagonist (n-methyl-d-aspartate) |
| nmda antagonist (n-methyl-d-aspartate, competitive) |
| nmda antagonist (nr2a/b selective) |
| nmda antagonist (nr2c/d selective) |
| nmda blocker (n-methyl-d-aspartate) |
psd-95/ | nmda inhibitor |
| nmda ligand (glu-n1/2b selective) |
glu-n1/2a | nmda receptor inhibitor |
n-myristoyl transferase inhibitor ( | nmt) |
| nmur-1 agonist (neuromedin) |
| nmur-2 agonist (neuromedin) |
neuronal nitric oxide synthase inhibitor ( | nnos) |
| nociceptin nop agonist |
| nociceptin nop antagonist |
analgesic (anti- | nociceptive) |
nafld treatment ( | non-alcoholic fatty liver disease) |
autophagy inducer ( | non-apoptosis) |
anti-neoplastic ( | non-hodgkin lymphoma) |
dna binder ( | non-intercalating) |
ph indicator, | non-invasive |
ames test negative ( | non-mutagenic) |
| non-mutagenic (likely) |
| non-nutritive sweetener |
blood-brain | non-penetrant (relatively bbb-) |
renin inhibitor ( | non-peptide) |
anti-bacterial (tuberculosis,dormant, | non-replicating) |
anxiolytic ( | non-sedating) |
anti-histamine ( | non-sedating) |
anti-neoplastic (lung | non-small cell, nsclc) |
synergist ( | non-specific) |
anti-inflammatory | non-steroidal (nsaid) |
gene repair of | nonsense mutation damage |
| nootropic (cerebral stimulant) |
nociceptin | nop agonist |
nociceptin | nop antagonist |
| nop binder (opiate-like) |
| noradrenaline/norepinephrine transport inhibitor (net) |
| noradrenergic-a2 |
triple reuptake inhibitor (serotonin, | norepinephrine, dopamine) |
ndri inhibitor ( | norepinephrine dopamine reuptake) |
| norepinephrine reuptake inhibitor (nri) |
serotonin- | norepinephrine reuptake inhibitor (snri) |
noradrenaline/ | norepinephrine transport inhibitor (net) |
nitric oxide synthase inhibitor ( | nos, ec 1.14.13.39) |
nps inhibitor ( | notch protein signaling) |
| notch sparing |
| nox-1 inhibitor (nadph oxidase-1) |
| nox-4 inhibitor (nadph oxidase-4) |
| npff ligand (neuropeptide ff) |
| npp-1 inhibitor (nucleotide pyrophosphate/phosphodiesterase-1) |
| nps inhibitor (notch protein signaling) |
| npsr antagonist (neuropeptide-s receptor) |
| npy-1 antagonist (neuropeptide-y1) |
| npy-5 antagonist (neuropeptide-y5) |
| nqo1 inhibitor (nad quinone oxidoreductase, ec 1.6.99.2) |
| nqo2 inhibitor (nad quinone oxidoreductase, ec 1.10.99.2) |
nmda antagonist ( | nr2a/b selective) |
nmda antagonist ( | nr2c/d selective) |
| nrf-2 activator (nuclear factor erythroid) |
| nrf2 activator (keap-1 modifier) |
norepinephrine reuptake inhibitor ( | nri) |
dengue 2 | ns2b protease inhibitor |
hcv- | ns3 protease inhibitor (hepatitis c) |
hcv- | ns4a inhibitor (hepatitis c) |
hcv- | ns4b inhibitor (hepatitis c) |
hcv- | ns5a inhibitor (hepatitis c) |
hcv- | ns5b rna polymerase inhibitor (hepatitis c) |
anti-inflammatory non-steroidal ( | nsaid) |
anti-neoplastic (lung non-small cell, | nsclc) |
neuropathy target esterase inhibitor ( | nte) |
| nts-2 agonist (neurotensin) |
nrf-2 activator ( | nuclear factor erythroid) |
| nuclear factor kappa b inhibitor (nf-k-b) |
rorgt antagonist ( | nuclear hormone receptor gamma) |
hiv- | nucleocapsid binder (nc) |
sah-mta | nucleosidase inhibitor |
p2x4 antagonist (purine | nucleoside) |
hcn-1 blocker (hyperpolarization-activated cyclic | nucleoside-gated) |
hcn-2 blocker (hyperpolarization-activated cyclic | nucleoside-gated) |
purine | nucleoside phosphorylase inhibitor (pnp, ec 2.4.2.1) |
| nucleoside transport inhibitor |
p2y12 antagonist (purine, | nucleotide) |
p2y-2 agonist (purine, | nucleotide) |
p2y-4 agonist (purine, | nucleotide) |
p2y-6 agonist (purine, | nucleotide) |
p2y1 agonist (purine, | nucleotide) |
cng antagonist (cyclic | nucleotide-gated channel) |
npp-1 inhibitor ( | nucleotide pyrophosphate/phosphodiesterase-1) |
| nutrient |
| nutrition aid: vitamin b deficiency |
| nutritional factor |
non- | nutritive sweetener |
| nvp-3cl inhibitor (neurovirus peptidase) |
lesch- | nyhan treatment |
| nystagmus inhibitor |
| o-glc-ncase inhibitor (o-linked glucose-n-acetyl) |
o-glc-ncase inhibitor ( | o-linked glucose-n-acetyl) |
urinary incontinence (dysuria, overactive bladder, | oab) |
| oatp1-b1 inhibitor (organic anion transporting polypeptide) |
| oatp1-b3 inhibitor (organic anion transporting polypeptide) |
| oatp2-b1 inhibitor (organic anion transporting polypeptide) |
anti- | obesity |
fto inhibitor (fatty mass & | obesity assoc. protein) |
ocpd treatment ( | obsessive compulsive personality) |
diagnostic aid: | obstetrics |
anti-copd (chronic | obstructive pulmonary disease) |
anti- | occlusion peripheral arteries |
| ocpd treatment (obsessive compulsive personality) |
| octopamine agonist |
| odcase inhibitor (orotidine 5'-monophosphate decarboxylase, ec 4.1.1.23) |
musk | odorant |
terpine ( | often toxic/irritant) |
pep/pop inhibitor (prolylendopeptidase/prolyl | oligopeptidase) |
prep inhibitor (prolyl | oligopeptidase, ec 3.4.21.26) |
pim-1 kinase inhibitor (proto- | oncogene) |
anti-cholinergic ( | ophthalmic) |
anesthetic ( | ophthalmic) |
anti-viral ( | ophthalmic) |
anti-bacterial ( | ophthalmic) |
| ophthalmic adrenergic |
| ophthalmic (anti-oxidant) |
| ophthalmic cholinergic |
| ophthalmic hypotensive |
anti-inflammatory ( | ophthalmic-topical) |
| opiate |
nop binder ( | opiate-like) |
anti-addictive (cocaine, | opiates, methamphetamine, etc.) |
dcx-1 | opioid agonist |
dcx-2 | opioid agonist |
k2-b | opioid agonist |
delta | opioid agonist |
mu | opioid agonist |
mu | opioid agonist (mor-1 6tm/e11) |
kappa | opioid agonist (sedating) |
mu | opioid antagonist |
delta | opioid antagonist |
kappa | opioid antagonist |
| opioid antagonist |
mu | opioid binder |
| opioid-like antagonist (orli-1) |
slos treatment (smith-lemli- | opitz syndrome) |
p-gp efflux | optimized (p-glycoprotein) |
herg channel | optimized (qt interval decreased) |
appetite stimulant ( | orexigenic) |
ox-1 antagonist ( | orexin-1) |
ox-2 antagonist ( | orexin-2) |
oatp1-b1 inhibitor ( | organic anion transporting polypeptide) |
oatp1-b3 inhibitor ( | organic anion transporting polypeptide) |
oatp2-b1 inhibitor ( | organic anion transporting polypeptide) |
| organophosphate nerve gas reactivator (ache, bche) |
opioid-like antagonist ( | orli-1) |
| ornithine decarboxylase inhibitor (ec 4.1.1.17) |
odcase inhibitor ( | orotidine 5'-monophosphate decarboxylase, ec 4.1.1.23) |
anti-viral | orthopox (vaccinia/cow, smallpox) |
anti-fungal (pyricularia | oryzae) |
fop (fibrodysplasia | ossificans progressiva) |
| osteoarthritis treatment |
bone resorption ( | osteoclast) inhibitor |
anti- | osteomylitic |
anti- | osteoporitic |
anti-neoplastic ( | osteosarcoma, bone) |
yoph inhibitor (yersinia | outer protein phosphatase) |
anti-neoplastic ( | ovarian) |
anti-neoplastic ( | ovarian a2780r) |
| ovarian e2 secretion inhibitor |
| ovarian inhibitor (worker bees) |
anti-neoplastic (active | over nci cell panel) |
urinary incontinence (dysuria, | overactive bladder, oab) |
pgp | overexpression inhibitor (plasma membrane glycoprotein) |
soicr suppressor (store- | overloaded-induced calcium release) |
| ovulation inhibitor |
| ovulation stimulant |
| ox-1 antagonist (orexin-1) |
| ox-2 antagonist (orexin-2) |
anti- | oxidant |
ophthalmic (anti- | oxidant) |
anti- | oxidant (animal feed) |
anti- | oxidant (food) |
anti- | oxidant (lipid) |
mao-a inhibitor (monamine | oxidase) |
nox-1 inhibitor (nadph | oxidase-1) |
nox-4 inhibitor (nadph | oxidase-4) |
mao-b inhibitor (monamine | oxidase, ec 1.4.3.4) |
ssao inhibitor (semicarbazide-sensitive amino | oxidase, ec 1.4.3.6) |
xanthine | oxidase inhibitor |
protoporphyrinogen | oxidase inhibitor |
d-amino acid | oxidase inhibitor(daao) |
| oxidative phosphorylation uncoupler |
no attenuated mimic (nitric | oxide) |
nitric | oxide donor |
nitric | oxide scavenger |
allene | oxide synthase inhibitor (cyp-74) |
inducible nitric | oxide synthase inhibitor (inos) |
neuronal nitric | oxide synthase inhibitor (nnos) |
nitric | oxide synthase inhibitor (nos, ec 1.14.13.39) |
nqo2 inhibitor (nad quinone | oxidoreductase, ec 1.10.99.2) |
nqo1 inhibitor (nad quinone | oxidoreductase, ec 1.6.99.2) |
2,3- | oxidosqualene cyclase inhibitor (ec 5.4.99.7) |
| oxygen mimetic |
kmo inhibitor (kynurenine-3 | oxygenase) |
heme | oxygenase-1 inhibitor |
anti-fungal (fusarium | oxysporum) |
abortifacient | oxytocic |
| oxytocin agonist |
| oxytocin antagonist (tocolytic, delays labor) |
| p-cab (potassium-competitive acid blocker) |
p-gp efflux high ( | p-glycoprotein) |
p-gp efflux optimized ( | p-glycoprotein) |
| p-glycoprotein inhibitor (p-gp) |
p-glycoprotein inhibitor ( | p-gp) |
| p-gp efflux high (p-glycoprotein) |
| p-gp efflux optimized (p-glycoprotein) |
pfldh inhibitor ( | p.falciparum lactate dehydrogenase) |
purinergic | p2 antagonist |
pak-4 inhibitor ( | p21-activated kinase) |
| p2x2 antagonist (purinergic) |
purinergic antagonist ( | p2x3) |
| p2x4 antagonist (purine nucleoside) |
purinergic | p2x7 antagonist |
| p2y-11 receptor agonist (purine metabromic) |
| p2y-2 agonist (purine, nucleotide) |
| p2y-4 agonist (purine, nucleotide) |
| p2y-6 agonist (purine, nucleotide) |
| p2y1 agonist (purine, nucleotide) |
| p2y1 platelet antagonist |
| p2y12 antagonist (purine, nucleotide) |
mitogen-activated protein kinase inhibitor ( | p38-map) |
anti-neoplastic ( | p388 leukemia) |
cytochrome | p450 inducer (drug interaction?) |
cytochrome | p450 inducer (ethoxyresorufin o-deethylase) |
cytochrome | p450 inhibitor (cyp-11b1, corticosterone synthase) |
cytochrome | p450 inhibitor (cyp-11b2, aldosterone synthase) |
cytochrome | p450 inhibitor (cyp-17) |
cytochrome | p450 inhibitor (cyp-1a1) |
cytochrome | p450 inhibitor (cyp-26a) |
cytochrome | p450 inhibitor (cyp-2c8) |
cytochrome | p450 inhibitor (cyp-2c9) |
cytochrome | p450 inhibitor (cyp-2d6) |
cytochrome | p450 inhibitor (cyp-2d6 or cyp-2c19) |
cytochrome | p450 inhibitor (cyp-3a4, grapefruit effect) |
cytochrome | p450 inhibitor (cyp-51) |
cytochrome | p450 inhibitor (cyp1b1)(pah activator) |
cytochrome | p450 inhibitor (cyp2w1) |
cytochrome | p450 inhibitor (drug interaction?) |
amyloidosis treatment (ttr, sodi, or | p53) |
mdm2- | p53 disruptors |
cytochrome | p680 photosynthesis inhibitor (hill reaction) |
hcv- | p7 inhibitor (hepatitis c) |
ledgf- | p75 integrase blocker (lens epithelial-cell derived) |
| p97 inhibitor (vcp, valosine containing protein) |
| pad inhibitor (protein arginine deaminase) |
platelet anti-aggregant ( | paf) |
| paf receptor binder |
anti- | paget's disease |
anti-hypertensive (pulmonary, | pah) |
cytochrome p450 inhibitor (cyp1b1)( | pah activator) |
anti-fouling | paint |
| pak-4 inhibitor (p21-activated kinase) |
cpt-1a inhibitor (carnitine | palmitoyl transferase) |
cpt-1a activator (carnitine | palmitoyl transferase) |
anti-cerebral disease/injury/ | palsy |
| pam (positive allosteric modifier) |
dub inhibitors (deubiquitinating enzymes, | pan) |
| pan-selectin antagonist (p-selectin) |
dpb treatment (diffuse | panbronchiolitis) |
diagnostic aid: | pancreas |
anti-neoplastic ( | pancreatic) |
| pancreatic cell manipulator |
human | pancreatic elastase inhibitor |
| pancreatic insulin secretion inhibitor |
| pancreatic lipase inhibitor |
human | pancreatic trypsin inhibitor |
anti-neoplastic (active over nci cell | panel) |
| pank-1b inhibitor (pantothenate kinase) |
| pank-3 activator (pantothenate kinase) |
| pank-3 inhibitor (pantothenate kinase) |
pank-3 inhibitor ( | pantothenate kinase) |
pank-3 activator ( | pantothenate kinase) |
pank-1b inhibitor ( | pantothenate kinase) |
| pantothenate synthase inhibitor |
anti-hpv (human | papilloma virus) |
| par-1 antagonist (protease-activated receptor) |
| par-2 agonist (protease-activated receptor) |
| par-2 agonist (proteinase activated receptor) |
| par-2 antagonist (protease-activated receptor) |
anti-viral measles ( | paramyxovirus) |
anti-fungal (candida | parapsilosis) |
anti- | parasitic |
anti-fungal (anti- | parasitic, fish) |
anti- | parasitic (topical) |
| parasiticide |
| parasiticide (veterinary) |
| parasympathomimetic |
pth-1 antagonist ( | parathyroid hormone) |
| parg inhibitor (poly-adp-ribose glycohydrolase) |
anti- | parkinsonian |
| parkinsonism inducer (as mpp+) |
poly adp-ribose polymerase-1 inhibitor ( | parp-1, ec 2.4.2.30) |
poly adp-ribose polymerase-2 inhibitor ( | parp-2) |
poly adp ribose polymerase-3 inhibitor ( | parp-3) |
svps inhibitor (subviral | particle secretion, hepatitis-b) |
anti-protozoal (cryptosporidium | parvum/ hominis) |
polyamine transport inhibitor ( | pat) |
treatment of eskape | pathogens |
| pbp2a inhibitor (penicillin-binding protein) |
bz3 benzodiazepine agonist peripheral ( | pbr) |
bz2 benzodiazepine antagonist peripheral ( | pbr) |
| pc (pharmacological chaperone) |
bacterial apoptosis promoter ( | pcd) |
| pcft inhibitor (proton-coupled folate transporter) |
phencyclidine antagonist ( | pcp) |
phencyclidine binding ( | pcp) |
| pde-b1/2 inhibitor (phosphodiesterase) |
| pde-delta inhibitor (phosphodiesterase) |
| pde inhibitor (phosphodiesterase, ec 3.1.4) |
| pde10a inhibitor (phosphodiesterase) |
| pde11 inhibitor (phosphodiesterase) |
| pde2 inhibitor (phosphodiesterase) |
| pde3 inhibitor (phosphodiesterase) |
| pde4a inhibitor (phosphodiesterase) |
| pde4b inhibitor (phosphodiesterase) |
| pde4c inhibitor (phosphodiesterase) |
| pde4d inhibitor (phosphodiesterase) |
| pde5 inhibitor (phosphodiesterase) |
| pde6 inhibitor (phosphodiesterase) |
| pde7 inhibitor (phosphodiesterase) |
| pde9 inhibitor (phosphodiesterase) |
platelet-derived growth factor inhibitor ( | pdgf) |
pyruvate dehydrogenase kinase inhibitor ( | pdhk) |
| pe treatment (premature ejaculation) |
| pediculicide (lice) |
anti-fungal (fonsecaea | pedrosoi) |
blood-brain | penetrant activated |
blood-brain non- | penetrant (relatively bbb-) |
blood-brain | penetrant (relatively bbb+) |
inhibits excretion of | penicillin |
| penicillin adjuvant |
pbp2a inhibitor ( | penicillin-binding protein) |
| penicillin & cephalosporin precursor |
anti-bacterial ( | penicillin-resistant streptococcus pneumoniae, prsp) |
| pep/pop inhibitor (prolylendopeptidase/prolyl oligopeptidase) |
phosphoenolpyruvate carboxykinase inhibitor ( | pepck) |
nvp-3cl inhibitor (neurovirus | peptidase) |
dpp2 inhibitor (dipeptidyl | peptidase-2) |
tripeptidyl | peptidase 2 inhibitor |
dipeptidyl | peptidase 3 inhibitor |
dpp4 inhibitor (dipeptidyl | peptidase 4, ec 3.4.14.5) |
dpp-8 inhibitor (dipeptidyl | peptidase-8) |
ddp-9 inhibitor (dipeptidyl | peptidase-9) |
spase-1 inhibitor (signal | peptidase bacterial) |
| peptidase inhibitor |
n-acetyl-aspartyl-glutamate | peptidase inhibitor (naag) |
cgrp antagonist (calcitonin gene-related | peptide) |
glp-1 agonist (glucagon-like | peptide) |
renin inhibitor (non- | peptide) |
| peptide deformylase inhibitor |
beta-amyloid | peptide polymerization/aggregation inhibitor |
| peptidoleukotriene antagonist |
| peptidyl prolyl isomerase inhibitor (fkbp) |
| peptidyl transferase inhibitor |
cpp inhibitor (cytolytic protein | performin) |
| perfume fixative |
| perfume or fragrance ingredient/intermediate |
treatment for myocardial infarction or | perfusion injury |
circadian | period decrease |
circadian | period increase |
vasodilator ( | peripheral) |
dopaminergic ( | peripheral) |
anti-occlusion | peripheral arteries |
| peripheral neuropathy treatment |
bz3 benzodiazepine agonist | peripheral (pbr) |
bz2 benzodiazepine antagonist | peripheral (pbr) |
anti-neoplastic (ptcl, | peripheral t-cell lymphoma) |
anti- | peristaltic |
anti-neoplastic, | peritoneal |
| perk inhibitor (endoplasmic reticulum kinase) |
mptp inhibitor (mitochondrial | permeability transition pore) |
lipid | peroxidation inhibitor |
hydrogen | peroxide probe |
ppar-g activator ( | peroxisome proliferator) |
ppar-d activator ( | peroxisome proliferator) |
ppar-b activator ( | peroxisome proliferator) |
ppar-g partial agonist ( | peroxisome proliferator) |
ppar-a antagonist ( | peroxisome proliferator) |
ppar-g antagonist ( | peroxisome proliferator) |
ppar b/d inverse agonist ( | peroxisome proliferator) |
ppar b/d partial agonist ( | peroxisome proliferator) |
ppar-a activator ( | peroxisome proliferator) |
ocpd treatment (obsessive compulsive | personality) |
anti- | perspirant (anti-hidrotic) |
diaphoretic ( | perspiration) |
anti-bacterial (yersinia | pestis) |
| pet imaging (positron emission tomography) |
cardiac | pet imaging (positron emission tomography) |
dhodh- | pf inhibitor (dihydroorotate dehydrogenase-falciparum) |
| pfa-m1 inhibitor (malarial metalloaminopeptidase) |
| pfbkfb3 inhibitor (metabolic kinase) |
| pfkasiii inhibitor (fatty acid synthase) |
| pfldh inhibitor (p.falciparum lactate dehydrogenase) |
prostaglandin dp antagonist ( | pgd2) |
15- | pgdh inhibitor (15-hydroxyprostaglandin dehydrogenase) |
6- | pgdh inhibitor (6-phosphogluconate dehydrogenase) |
| pgf2a allosteric modulator (prostaglandin-f2a) |
| pgk phosphoglycerate kinase inhibitor (ec 2.7.2.3) |
| pgp overexpression inhibitor (plasma membrane glycoprotein) |
| ph indicator, non-invasive |
| phagocytosis stimulant |
chimp-human | pharmacokinetics compared |
pc ( | pharmacological chaperone) |
cell arrest at g2/m | phase |
| phd2 inhibitor (prolyl hydroxylase-2) |
| phencyclidine antagonist (pcp) |
| phencyclidine binding (pcp) |
| phenylethanolamine methyl-transferase inhibitor (pnmt, ec 2.1.1.28) |
lamprey | pheromone |
insect | pheromone |
lmw-ptp inhibitor (low mw protein tyrosine | phosphatase) |
mkp-1 inhibitor (mitogen activated protein kinase | phosphatase) |
cdc25a inhibitor ( | phosphatase) |
mptp-b inhibitor (microbacterium tyrosine | phosphatase) |
yoph inhibitor (yersinia outer protein | phosphatase) |
ptp-1b inhibitor (protein tyrosine | phosphatase) |
protein | phosphatase 1 inhibition (pp1) |
protein | phosphatase 2a inhibition (pp2a) |
alkaline | phosphatase inducer |
hepatic glucose-6- | phosphatase inhibitor |
cdc-25b cell division cycle | phosphatase inhibitor |
alkaline | phosphatase inhibitor (ec 3.1.3.1) |
ptpn-22 inhibitor (lymphoid tyrosine | phosphatase, lyp) |
pme-1 inhibitor (protein | phosphatase methylesterase) |
ptp-shp2 inhibitor (protein tyrosine | phosphatase-src) |
sphingosine-1- | phosphate-5 agonist (s1p-5, aequorin) |
sphingosine-1- | phosphate agonist-1 (s1p-1, b-arrestin) |
sphingosine-1- | phosphate antagonist (s1p) |
g6pd inhibitor (glucose-6- | phosphate dehydrogenase) |
cysk1 inhibitor (pyridoxal | phosphate-dependent-o-acetyl sulfhydrylase) |
gadph binder (glyceraldehyde-3- | phosphate, g3dph) |
hlda inhibitor (glycero-manno-heptose-7- | phosphate kinase) |
hlde inhibitor (glycero-manno-heptose-7- | phosphate kinase) |
sphingosine-1- | phosphate modulator |
dxr inhibitor (deoxyxylulose- | phosphate reductoisomerase, ispc) |
glucosamine-6- | phosphate synthase inhibitor |
enolpyruvateshikamate-3- | phosphate synthase inhibitor (epsps) |
pts inhibitor ( | phosphatidylcholine synthase) |
pi4kiiia inhibitor ( | phosphatidylinositol kinase) |
| phospho-stat3 inhibitor |
pde4a inhibitor ( | phosphodiesterase) |
pde6 inhibitor ( | phosphodiesterase) |
pde11 inhibitor ( | phosphodiesterase) |
pde7 inhibitor ( | phosphodiesterase) |
pde10a inhibitor ( | phosphodiesterase) |
pde2 inhibitor ( | phosphodiesterase) |
pde9 inhibitor ( | phosphodiesterase) |
pde4d inhibitor ( | phosphodiesterase) |
tdp1 inhibitor (tyrosyl-dna | phosphodiesterase) |
pde-b1/2 inhibitor ( | phosphodiesterase) |
pde4b inhibitor ( | phosphodiesterase) |
pde4c inhibitor ( | phosphodiesterase) |
pde-delta inhibitor ( | phosphodiesterase) |
pde5 inhibitor ( | phosphodiesterase) |
pde3 inhibitor ( | phosphodiesterase) |
npp-1 inhibitor (nucleotide pyrophosphate/ | phosphodiesterase-1) |
tdp2 inhibitor (tyrosyl-dna- | phosphodiesterase-2) |
pde inhibitor ( | phosphodiesterase, ec 3.1.4) |
cgmp | phosphodiesterase inhibitor |
cyclic amp | phosphodiesterase inhibitor (camp) |
| phosphoenolpyruvate carboxykinase inhibitor (pepck) |
6-pgdh inhibitor (6- | phosphogluconate dehydrogenase) |
pgk | phosphoglycerate kinase inhibitor (ec 2.7.2.3) |
pi-3ka inhibitor ( | phosphoinositide kinase alpha) |
pi-3kb inhibitor ( | phosphoinositide kinase beta) |
pi-3kd inhibitor ( | phosphoinositide kinase delta) |
pi-3kg inhibitor ( | phosphoinositide kinase gamma) |
pi-3kc inhibitor ( | phosphoinositide kinase) (vps-34) |
pld-1 inhibitor ( | phospholipase-1) |
pld2 inhibitor ( | phospholipase-2) |
| phospholipase a2 inhibitor (ec 3.1.1.4) |
| phospholipase c inhibitor |
pld inducer ( | phospholipidosis) |
ppt inhibitor ( | phosphopantetheinyl transferase) |
atp-prt inhibitor (atp | phosphoribosyl transferase) |
pyrimidine | phosphoribosyl transferase inhibitor |
nampt inhibitor (nicotinamide | phosphororibosyltransferase) |
| phosphorus source (veterinary) |
uridine | phosphorylase inhibitor |
thymidine | phosphorylase inhibitor |
glycogen | phosphorylase inhibitor (ec 2.4.1.1) |
purine nucleoside | phosphorylase inhibitor (pnp, ec 2.4.2.1) |
tau | phosphorylation inhibitor |
oxidative | phosphorylation uncoupler |
| photo-unstable |
| photoactivatable probe |
| photoaffinity label |
| photoaffinity probe |
dna | photocleaver |
| photoluminescence reduction |
spect imaging (single | photon emission computed tomography) |
| photosensitizer |
| photoswitchable |
cytochrome p680 | photosynthesis inhibitor (hill reaction) |
| photosystem-2 inhibitor |
| phytoalexin |
| phytoene desaturase inhibitor |
| pi-3ka inhibitor (phosphoinositide kinase alpha) |
| pi-3kb inhibitor (phosphoinositide kinase beta) |
| pi-3kc inhibitor (phosphoinositide kinase) (vps-34) |
| pi-3kd inhibitor (phosphoinositide kinase delta) |
| pi-3kg inhibitor (phosphoinositide kinase gamma) |
| pi4kiiia inhibitor (phosphatidylinositol kinase) |
bleaching agent ( | pigment synthesis inhibitor) |
| pigmentation agent |
xeroderma | pigmentosum-g (xpg) |
pilus chaperone blocker ( | pilicide) |
| pilus chaperone blocker (pilicide) |
| pim-1 kinase inhibitor (proto-oncogene) |
| pim-2 kinase inhibitor |
| pim-3 kinase inhibitor |
| pineal hormone |
| piscicide (fish) |
anterior | pituitary activator |
anterior | pituitary activator (swine) |
diagnostic aid: | pituitary function |
| pituitary inhibitor (hypophysis) |
anterior | pituitary suppressant |
| pk activator (pyruvate kinase) |
dna- | pk inhibitor (dna-dependent protein kinase) |
| pk inhibitor (pyruvate kinase) |
protein kinase a inhibitor ( | pka) |
| pkc-e inhibitor (protein kinase-c-epsilon) |
| pkc-theta inhibitor (protein kinase-c) |
| pkcz inhibitor (protein kinase-c zeta) |
| pkk-4 inhibitor (polo-like kinase) |
anti-neoplastic ( | placlitaxel/mdr resistant) |
| plant extract |
| plant fertility regulator |
alkaloid-like ( | plant/fungal) |
| plant growth inhibitor |
| plant growth regulator |
| plant growth stimulant |
anti- | plaque |
anti-bacterial (dental | plaque) |
half-life in animal/ | plasma |
| plasma kallikrein inhibitor |
pgp overexpression inhibitor ( | plasma membrane glycoprotein) |
| plasmepsin-1 inhibitor (malarial) |
| plasmepsin ii inhibitor (malarial) |
| plasmin inhibitor |
upa inhibitor (urokinase | plasminogen activator) |
| plasminogen activator inhibitor |
tissue | plasminogen activator (tpa) |
urokinase | plasminogen activator (upa) |
anti-neoplastic ( | plasmocytoma) |
anti- | plasmodial (berghei) |
anti- | plasmodial (chabaudi) |
anti- | plasmodial (falciparum) |
anti- | plasmodial (falciparum chloroquine resistant) |
anti- | plasmodial (plasmodium cynomolgi) |
anti- | plasmodial (veterinary) |
anti- | plasmodial (yoelii) |
anti-plasmodial ( | plasmodium cynomolgi) |
anti- | plasmodium (vivax) |
| platelet activator |
thrombogenic ( | platelet aggregant) |
p2y1 | platelet antagonist |
| platelet anti-aggregant (paf) |
| platelet-derived growth factor inhibitor (pdgf) |
larvicide (hylemya | platura, seed corn borer) |
| pld-1 inhibitor (phospholipase-1) |
| pld inducer (phospholipidosis) |
| pld2 inhibitor (phospholipase-2) |
treatment | pleural effusion |
anti-neoplastic ( | pleural mesothelioma) |
| plk-1 inhibitor (polo-like kinase) |
psc inducer ( | pluripotent stem cell) |
| pme-1 inhibitor (protein phosphatase methylesterase) |
anti- | pneumocystic carinii |
anti-bacterial (klebsiella | pneumoniae gram-) |
anti-bacterial (streptococcus | pneumoniae gram+) |
anti-bacterial (penicillin-resistant streptococcus | pneumoniae, prsp) |
phenylethanolamine methyl-transferase inhibitor ( | pnmt, ec 2.1.1.28) |
purine nucleoside phosphorylase inhibitor ( | pnp, ec 2.4.2.1) |
| poison |
castor bean | poison |
| poison (hemlock) |
| poison (hemlock water dropwort) |
| poison rhododendron |
| poison (toad/frog) |
antidote glycol methanol | poisoning |
cyanide | poisoning antidote |
arsine | poisoning antidote |
anti-viral ( | polio t1 maheney) |
plk-1 inhibitor ( | polo-like kinase) |
pkk-4 inhibitor ( | polo-like kinase) |
parg inhibitor ( | poly-adp-ribose glycohydrolase) |
| poly adp-ribose polymerase-1 inhibitor (parp-1, ec 2.4.2.30) |
| poly adp-ribose polymerase-2 inhibitor (parp-2) |
| poly adp ribose polymerase-3 inhibitor (parp-3) |
| poly d(a-t) dna binder |
| poly d(c-g) dna binder |
| poly-q anti-aggregant (anti-huntington's) |
| polyamine transport inhibitor (pat) |
| polycystic kidney disease treatment |
hbvp inhibitor (hepatitis-b viral | polymerase) |
rdp2 inhibitor (rna | polymerase) |
poly adp-ribose | polymerase-1 inhibitor (parp-1, ec 2.4.2.30) |
poly adp-ribose | polymerase-2 inhibitor (parp-2) |
poly adp ribose | polymerase-3 inhibitor (parp-3) |
dna directed rna | polymerase inhibitor |
dna | polymerase inhibitor |
hepatitis c | polymerase inhibitor (hcv) |
hcv-ns5b rna | polymerase inhibitor (hepatitis c) |
tau fibrilization inhibitor ( | polymerization, aggregation) |
beta-amyloid peptide | polymerization/aggregation inhibitor |
tubulin | polymerization inhibitor |
oatp1-b1 inhibitor (organic anion transporting | polypeptide) |
oatp1-b3 inhibitor (organic anion transporting | polypeptide) |
oatp2-b1 inhibitor (organic anion transporting | polypeptide) |
anti-diuretic ( | polyuria) |
| pompe disease treatment |
pep/ | pop inhibitor (prolylendopeptidase/prolyl oligopeptidase) |
wnt inhibition ( | porcn) |
k2p potassium channel modulator (twin | pore) |
mptp inhibitor (mitochondrial permeability transition | pore) |
carcinogenicity tested not | positive |
pam ( | positive allosteric modifier) |
| positive chronotropic (increase heart rate) |
| positive inotrope (strengthen muscle contraction) |
pet imaging ( | positron emission tomography) |
cardiac pet imaging ( | positron emission tomography) |
contraceptive ( | post-coital) |
herbicide ( | post-emergence) |
| potassium atp channel opener (sarcolemmal) |
| potassium channel blocker |
ikca calcium activated | potassium channel blocker |
| potassium channel k-7 modulator/inhibitor (kcnq-2) |
kir | potassium channel modulator (inwardly rectifying) |
k2p | potassium channel modulator (twin pore) |
ik/sk | potassium channel modulators |
| potassium channel opener |
kca1.1 | potassium channel opener (ca and voltage gated) |
p-cab ( | potassium-competitive acid blocker) |
ikur inhibitor ( | potassium ion current, atrium) |
diuretic ( | potassium-sparing) |
larvicide (colorado | potato beetle) |
insecticide ( | potential) |
trpa1 agonist (transient receptor | potential ankyrin) |
trpa1 antagonist (transient receptor | potential ankyrin) |
trpm8 antagonist (transient receptor | potential melastatin) |
anti-biotic | potentiator |
liposome | potentiator |
catacholamine | potentiator |
anti-neoplastic ( | potentiator) |
cftr | potentiator (cycstic fibrosis transmembrane conductance regulator) |
anti-viral ( | poultry) |
anti-fungal ( | powdery mildew) |
anti-viral (vzv, | pox) |
rdrp inhibitor (rna-dependent,rna- | poylmerase, ec 2.7.7.48) |
protein phosphatase 1 inhibition ( | pp1) |
protein phosphatase 2a inhibition ( | pp2a) |
| ppar-a activator (peroxisome proliferator) |
| ppar-a antagonist (peroxisome proliferator) |
| ppar-b activator (peroxisome proliferator) |
| ppar b/d inverse agonist (peroxisome proliferator) |
| ppar b/d partial agonist (peroxisome proliferator) |
| ppar-d activator (peroxisome proliferator) |
| ppar-g activator (peroxisome proliferator) |
| ppar-g antagonist (peroxisome proliferator) |
| ppar-g partial agonist (peroxisome proliferator) |
proton pump inhibitor ( | ppi) |
| ppt inhibitor (phosphopantetheinyl transferase) |
| prcp inhibitor (prolylcarboxypeptidase, ec 3.4.16.2) |
sedative ( | pre-anesthetic) |
herbicide ( | pre-emergence) |
treatment | precocious puberty |
treatment of | precocious puberty |
drug | precursor |
prostaglandin | precursor |
penicillin & cephalosporin | precursor |
coenzyme | precursor |
aromatic amino acids ( | precursor) |
| pregnane-x agonist (px) |
| pregnane-x antagonist (px) |
pe treatment ( | premature ejaculation) |
| prep inhibitor (prolyl oligopeptidase, ec 3.4.21.26) |
| preservative |
wood | preservative |
dopamine agonist (cns | presynaptic) |
cancer | preventative |
immunosuppressant ( | prevents implant rejection) |
dna | primase inhibitor |
anti- | prion (tse, cjd, scrapie, misfolded protein) |
| prmt-1 inhibitor (protein arginine methyl-transferase) |
| prmt-3 inhibitor (protein methyltransferase) |
apc inhibitor ( | pro-coagulant) |
hyperglycemic ( | pro-diabetic) |
| pro-vitamin d |
| procollagenase-c proteinase inhibitor |
| prodrug |
anti-arthritic | prodrug |
hypoxia activated | prodrug |
adept (antibody directed | prodrug therapy) |
gdept (gene directed | prodrug therapy) |
eph-b3 inhibitor (erythropoietin- | producing hepatocarcinoma receptor) |
beta-amyloid | production inhibitor |
a2e | production inhibitor |
rage inhibitor (receptor advanced glycation end | products) |
age inhibitor (advanced glycation end | products) |
stem/ | progenitor cell inhibitor |
| progeria treatment |
| progesterone antagonist |
| progesterone modulator (sprm) |
| progestin (progestogen agonist) |
| progestin (veterinary) |
progestin ( | progestogen agonist) |
| progestogen (oral) |
fop (fibrodysplasia ossificans | progressiva) |
| prohibited (regulated) drug |
laxative (cathartic, | prokinetic) |
anti- | prolactin |
| prolactin inhibitor |
t-cell | proliferation inhibitor |
anti- | proliferative |
mesangial cell | proliferaton inhibitor (mcp) |
ppar-g activator (peroxisome | proliferator) |
ppar-d activator (peroxisome | proliferator) |
ppar-b activator (peroxisome | proliferator) |
ppar-g partial agonist (peroxisome | proliferator) |
ppar-a antagonist (peroxisome | proliferator) |
ppar-g antagonist (peroxisome | proliferator) |
ppar b/d inverse agonist (peroxisome | proliferator) |
ppar b/d partial agonist (peroxisome | proliferator) |
ppar-a activator (peroxisome | proliferator) |
| prolificate for agc kinases |
pyk2 inhibitor ( | proline-rich tyrosine kinase) |
phd2 inhibitor ( | prolyl hydroxylase-2) |
peptidyl | prolyl isomerase inhibitor (fkbp) |
pep/pop inhibitor (prolylendopeptidase/ | prolyl oligopeptidase) |
prep inhibitor ( | prolyl oligopeptidase, ec 3.4.21.26) |
prcp inhibitor ( | prolylcarboxypeptidase, ec 3.4.16.2) |
pep/pop inhibitor ( | prolylendopeptidase/prolyl oligopeptidase) |
tumorogenic or tumor | promoter |
drought tolerance | promoter |
animal growth | promoter |
hematinic (hemaglobin | promoter) |
sleep | promoter (anti-insomnia) |
bacterial apoptosis | promoter (pcd) |
stomachic ( | promotes function) |
apl treatment (acute | promyelocytic leukemia) |
nerve gas | prophylactic |
malaria | prophylactic |
dental caries ( | prophylactic) |
| prostaglandin |
| prostaglandin d1 antagonist |
| prostaglandin d2 agonist |
| prostaglandin d2 antagonist |
| prostaglandin d2 synthase inhibitor |
| prostaglandin dp antagonist (pgd2) |
| prostaglandin e1 agonist |
| prostaglandin e1 antagonist |
| prostaglandin e2 agonist |
| prostaglandin e2 antagonist |
mpges-1 inhibitor (microsomal | prostaglandin e2 synthase) |
| prostaglandin e3 agonist |
| prostaglandin e3 antagonist |
| prostaglandin e4 agonist |
| prostaglandin e4 antagonist |
pgf2a allosteric modulator ( | prostaglandin-f2a) |
| prostaglandin f2a agonist |
| prostaglandin f2a antagonist |
| prostaglandin h2 antagonist |
| prostaglandin i2 agonist |
| prostaglandin i2 antagonist |
| prostaglandin precursor |
| prostaglandin synthetase inhibitor |
anti-neoplastic ( | prostate) |
crpc treatment (castration resistant | prostate cancer) |
| prostate growth inhibitor |
| prostate specific membrane antigen inhibitor (psma) |
bph treatment (benign | prostatic hyperplasia) |
anti- | prostatic hypertrophy |
pzu antagonist ( | protamine zinc uracil) |
maspin inducer (mammary serine | protease) |
usp1/uaf1 inhibitor (ubiquitin-specific | protease) |
uch-l1 inhibitor (ubiquitin-specific | protease) |
par-1 antagonist ( | protease-activated receptor) |
par-2 antagonist ( | protease-activated receptor) |
par-2 agonist ( | protease-activated receptor) |
hiv | protease dimerization inhibitor |
thiol | protease inhibitor |
chymotrypsin | protease inhibitor |
cysteine | protease inhibitor |
dengue 2 ns2b | protease inhibitor |
| protease inhibitor |
hiv | protease inhibitor |
aspartyl | protease inhibitor (bace-2) |
hepatitis c | protease inhibitor (hcv) |
hcv-ns3 | protease inhibitor (hepatitis c) |
| proteasome inhibitor |
anti-prion (tse, cjd, scrapie, misfolded | protein) |
hsp-90 inhibitor (heat shock | protein) |
bcl-2 inhibitor (anti-apoptotic | protein) |
sfrp-1 inhibitor (secreted frizzled-related | protein) |
tspo binder (translocator | protein) |
hsp-70 inhibitor (heat shock | protein) |
xiap antagonist (x-linked inhibitor apoptosis | protein) |
fap inhibitor (fibroblast activator | protein) |
vap-1 inhibitor (vascular adhesion | protein) |
mbt antagonist (methyl-lysine binding | protein) |
hsp-78d inhibitor (grp-78 glucose regulated | protein) |
srebp inhibitor (sterol regulatory element binding | protein) |
myd-88 inhibitor (myeloid differentiation | protein) |
bmp-2 stimulator (bone morphogenic | protein) |
bcl-xl inhibitor (anti-apoptotic | protein) |
p97 inhibitor (vcp, valosine containing | protein) |
idp inhibitor (inhibitor differentiation | protein) |
fto inhibitor (fatty mass & obesity assoc. | protein) |
hsp-27 inhibitor (heat shock | protein) |
gkrp modulator (glucokinase regulatory | protein) |
bmp-6 inhibitor (bone morphogenic | protein) |
pbp2a inhibitor (penicillin-binding | protein) |
rpa inhibitor (replication | protein-a) |
g- | protein activator |
pad inhibitor ( | protein arginine deaminase) |
prmt-1 inhibitor ( | protein arginine methyl-transferase) |
epac-2 antagonist (exchange | protein camp activated) |
gpcr-35 agonist (g- | protein-coupled) |
gpcr-109a modulator (g- | protein-coupled) |
gpba-1 agonist (g- | protein-coupled bile acid) |
gpcr-109a agonist (g- | protein coupled, niacin-109a) |
gpcr119 agonist (g- | protein coupled receptor) |
tgr-5 agonist (g- | protein coupled receptor) |
gpcr-30 agonist (g- | protein coupled receptor) |
gpcr119 antagonist (g- | protein coupled receptor) |
gpcr-120 agonist (g- | protein coupled receptor) |
gpcr-139 agonist (g- | protein coupled receptor) |
gpr-119 agonist (g- | protein coupled receptor) |
gpcr-52 (g- | protein coupled receptor) |
gpcr-40 agonist (g- | protein coupled receptor, ffa-1) |
gpcr-40 antagonist (g- | protein coupled receptor, ffa-1) |
protein- | protein disruptor |
cenp-e inhibitor (centromere-assoc. | protein-e)(kinase-7) |
chaperone of | protein folding |
anti-apoptosis | protein inhibitor (aap) |
cholesterolester transfer | protein inhibitor (cetp) |
kinesin spindle | protein inhibitor (ksp) |
eif4e/eif4g | protein interaction inhibitor |
dna-pk inhibitor (dna-dependent | protein kinase) |
cdpk-1 inhibitor (calcium-dependent | protein kinase) |
apkc modulator (atypical | protein kinase) |
map4k2 inhibitor (mitogen-activated | protein kinase) |
| protein kinase a inhibitor (pka) |
| protein kinase b inhibitor (akt) |
| protein kinase b inhibitor (akt-1) |
| protein kinase b inhibitor (akt-2) |
| protein kinase b inhibitor (akt-3) |
pkc-theta inhibitor ( | protein kinase-c) |
| protein kinase c activator |
pkc-e inhibitor ( | protein kinase-c-epsilon) |
| protein kinase c inhibitor |
pkcz inhibitor ( | protein kinase-c zeta) |
| protein kinase-c1 modulator |
| protein kinase ck2 inhibitor |
| protein kinase d inhibitor |
| protein kinase g inhibitor |
abl | protein kinase inhibitor (bcr-abl) |
mitogen-activated | protein kinase inhibitor (p38-map) |
| protein kinase inhibitor (rsk2) |
mkp-1 inhibitor (mitogen activated | protein kinase phosphatase) |
prmt-3 inhibitor ( | protein methyltransferase) |
covalent | protein modifier (irreversible) |
microsomal triglyceride transfer | protein (mtp) inhibitor |
cpp inhibitor (cytolytic | protein performin) |
yoph inhibitor (yersinia outer | protein phosphatase) |
| protein phosphatase 1 inhibition (pp1) |
| protein phosphatase 2a inhibition (pp2a) |
pme-1 inhibitor ( | protein phosphatase methylesterase) |
| protein-protein disruptor |
gpr-103 antagonist (g- | protein receptor) |
rgs4 inhibitor (regulator g- | protein signaling) |
nps inhibitor (notch | protein signaling) |
acps inhibitor (acyl carrier | protein synthase) |
| protein synthesis inhibitor |
bacterial | protein synthesis inhibitor (23s-ribosome) |
lck sh2 inhibitor (lymphocyte-specific | protein tyrosine kinase) |
| protein tyrosine kinase inhibitor (ptk) |
lmw-ptp inhibitor (low mw | protein tyrosine phosphatase) |
ptp-1b inhibitor ( | protein tyrosine phosphatase) |
ptp-shp2 inhibitor ( | protein tyrosine phosphatase-src) |
ftsz inhibition (filimentation temp.-sensitive | protein z) |
par-2 agonist ( | proteinase activated receptor) |
procollagenase-c | proteinase inhibitor |
| prothrombinogenic |
| prothyrotropin |
pim-1 kinase inhibitor ( | proto-oncogene) |
pcft inhibitor ( | proton-coupled folate transporter) |
| proton pump inhibitor (ppi) |
| protoporphyrinogen oxidase inhibitor |
anti- | protozoal |
anti- | protozoal (babesia) |
anti- | protozoal (coccidia) |
anti- | protozoal (cryptosporidium parvum/ hominis) |
anti- | protozoal (giardia) |
anti- | protozoal (histomonas) |
anti- | protozoal (leishmaniasis) |
anti- | protozoal (toxoplasma gondii) |
anti- | protozoal (trichomonas) |
anti- | protozoal (trypanosoma) |
anti- | protozoal (trypanosoma cruzi or t.brucei, chagas, sleeping sickness) |
anti- | protozoal (veterinary) |
| protozoan super toxicant (tetrahymena spp.) |
prrb- | prra two-component histidine kinase |
| prrb-prra two-component histidine kinase |
anti-bacterial (penicillin-resistant streptococcus pneumoniae, | prsp) |
atp- | prt inhibitor (atp phosphoribosyl transferase) |
anti- | pruritic (keratolytic) |
anti- | pruritic (topical) |
| ps inhibitor (pyrimidine synthesis) |
| psc inducer (pluripotent stem cell) |
| psd-95/nmda inhibitor |
anti-bacterial ( | pseudomonas) |
anti-bacterial ( | pseudomonas aeruginosa gram-) |
prostate specific membrane antigen inhibitor ( | psma) |
anti- | psoriatic (keratolytic) |
| psychodysleptic (hallucinogenic) |
| psychostimulant |
anti- | psychotic (neuroleptic) |
| psychotomimetic |
| psychotropic (mental modifier) |
anti-neoplastic ( | ptcl, peripheral t-cell lymphoma) |
| pten-deficient cancer treatment |
ptr-1 inhibitor ( | pteridine reductase) |
| pteroic acid synthase inhibitor |
| pth-1 antagonist (parathyroid hormone) |
protein tyrosine kinase inhibitor ( | ptk) |
| ptp-1b inhibitor (protein tyrosine phosphatase) |
lmw- | ptp inhibitor (low mw protein tyrosine phosphatase) |
| ptp-shp2 inhibitor (protein tyrosine phosphatase-src) |
| ptpn-22 inhibitor (lymphoid tyrosine phosphatase, lyp) |
| ptr-1 inhibitor (pteridine reductase) |
| pts inhibitor (phosphatidylcholine synthase) |
treatment precocious | puberty |
treatment of precocious | puberty |
hypertensive ( | pulmonary) |
anti-copd (chronic obstructive | pulmonary disease) |
ipf treatment (ideopathic | pulmonary fibrosis) |
anti-hypertensive ( | pulmonary, pah) |
| pulmonary surfactant |
bradycardic (reduce | pulse rate) |
efflux | pump inhibitor |
proton | pump inhibitor (ppi) |
miotic ( | pupil contraction) |
mydriatic (dilates | pupils) |
p2y-11 receptor agonist ( | purine metabromic) |
p2x4 antagonist ( | purine nucleoside) |
| purine nucleoside phosphorylase inhibitor (pnp, ec 2.4.2.1) |
p2y12 antagonist ( | purine, nucleotide) |
p2y-2 agonist ( | purine, nucleotide) |
p2y-4 agonist ( | purine, nucleotide) |
p2y-6 agonist ( | purine, nucleotide) |
p2y1 agonist ( | purine, nucleotide) |
| purine synthesis inhibitor |
p2x2 antagonist ( | purinergic) |
| purinergic a2a antagonist |
| purinergic antagonist (p2x3) |
| purinergic p2 antagonist |
| purinergic p2x7 antagonist |
pregnane-x agonist ( | px) |
pregnane-x antagonist ( | px) |
| pyk2 inhibitor (proline-rich tyrosine kinase) |
anti-bacterial (helicobacter | pylori gram-) |
anti-bacterial (streptococcus | pyogenes gram+) |
anti- | pyretic hypothermic (anti-febric) |
anti-fungal ( | pyricularia oryzae) |
cysk1 inhibitor ( | pyridoxal phosphate-dependent-o-acetyl sulfhydrylase) |
| pyrimidine phosphoribosyl transferase inhibitor |
ps inhibitor ( | pyrimidine synthesis) |
| pyrogen |
npp-1 inhibitor (nucleotide | pyrophosphate/phosphodiesterase-1) |
| pyruvate dehydrogenase kinase inhibitor (pdhk) |
4-hppd inhibitor (hydroxyphenyl | pyruvate dioxygenase) |
pk inhibitor ( | pyruvate kinase) |
pk activator ( | pyruvate kinase) |
| pzu antagonist (protamine zinc uracil) |
| qfr inhibitor (quinol/fumarate reductase) |
mitochondrial electron transport complex iii ( | qi) inhibitor |
| qr-2 inhibitor (quinone reductase) |
herg channel blocker (increase | qt interval, cardiac risk) |
herg channel optimized ( | qt interval decreased) |
qfr inhibitor ( | quinol/fumarate reductase) |
nqo2 inhibitor (nad | quinone oxidoreductase, ec 1.10.99.2) |
nqo1 inhibitor (nad | quinone oxidoreductase, ec 1.6.99.2) |
qr-2 inhibitor ( | quinone reductase) |
anti-bacterial ( | quorum sensing inhibitor) |
| r67 dhfr inhibitor (dihydrofolate reductase) |
| raas inhibitor (renin-angiotensin-aldosterone system) |
| rabggtase inhibitor |
| rac-1 inhibitor (rho-gtp-ase) |
glutamate | racemase (muri) |
| rad-51 inhibitor |
atr inhibitor (ataxia | rad-related) |
atr inhibitor (ataxia telangiectasia | rad3 related) |
free | radical generator |
free | radical scavenger |
| radioactive agent |
| radiodiagnostic/ligand |
| radiopaque contrast agent |
| radioprotector |
| radiosensitizer |
c- | raf kinase inhibitor |
b- | raf kinase inhibitor (braf) |
| rage inhibitor (receptor advanced glycation end products) |
mtor inhibitor (mammalian target of | rapamycin) |
mtor c1/c2 inhibitor (mamalian target of | rapamycin) |
retinoic acid receptor agonist ( | rar) |
| rar-b2 ligand (retinoic acid receptor b2) |
| ras inhibitor (signaling) |
dihydrofolate reductase inhibitor (dhfr, | rat liver) |
carcinogen ( | rat, mouse) |
cox-2/cox-1 inhibition | ratio |
| rdp2 inhibitor (rna polymerase) |
recombinant-dependent replication inhibition ( | rdr) |
| rdrp inhibitor (rna-dependent,rna-poylmerase, ec 2.7.7.48) |
kif5b-ret inhibitor (kinase fusion, | rearranged during transport) |
sigma | receptors inhibitor |
| recombinant-dependent replication inhibition (rdr) |
b-arrestin signaling | recruiter |
kir potassium channel modulator (inwardly | rectifying) |
insecticide ( | red mites) |
rubefacient (skin | reddener) |
bradycardic ( | reduce pulse rate) |
anoikis (tumor adhesion | reducer) |
chcr-1 inhibitor (chinese hamster carbonyl | reductase) |
mur-b inhibitor (udp-ep-glu-nac | reductase) |
try-r inhibitor (trypanothione | reductase) |
fab-g inhibitor (b-ketoacyl-acp- | reductase) |
fab-i inhibitor (enoyl-acp- | reductase) |
qr-2 inhibitor (quinone | reductase) |
akr1c3 inhibitor (aldo-keto | reductase) |
r67 dhfr inhibitor (dihydrofolate | reductase) |
ptr-1 inhibitor (pteridine | reductase) |
qfr inhibitor (quinol/fumarate | reductase) |
aldh-3 inhibitor (aldose | reductase) |
5-alpha | reductase-2 inhibitor |
aldh-1 inhibitor (aldose | reductase, ec 1.1.1.21) |
7dhcr inhibitor (7-dehydrocholesterol | reductase, ec 1.3.1.21) |
ribonucleotide | reductase inhibitor |
enoyl-acp | reductase inhibitor |
dihydrofolate | reductase inhibitor (dhfr, bacillus anthracis) |
dihydrofolate | reductase inhibitor (dhfr, candida) |
dihydrofolate | reductase inhibitor (dhfr, ec 1.5.1.3) |
dihydrofolate | reductase inhibitor (dhfr, rat liver) |
dihydrofolate | reductase inhibitor (dhrf, chicken liver) |
hmg-coa | reductase inhibitor (hmgr, ec 1.1.1.34) |
5-alpha | reductase inhibitor (testosterone) |
thioredoxin | reductase inhibitor (trxr, ec 1.8.1.9) |
photoluminescence | reduction |
dxr inhibitor (deoxyxylulose-phosphate | reductoisomerase, ispc) |
anti-gerd (gastroesophagael | reflux) |
anti-gerd (gastroesophageal | reflux disease) |
cholesterol ester | reformation inhibitor |
anti-neoplastic (taxane | refractory) |
| refrigerant |
irap inhibitor (insulin- | regulated aminopeptidase) |
prohibited ( | regulated) drug |
erk-1/erk-2 inhibitor (extracellular signal- | regulated kinase) |
sgk-1 inhibitor (serum glucocorticoid- | regulated kinase) |
erk-5 inhibitor (extracellular signal- | regulated kinase, mapk-7) |
hsp-78d inhibitor (grp-78 glucose | regulated protein) |
growth | regulator |
bone calcium | regulator |
plant growth | regulator |
insect growth | regulator |
plant fertility | regulator |
mood | regulator |
hepato-biliary | regulator |
cftr blocker (cystic fibrosis transmembrane conductuctance | regulator) |
cftr potentiator (cycstic fibrosis transmembrane conductance | regulator) |
cftr corrector (cystic fibrosis transmembrane conductance | regulator) |
agr inhibitor (accessory gene | regulator) |
serd (estrogen receptor down- | regulator) |
rgs4 inhibitor ( | regulator g-protein signaling) |
turf growth | regulator (grass) |
srebp inhibitor (sterol | regulatory element binding protein) |
gkrp modulator (glucokinase | regulatory protein) |
treatment renal transplant | rejection |
immunosuppressant (prevents implant | rejection) |
uterine | relaxant |
skeletal muscle | relaxant |
muscle | relaxant |
smooth muscle | relaxant |
cervical | relaxant |
muscle | relaxant (short duration) |
muscle | relaxant (veterinary) |
rxfp-1 agonist ( | relaxin) |
vasodilator ( | renal) |
| renal dihydropeptidase inhibitor |
| renal failure treatment |
diagnostic aid: | renal function |
anti-neoplastic ( | renal / kidney) |
treatment | renal transplant rejection |
raas inhibitor ( | renin-angiotensin-aldosterone system) |
| renin inhibitor |
| renin inhibitor (non-peptide) |
| renin inhibitor (oral) |
gene | repair of nonsense mutation damage |
| repartitioning agent |
bir2 selective (second baculovirus iap | repeat) |
lrrk2 inhibitor (leucine-rich | repeat kinase) |
insect | repellant |
cockroach | repellant |
bird | repellant |
arthropod | repellant |
ishemia/ | reperfusion treatment |
estrogenic hrt (hormone | replacement therapy) |
electrolyte | replenisher adjuvant |
anti-bacterial (tuberculosis,dormant,non- | replicating) |
recombinant-dependent | replication inhibition (rdr) |
sl3-rna hiv | replication inhibitor |
rpa inhibitor ( | replication protein-a) |
| reproductive toxicity (ca prop. 65) |
| reproductive toxicity (ca prop. 65, female) |
| reproductive toxicity (ca prop. 65, male) |
ire-1 inhibitor (inositol- | requiring enzyme) |
multi-drug | resistance inhibitor/extruder (mdr1, mrp1) |
beta-lactamase | resistant |
anti-bacterial (enterococcus casselflavus gram-, vancomycin | resistant) |
anti-bacterial (s. aureus, mrsa, methicillin & linezolid | resistant) |
anti-plasmodial (falciparum chloroquine | resistant) |
anti-neoplastic (placlitaxel/mdr | resistant) |
anti-bacterial (vancomycin- | resistant enterococcus faecalis, vre) |
crpc treatment (castration | resistant prostate cancer) |
anti-bacterial (penicillin- | resistant streptococcus pneumoniae, prsp) |
bone | resorption (osteoclast) inhibitor |
anti-bacterial ( | respiratory) |
anti-spasmodic ( | respiratory) |
anti-inflammatory ( | respiratory) |
| respiratory aid |
| respiratory stimulant |
| respiratory stimulant (cardiac) |
| respiratory stimulant (cns) |
rsv anti-viral ( | respiratory syncytial fusion) |
| restenosis inhibitor |
| restless leg treatment |
kif5b- | ret inhibitor (kinase fusion, rearranged during transport) |
| ret kinase inhibitor |
mineralocorticoid (na | retention, k loss) |
erap-1 inhibitor (endoplasmic | reticulum aminopeptidase) |
erap-2 inhibitor (endoplasmic | reticulum aminopeptidase) |
perk inhibitor (endoplasmic | reticulum kinase) |
| retinoic acid receptor agonist (rar) |
| retinoic acid receptor antagonist |
rar-b2 ligand ( | retinoic acid receptor b2) |
| retinoic acid receptor binder |
| retinoid isomerohydrolase inhibitor |
alpha | retinoid x agonist (rxr) |
alpha | retinoid x antagonist |
anti- | retinopathic |
anti- | retroviral |
ndri inhibitor (norepinephrine dopamine | reuptake) |
dopamine | reuptake inhibitor |
gaba | reuptake inhibitor (gamma amino butyric acid) |
norepinephrine | reuptake inhibitor (nri) |
triple | reuptake inhibitor (serotonin, norepinephrine, dopamine) |
serotonin-norepinephrine | reuptake inhibitor (snri) |
5-ht serotonin | reuptake inhibitor (ssri) |
ncx | reverse inhibitor (sodium/calcium) |
anti-viral (hiv, | reverse transcriptase) |
anesthesia | reverser |
| rgs4 inhibitor (regulator g-protein signaling) |
| rhabdomyosarcoma treatment |
anti- | rheumatic |
anti- | rheumatoid arthritis |
allergic | rhinitis treatment |
anti-viral (human | rhinovirus) |
anti-fungal ( | rhizoctonia bataticola) |
rac-1 inhibitor ( | rho-gtp-ase) |
rock-1 inhibitor ( | rho kinase-1) |
rock-2 inhibitor ( | rho kinase-2) |
poison | rhododendron |
| riboflavine antagonist |
| ribonuclease-a inhibitor |
| ribonuclease-h inhibitor |
garft inhibitor (glycinamide | ribonucleotide formyl transferase) |
| ribonucleotide reductase inhibitor |
dpre1 inhibitor (decaprenylphosphoryl-b-d- | ribose-2'-epimerase) |
parg inhibitor (poly-adp- | ribose glycohydrolase) |
1heh inhibitor (nicotinamide | ribose kinase) |
poly adp- | ribose polymerase-1 inhibitor (parp-1, ec 2.4.2.30) |
poly adp- | ribose polymerase-2 inhibitor (parp-2) |
poly adp | ribose polymerase-3 inhibitor (parp-3) |
| ribosomal amino acid |
| ribosomal translation inhibitor |
bacterial protein synthesis inhibitor (23s- | ribosome) |
hcv ires inhibitor (internal | ribosome entry site, hepatitis c) |
arf-1 inhibitor (adp- | ribosylation factor) |
1hur inhibitor ( | ribosylation factor-1) |
lux-s inhibitor (s- | ribosylhomocysteinase) |
artd-8 inhibitor (adp- | ribotransferase) |
larvicide ( | rice borer) |
lrrk2 inhibitor (leucine- | rich repeat kinase) |
pyk2 inhibitor (proline- | rich tyrosine kinase) |
anti- | rickettsial |
anti-fungal (trichophyton spp., | ringworm, jock-itch) |
| riot control |
herg channel blocker (increase qt interval, cardiac | risk) |
u1061-a | rna binder |
rdrp inhibitor ( | rna-dependent,rna-poylmerase, ec 2.7.7.48) |
tgt inhibitor (t- | rna guanine transglycolase) |
| rna helicase inhibitor |
sl3- | rna hiv replication inhibitor |
trmd inhibitor (t- | rna-n1-g37 methyltransferase) |
rdp2 inhibitor ( | rna polymerase) |
dna directed | rna polymerase inhibitor |
hcv-ns5b | rna polymerase inhibitor (hepatitis c) |
rdrp inhibitor (rna-dependent, | rna-poylmerase, ec 2.7.7.48) |
leucyl t- | rna synthesis inhibitor |
| rna synthesis inhibitor |
thrs inhibitor (threonyl-t- | rna synthetase) |
methionyl t- | rna synthetase inhibitor |
| rna tetraloop binder |
cap-dependent m- | rna translation inhibitor |
| rnase-h inhibitor (cleavage) |
tonic ( | roborant, restorative) |
| rock-1 inhibitor (rho kinase-1) |
| rock-2 inhibitor (rho kinase-2) |
| rodenticide |
fms inhibitor (macrophage colony-stimulating factor, csf-1, | ron) |
| rorgt antagonist (nuclear hormone receptor gamma) |
| rotavirus treatment |
anti-viral ( | rous sarcoma) |
| rpa inhibitor (replication protein-a) |
protein kinase inhibitor ( | rsk2) |
| rsv anti-viral (respiratory syncytial fusion) |
tyrosinase inhibitor ( | rtk, ec 1.14.18.1) |
mer- | rtk inhibitor (receptor tyrosine kinase) |
| rubefacient (skin reddener) |
anti-viral ( | rubella) |
anti-fungal (trichophyton | rubrum) |
artificial | rum flavoring |
anti-fungal (wheat | rust) |
| rxfp-1 agonist (relaxin) |
alpha retinoid x agonist ( | rxr) |
anti-bacterial ( | s. aureus, mrsa, methicillin & linezolid resistant) |
sphingosine-1-phosphate antagonist ( | s1p) |
sphingosine-1-phosphate agonist-1 ( | s1p-1, b-arrestin) |
sphingosine-1-phosphate-5 agonist ( | s1p-5, aequorin) |
anti-fungal ( | saccharomyces cerevisiae) |
tsd/sd treatment (tay- | sachs, sandhoff diseases) |
| sah-mta nucleosidase inhibitor |
| sahr modulator (selective aromatic hydrocarbon receptor) |
| salivatory (sialagogue) |
anti-bacterial ( | salmonella typhi gram-ve) |
adrenocortical steroid ( | salt regulating) |
| saluretic (na+, cl- excretion) |
| sam-dc inhibitor (s-adenosylmethionine decarboxylase) |
tsd/sd treatment (tay-sachs, | sandhoff diseases) |
anti-bacterial (staphylococcus | saprophyticus gram+) |
potassium atp channel opener ( | sarcolemmal) |
anti-viral (rous | sarcoma) |
es treatment (ewing's | sarcoma) |
anti-neoplastic ( | sarcoma 180) |
| sarm (selective androgen modulator) |
anti-viral ( | sars-corona) |
| scabicide |
free radical | scavenger |
nitric oxide | scavenger |
| scd-1 inhibitor (stearoyl-coa-desaturase) |
anti-fungal (sporothrix | schenckii) |
anti- | schistosomal (flukicide) |
anti- | schizophrenic |
| sclerosing agent (hardening) |
als treatment (amyotrophic lateral | sclerosis, lou gehrig's disease) |
ms (multiple | sclerosis) treatment |
anti- | sclerotic |
anti- | scorbutic |
anti-prion (tse, cjd, | scrapie, misfolded protein) |
ultraviolet | screen (sunscreen) |
tsd/ | sd treatment (tay-sachs, sandhoff diseases) |
anti- | seborrheic |
bir2 selective ( | second baculovirus iap repeat) |
smac activator mimetic ( | second mitochondria activator caspases) |
growth hormone inhibitor ( | secretagogue) |
a- | secretase enhancer |
g- | secretase inhibitor |
k- | secretase inhibitor |
b- | secretase inhibitor (bace-1) |
g- | secretase modulator |
sfrp-1 inhibitor ( | secreted frizzled-related protein) |
diagnostic aid: gastric | secretion |
svps inhibitor (subviral particle | secretion, hepatitis-b) |
ovarian e2 | secretion inhibitor |
pancreatic insulin | secretion inhibitor |
gastric anti- | secretory |
anxiolytic (non- | sedating) |
anti-histamine (non- | sedating) |
kappa opioid agonist ( | sedating) |
| sedative |
| sedative (pre-anesthetic) |
| sedative (veterinary) |
larvicide (hylemya platura, | seed corn borer) |
| seed germinator |
| seizure inducing |
pan-selectin antagonist (p- | selectin) |
pan- | selectin antagonist (p-selectin) |
ssao inhibitor ( | semicarbazide-sensitive amino oxidase, ec 1.4.3.6) |
anti-bacterial (quorum | sensing inhibitor) |
calcium- | sensing receptor antagonist (csr, calcilytic) |
ssao inhibitor (semicarbazide- | sensitive amino oxidase, ec 1.4.3.6) |
asic blocker (acid | sensitive ion channel) |
hormone | sensitive lipase inhibitor (hsl) |
ftsz inhibition (filimentation temp.- | sensitive protein z) |
insulin | sensitizer |
anti- | septic (anti-infective) |
anti- | septic (intestinal) |
anti- | septic (oral) |
anti- | septic shock |
anti- | septic (topical) |
anti- | septic (urinary) |
| serd (estrogen receptor down-regulator) |
shmt inhibitor ( | serine hydroxymethyltransferase |
maspin inducer (mammary | serine protease) |
anti-estrogen ( | serm, selective estrogen receptor modulator) |
5-ht7 | serotonin agonist |
5-ht1f | serotonin agonist |
5-ht1a | serotonin agonist |
5-ht2a | serotonin agonist |
5-ht6 | serotonin agonist |
5-ht3 | serotonin agonist |
5-ht4 | serotonin agonist |
5-ht2b | serotonin agonist |
5-ht1bd | serotonin agonist |
5-ht2 | serotonin agonist |
5-ht1b | serotonin agonist |
5-ht2c | serotonin agonist |
5-ht1d | serotonin agonist |
5-ht7 | serotonin antagonist |
5-ht1d | serotonin antagonist |
5-ht | serotonin antagonist |
5-ht2b | serotonin antagonist |
5-ht5a | serotonin antagonist |
5-ht2a | serotonin antagonist |
5-ht4 | serotonin antagonist |
5-ht6 | serotonin antagonist |
5-ht3 | serotonin antagonist |
5-ht1b | serotonin antagonist |
5-ht1a | serotonin antagonist |
5-ht2c | serotonin antagonist |
5-ht2 | serotonin antagonist |
5-ht1a | serotonin binder |
5-ht1b | serotonin inverse agonist |
5-ht3 | serotonin ligand |
triple reuptake inhibitor ( | serotonin, norepinephrine, dopamine) |
| serotonin-norepinephrine reuptake inhibitor (snri) |
| serotonin receptor binder |
5-ht | serotonin reuptake inhibitor (ssri) |
5-ht | serotonin transport inhibitor (sert) |
5-ht | serotonin uptake inhibitor |
5-htp | serotonin uptake inhibitor |
5-ht serotonin transport inhibitor ( | sert) |
sgk-1 inhibitor ( | serum glucocorticoid-regulated kinase) |
treatment of | sex-hormone disorders |
fsd therapy (female | sexual dysfunction) |
| sexual stimulant |
steroidogenesis inducer ( | sf-1) |
| sfrp-1 inhibitor (secreted frizzled-related protein) |
| sgk-1 inhibitor (serum glucocorticoid-regulated kinase) |
sodium-dependent glucose transporter-2 inhibitor ( | sglt2) |
lck | sh2 inhibitor (lymphocyte-specific protein tyrosine kinase) |
| shmt inhibitor (serine hydroxymethyltransferase |
anti-septic | shock |
hsp-90 inhibitor (heat | shock protein) |
hsp-70 inhibitor (heat | shock protein) |
hsp-27 inhibitor (heat | shock protein) |
ptp- | shp2 inhibitor (protein tyrosine phosphatase-src) |
salivatory ( | sialagogue) |
| sickle cell treatment |
anti-protozoal (trypanosoma cruzi or t.brucei, chagas, sleeping | sickness) |
iron chelator ( | siderophore) |
| siderophore synthesis inhibitor |
| sigma-1 agonist |
| sigma-1 antagonist |
| sigma-1 ligand |
| sigma-2 agonist |
| sigma-2 antagonist |
| sigma 2 ligand |
| sigma-3 inhibitor |
| sigma receptor agonist |
| sigma receptors inhibitor |
spase-1 inhibitor ( | signal peptidase bacterial) |
erk-1/erk-2 inhibitor (extracellular | signal-regulated kinase) |
erk-5 inhibitor (extracellular | signal-regulated kinase, mapk-7) |
stat-5 inhibitor ( | signal transducer activator of transcript) |
stat-3 inhibitor ( | signal transducer activator of transcript.3) |
ras inhibitor ( | signaling) |
rgs4 inhibitor (regulator g-protein | signaling) |
nps inhibitor (notch protein | signaling) |
hedgehog | signaling antagonist (hh, smo) |
virulence | signaling inhibitor |
b-arrestin | signaling recruiter |
| significant metabolite |
anti- | silicosis |
hsv-1 imaging (herpes | simplex) |
anti-viral (hsv-1 herpes | simplex) |
spect imaging ( | single photon emission computed tomography) |
| sirt-1 activator (sirtuin) |
| sirt-1 inhibitor (sirtuin-1) |
| sirt-2 inhibitor (sirtuin-2) |
| sirt-3 inhibitor (sirtuin-3) |
sirt-1 activator ( | sirtuin) |
sirt-1 inhibitor ( | sirtuin-1) |
sirt-2 inhibitor ( | sirtuin-2) |
sirt-3 inhibitor ( | sirtuin-3) |
ik/ | sk potassium channel modulators |
| skeletal muscle relaxant |
anti-neoplastic ( | skin basal cell bcc) |
rubefacient ( | skin reddener) |
| sl3-rna hiv replication inhibitor |
| sle treatment (systemic lupus erythematous) |
| sleep promoter (anti-insomnia) |
anti-protozoal (trypanosoma cruzi or t.brucei, chagas, | sleeping sickness) |
bacterial | sliding clamp inhibitor |
| slos treatment (smith-lemli-opitz syndrome) |
| smac activator mimetic (second mitochondria activator caspases) |
anti-neoplastic (lung | small cell) |
anti-neoplastic (lung non- | small cell, nsclc) |
anti-viral orthopox (vaccinia/cow, | smallpox) |
slos treatment ( | smith-lemli-opitz syndrome) |
| smn2 gene activator/modulator |
hedgehog signaling antagonist (hh, | smo) |
anti-addictive (nicotine, | smoking cessation) |
| smooth muscle contractant |
| smooth muscle relaxant |
serotonin-norepinephrine reuptake inhibitor ( | snri) |
anti-autistic ( | social withdrawal) |
mutant | sod-1 anti-aggregant (superoxide dismutase) |
| sod inhibitor (superoxide dismutase, ec 1.15.1.1) |
amyloidosis treatment (ttr, | sodi, or p53) |
hyponatremia treatment (low | sodium) |
ncx reverse inhibitor ( | sodium/calcium) |
| sodium channel blocker |
epithelial | sodium channel blocker |
voltage gated | sodium channel blocker (vgsc) |
| sodium channel modulator |
| sodium channel nav1.3 modulator |
| sodium channel nav1.4 blocker |
| sodium channel nav1.7 modulator |
| sodium channel nav1.8 modulator |
| sodium channel opener |
asbt inhibitor (apical | sodium-dependent bile acid transporter) |
| sodium-dependent glucose transporter-2 inhibitor (sglt2) |
natriuretic ( | sodium excretion) |
| sodium-hydrogen exchange inhibitor (nhe-1) |
controlled ( | soft) deactivation |
| soicr suppressor (store-overloaded-induced calcium release) |
nitrification inhibitor ( | soil) |
| soil fumigant |
anti-neoplastic ( | solid tumors) |
| somatostatin agonist |
| somatostatin antagonist (srif release-inhibiting factor) |
insecticide (spodoptura eridania, | southern army worm) |
notch | sparing |
diuretic (potassium- | sparing) |
| spase-1 inhibitor (signal peptidase bacterial) |
anti- | spasmodic |
anti- | spasmodic (gall bladder) |
anti- | spasmodic (gastric) |
anti- | spasmodic (respiratory) |
anti- | spasmodic (veterinary) |
| spasmogenic |
| spasmolytic |
| spect imaging (single photon emission computed tomography) |
spermicide ( | spermaticide) |
anti- | spermatogenic |
| spermicide (spermaticide) |
| spermidine synthase inhibitor |
| sphingolipid synthesis inhibitor |
| sphingomyelinase inhibitor |
| sphingosine-1-phosphate-5 agonist (s1p-5, aequorin) |
| sphingosine-1-phosphate agonist-1 (s1p-1, b-arrestin) |
| sphingosine-1-phosphate antagonist (s1p) |
| sphingosine-1-phosphate modulator |
sphk-1 inhibitor ( | sphingosine kinase) |
sphk-2 inhibitor ( | sphingosine kinase) |
| sphk-1 inhibitor (sphingosine kinase) |
| sphk-2 inhibitor (sphingosine kinase) |
arachnicide ( | spiders) |
| spin label imaging |
anesthetic ( | spinal) |
kinesin | spindle protein inhibitor (ksp) |
mps-1 inhibitor (monopolar | spindle, ttk) |
syk inhibitor ( | spleen tyrosine kinase) |
| spliceosome inhibitor |
insecticide ( | spodoptura eridania, southern army worm) |
marine toxin/metabolite (algal/ | sponge/fish) |
| sporicide |
anti-fungal ( | sporothrix schenckii) |
progesterone modulator ( | sprm) |
| squalene epoxidase inhibitor |
| squalene synthase inhibitor |
anti-neoplastic ( | squamous) |
ptp-shp2 inhibitor (protein tyrosine phosphatase- | src) |
c- | src kinase inhibitor |
c- | src tyrosine kinase inhibitor |
| srebp inhibitor (sterol regulatory element binding protein) |
somatostatin antagonist ( | srif release-inhibiting factor) |
| ssao inhibitor (semicarbazide-sensitive amino oxidase, ec 1.4.3.6) |
5-ht serotonin reuptake inhibitor ( | ssri) |
dopaminergic | stabilizer |
mitochondria | stabilizer |
microtubule | stabilizer (binder, tubulin inhibitor) |
anti-malarial (liver | stage) |
dehydrosqualene synthase inhibitor (crtm, | staphylococcus aureus) |
anti-bacterial ( | staphylococcus aureus gram+) |
anti-bacterial ( | staphylococcus saprophyticus gram+) |
| stat-3 inhibitor (signal transducer activator of transcript.3) |
| stat-5 inhibitor (signal transducer activator of transcript) |
phospho- | stat3 inhibitor |
scd-1 inhibitor ( | stearoyl-coa-desaturase) |
hepatic | steatosis treatment |
anti-fungal (candida | stellaloidea) |
esc differentiation blocker (embryonic | stem cell) |
hsc transplant enhancer (human | stem cell) |
psc inducer (pluripotent | stem cell) |
| stem cell differentiation director |
blood | stem cell mobilization agent |
| stem/progenitor cell inhibitor |
mst-1 kinase inhibitor (mammalian | sterile-20) |
adrenocortical | steroid |
| steroid 14-a-demethylase inhibitor |
adrenocortical | steroid (salt regulating) |
| steroid sulfatase inhibitor |
adrenocortical | steroid (topical) |
| steroid (topical) |
anti-inflammatory non- | steroidal (nsaid) |
| steroidogenesis inducer (sf-1) |
| sterol d8d7 isomerase binder |
srebp inhibitor ( | sterol regulatory element binding protein) |
| sterol synthesis inhibitor |
phagocytosis | stimulant |
respiratory | stimulant |
| stimulant |
cardiac | stimulant |
growth hormone | stimulant |
thymus | stimulant |
sexual | stimulant |
cns | stimulant |
plant growth | stimulant |
ovulation | stimulant |
cerebral circulation | stimulant |
glucagon | stimulant |
leukopoietic | stimulant |
gastroprokinetic (gastro-intestinal | stimulant) |
choleretic (cholagogue, bile | stimulant) |
nootropic (cerebral | stimulant) |
analeptic ( | stimulant) |
respiratory | stimulant (cardiac) |
respiratory | stimulant (cns) |
appetite | stimulant (orexigenic) |
cns | stimulant (veterinary) |
appetite | stimulant (veterinary) |
fms inhibitor (macrophage colony- | stimulating factor, csf-1, ron) |
fsh agonist (follicle | stimulating hormone) |
fsh antagonist (follicle | stimulating hormone) |
gonad | stimulator |
bmp-2 | stimulator (bone morphogenic protein) |
| stomachic (promotes function) |
cholelitholytic agent (gall | stones) |
lsd treatment (lysosomal | storage disease) |
soicr suppressor ( | store-overloaded-induced calcium release) |
positive inotrope ( | strengthen muscle contraction) |
anti-bacterial ( | streptococcus haemolyticus gram+) |
anti-bacterial ( | streptococcus mutans gram+) |
anti-bacterial ( | streptococcus pneumoniae gram+) |
anti-bacterial (penicillin-resistant | streptococcus pneumoniae, prsp) |
anti-bacterial ( | streptococcus pyogenes gram+) |
mitogen | stress response kinase inhibitor(msk-1) |
ischemic | stroke treatment (cardiac/cerebral) |
anti-addictive ( | substance abuse treatment, anti-craving) |
| substance p inhibitor |
blood | substitute |
anti-bacterial (bacillus | subtilis gram+) |
svps inhibitor ( | subviral particle secretion, hepatitis-b) |
| succinate dehydrogenase (complex ii) inhibitor (ec 1.3.5.1) |
| succinyl-choline synergist |
steroid | sulfatase inhibitor |
estrone | sulfatase inhibitor |
cysk1 inhibitor (pyridoxal phosphate-dependent-o-acetyl | sulfhydrylase) |
h2s donor (hydrogen | sulfide releasing) |
| sulfide releasing agent |
| sulfonylurea receptor binder |
b-aryl- | sulfotransferase-4 inhibitor (bast-4) |
| sulfotransferase inhibitor |
| sulfur mustard degredation product |
ultraviolet screen ( | sunscreen) |
microtox | super-active |
protozoan | super toxicant (tetrahymena spp.) |
mutant sod-1 anti-aggregant ( | superoxide dismutase) |
sod inhibitor ( | superoxide dismutase, ec 1.15.1.1) |
intracellular | superoxide generator |
keratolytic ( | suppreses keratinocyte hyperproliferation) |
anterior pituitary | suppressant |
anorexic (appetite | suppressant) |
dermatitis | suppressant (herpetiformis or atopic) |
anti-mitotic ( | suppresses cell division) |
anti-inflammatory (cytokine | suppressing, csaid) |
soicr | suppressor (store-overloaded-induced calcium release) |
hbsag inhibitor (hepatitis-b | surface antigen) |
| surfactant |
pulmonary | surfactant |
| svps inhibitor (subviral particle secretion, hepatitis-b) |
| sweetener |
non-nutritive | sweetener |
toxic | sweetener |
| syk inhibitor (spleen tyrosine kinase) |
| sympatholytic |
| sympathomimetic (adrenergic) |
estrus | synchronizer |
rsv anti-viral (respiratory | syncytial fusion) |
insecticide | synergist |
succinyl-choline | synergist |
anti-bacterial | synergist (mdr) |
| synergist (non-specific) |
acps inhibitor (acyl carrier protein | synthase) |
cytochrome p450 inhibitor (cyp-11b2, aldosterone | synthase) |
dhps inhibitor (dihydropteroate | synthase) |
mpges-1 inhibitor (microsomal prostaglandin e2 | synthase) |
pfkasiii inhibitor (fatty acid | synthase) |
cytochrome p450 inhibitor (cyp-11b1, corticosterone | synthase) |
thy-x inhibitor (fdts, flavin-dependent thymidylate | synthase) |
gcs inhibitor (glucosylceramide | synthase) |
ahas inhibitor (acetohydroxyacid | synthase) |
pts inhibitor (phosphatidylcholine | synthase) |
upps inhibitor (undecaprenyl diphosphate | synthase) |
fas-ii inhibitor (fatty acid | synthase) |
fab-b/f inhibitor (b-ketoacetyl-acp | synthase 1/2) |
fab-h inhibitor (b-ketoacetyl acp | synthase-3) |
gs inhibitor (glutamine | synthase ec 6.3.1.2) |
gsh | synthase inducer (glutathione) |
squalene | synthase inhibitor |
glucolipid | synthase inhibitor |
gmp guanosine monophosphate | synthase inhibitor |
pteroic acid | synthase inhibitor |
1,3-b-d-glucan | synthase inhibitor |
glucosamine-6-phosphate | synthase inhibitor |
chorismate | synthase inhibitor |
atp | synthase inhibitor |
pantothenate | synthase inhibitor |
spermidine | synthase inhibitor |
ceramide | synthase inhibitor |
prostaglandin d2 | synthase inhibitor |
acetolactate | synthase inhibitor (als) |
dehydrosqualene | synthase inhibitor (crtm, staphylococcus aureus) |
allene oxide | synthase inhibitor (cyp-74) |
chlorismate | synthase inhibitor (ec 4.6.1.4) |
enolpyruvateshikamate-3-phosphate | synthase inhibitor (epsps) |
20-hete | synthase inhibitor (hydroxyeicosatetraenoic acid) |
inducible nitric oxide | synthase inhibitor (inos) |
neuronal nitric oxide | synthase inhibitor (nnos) |
nitric oxide | synthase inhibitor (nos, ec 1.14.13.39) |
glycogen | synthase kinase-3-beta inhibitor (gsk-3beta) |
glycogen | synthase kinase-a inhibitor (gsk-3a) |
fasn-te inhibitor (fatty acid | synthase-thioesterase) |
inhibitor cell-wall | synthesis |
acc1 inhibitor (acetyl-coa-carboxylase-1, lipid | synthesis) |
ps inhibitor (pyrimidine | synthesis) |
protein | synthesis inhibitor |
carotenoid | synthesis inhibitor |
triglyceride | synthesis inhibitor |
sterol | synthesis inhibitor |
sphingolipid | synthesis inhibitor |
metallothionein | synthesis inhibitor |
dna | synthesis inhibitor |
cholesterol | synthesis inhibitor |
siderophore | synthesis inhibitor |
purine | synthesis inhibitor |
leucyl t-rna | synthesis inhibitor |
rna | synthesis inhibitor |
chitin- | synthesis inhibitor |
lipid | synthesis inhibitor |
bleaching agent (pigment | synthesis inhibitor) |
depigmentor (melanine | synthesis inhibitor) |
bacterial protein | synthesis inhibitor (23s-ribosome) |
acetylcholinesterase | synthesis inhibitor (ache) |
leukotriene b4 | synthesis inhibitor (ltb4) |
ethylene | synthesis inhibitor (ripening delayer) |
vlcfa | synthesis inhibitor (very long chain fatty acid) |
thrs inhibitor (threonyl-t-rna | synthetase) |
adss inhibitor (adenylosuccinate | synthetase, ec 6.3.4.4) |
methionyl t-rna | synthetase inhibitor |
prostaglandin | synthetase inhibitor |
thymidylate | synthetase inhibitor (ec 2.1.1.45) |
thromboxane | synthetase inhibitor (ec 5.3.99.5) |
farnesyl diphosphate | synthetase inhibitor (fpps, ec 2.5.1.10) |
nad | synthetase inhibitor (nicotinamide adenine dinucleotide) |
| synthetic auxin |
a- | synuclein aggregation inhibitor |
anti- | syphilitic |
raas inhibitor (renin-angiotensin-aldosterone | system) |
fungicide ( | systemic) |
insecticide ( | systemic) |
sle treatment ( | systemic lupus erythematous) |
| t-butylbicyclophosphorothionate binding inhibitor (tbps) |
| t-cell proliferation inhibitor |
| t-type calcium channel blocker |
anti-protozoal (trypanosoma cruzi or | t.brucei, chagas, sleeping sickness) |
anti-viral (polio | t1 maheney) |
anti-diabetic (type-2, | t2dm) |
bcr-abl and | t315i-mutant kinase inhibitor |
thyroxine | t4 antagonist |
tumor necrosis factor blocker (tnf-a, | tace, adam-17) |
| tachycardic (anti-bradycardic) |
tnk-1 antagonist ( | tachykinin neurotransmitter-1) |
tnk2 antagonist ( | tachykinin neurotransmitter-2) |
tnk-3 antagonist ( | tachykinin neurotransmitter-3) |
tnk-3 agonist ( | tachykinin neurotransmitter-3) |
| taeniacide (tape worm) |
thrombin-activatable fibrinolysis inhibitor ( | tafia) |
nft binder (neurofibriallary | tangle) |
tnks-1 inhibitior ( | tankyrase-1) |
tnks-2 inhibitor ( | tankyrase-2) |
taeniacide ( | tape worm) |
metacestocide ( | tape worm) |
anti-bacterial (edwardsiella | tarda gram+) |
neuropathy | target esterase inhibitor (nte) |
mtor inhibitor (mammalian | target of rapamycin) |
mtor c1/c2 inhibitor (mamalian | target of rapamycin) |
anti-viral (hiv, | tat) |
| tau fibrilization inhibitor (polymerization, aggregation) |
| tau phosphorylation inhibitor |
| tautomerase inhibitor |
anti-neoplastic ( | taxane refractory) |
tsd/sd treatment ( | tay-sachs, sandhoff diseases) |
t-butylbicyclophosphorothionate binding inhibitor ( | tbps) |
b-catenin/ | tcf4 pathway inhibitor |
| tdo inhibitor (tryptophan-2,3-dioxygenase, ec 1.13.11.11) |
| tdp1 inhibitor (tyrosyl-dna phosphodiesterase) |
| tdp2 inhibitor (tyrosyl-dna-phosphodiesterase-2) |
fasn- | te inhibitor (fatty acid synthase-thioesterase) |
atr inhibitor (ataxia | telangiectasia rad3 related) |
| telomerase inhibitor human (trap assay) |
| telomerase inhibitor tetrahymena |
ftsz inhibition (filimentation | temp.-sensitive protein z) |
anti-neoplastic ( | teratocarcinoma) |
| teratogen (animal) |
| teratogenic |
hsp-90 c- | terminal inhibitor |
jnk inhibitor (c-jun n- | terminal kinase) |
jnk-3 inhibitor (c-jun-n- | terminal kinase) |
| terpine (often toxic/irritant) |
mutagen (ames | test carcinogen suspect) |
ames | test negative (non-mutagenic) |
carcinogenicity | tested not positive |
microtox | tested (toxicity) |
anti-neoplastic ( | testicular) |
5-alpha reductase inhibitor ( | testosterone) |
telomerase inhibitor | tetrahymena |
protozoan super toxicant ( | tetrahymena spp.) |
rna | tetraloop binder |
transferrin inhibitor ( | tfr) |
transglutaminase-2 inhibitor ( | tg-2) |
| tgf-b1 inhibitor (transforming growth factor, alk5 dependent) |
| tgf-b2 inhibitor (transforming growth factor) |
| tgr-5 agonist (g-protein coupled receptor) |
| tgt inhibitor (t-rna guanine transglycolase) |
| th17 inhibitor (t-cell helper) |
| thalassimia treatment |
| thalassimia treatment |
anti-fungal (botrydiplodia | theobrome) |
vitamin b2 | therapeutic |
| thermogenic-b3-agonist |
| thermolysin inhibitor |
| thermosensation modulator |
pkc- | theta inhibitor (protein kinase-c) |
| thiamine-like |
fasn-te inhibitor (fatty acid synthase- | thioesterase) |
| thiol protease inhibitor |
| thioredoxin reductase inhibitor (trxr, ec 1.8.1.9) |
| thr-b agonist (thyromimetic) |
thrs inhibitor ( | threonyl-t-rna synthetase) |
insecticide ( | thrip) |
| thrombin-activatable fibrinolysis inhibitor (tafia) |
| thrombin inhibitor |
| thrombocytopenia treatment |
| thrombogenic (platelet aggregant) |
cerebral | thrombolytic |
| thrombopoietin agonist |
anti- | thrombotic |
| thromboxane a2 agonist |
| thromboxane a2 antagonist (txa2) |
| thromboxane antagonist (txra) |
| thromboxane synthetase inhibitor (ec 5.3.99.5) |
| thrs inhibitor (threonyl-t-rna synthetase) |
| thy-x inhibitor (fdts, flavin-dependent thymidylate synthase) |
vzv-tk inhibitor (varicella-zoster | thymidine kinase) |
| thymidine kinase inhibitor (ec 2.7.1.21) |
mitochondrial | thymidine kinase inhibitor (tk-2) |
tmpk inhibitor ( | thymidine monophosphate kinase) |
| thymidine phosphorylase inhibitor |
tmk inhibitor ( | thymidylate kinase, ec 2.7.4.9) |
thy-x inhibitor (fdts, flavin-dependent | thymidylate synthase) |
| thymidylate synthetase inhibitor (ec 2.1.1.45) |
| thymoleptic (affecting thymus) |
thymoleptic (affecting | thymus) |
| thymus stimulant |
anti-neoplastic ( | thyroid) |
| thyroid coactivator interaction inhibitor |
| thyroid hormone |
| thyroid inhibitor |
tr-b antagonist ( | thyroid receptor) |
thr-b agonist ( | thyromimetic) |
| thyrotropic |
| thyrotropin-releasing hormone agonist (trh) |
| thyroxine deiodinase inhibitor |
| thyroxine t4 antagonist |
acaricide ( | ticks mites) |
| tissue adhesive |
| tissue factor vii-a inhibitor |
| tissue plasminogen activator (tpa) |
mitochondrial thymidine kinase inhibitor ( | tk-2) |
vzv- | tk inhibitor (varicella-zoster thymidine kinase) |
| tlr-2 agonist (toll-like receptor) |
| tlr-4 agonist (toll-like receptor) |
| tlr-4 inhibitor (toll-like receptor) |
| tlr-7 agonist (toll-like receptor) |
| tlr-7 antagonist (toll-like receptor) |
| tlr-8 agonist (toll-like receptor) |
| tlr-9 antagonist (toll-like receptor) |
| tmk inhibitor (thymidylate kinase, ec 2.7.4.9) |
| tmpk inhibitor (thymidine monophosphate kinase) |
| tnbc treatment (triple-negative breast cancer) |
tumor necrosis factor blocker ( | tnf-a, tace, adam-17) |
| tnk-1 antagonist (tachykinin neurotransmitter-1) |
| tnk-3 agonist (tachykinin neurotransmitter-3) |
| tnk-3 antagonist (tachykinin neurotransmitter-3) |
| tnk2 antagonist (tachykinin neurotransmitter-2) |
| tnks-1 inhibitior (tankyrase-1) |
| tnks-2 inhibitor (tankyrase-2) |
poison ( | toad/frog) |
oxytocin antagonist ( | tocolytic, delays labor) |
drought | tolerance promoter |
tlr-4 inhibitor ( | toll-like receptor) |
tlr-7 agonist ( | toll-like receptor) |
tlr-7 antagonist ( | toll-like receptor) |
tlr-9 antagonist ( | toll-like receptor) |
tlr-2 agonist ( | toll-like receptor) |
tlr-8 agonist ( | toll-like receptor) |
tlr-4 agonist ( | toll-like receptor) |
pet imaging (positron emission | tomography) |
cardiac pet imaging (positron emission | tomography) |
spect imaging (single photon emission computed | tomography) |
uterotonic (uterus muscle | tone) |
moleuclar | tong |
| tonic (roborant, restorative) |
activity 'cliff' | top |
anti-microbial | topical |
anti-septic ( | topical) |
anti-bacterial ( | topical) |
anti-pruritic ( | topical) |
adrenocortical steroid ( | topical) |
fungicide ( | topical) |
vasodilator ( | topical) |
steroid ( | topical) |
protectant ( | topical) |
counter-irritant ( | topical) |
anti-parasitic ( | topical) |
anti-inflammatory (ophthalmic- | topical) |
disinfectant ( | topical) |
anti-inflammatory ( | topical) |
anesthetic ( | topical) |
anti-neoplastic ( | topical) |
glucocorticoid ( | topical) |
corticosteroid ( | topical) |
| topoisomerase i inhibitor |
| topoisomerase ii inhibitor |
| topoisomerase iv inhibitor |
anti-fungal (candida glabrata, | torulopsis) |
anti-dyskinetic (giles de la | tourette's syndrome) |
terpine (often | toxic/irritant) |
| toxic sweetener |
mitochondrial | toxicant |
neuromuscular | toxicant |
gastrointestinal | toxicant |
cns | toxicant |
protozoan super | toxicant (tetrahymena spp.) |
mock-infected mt4 cell | toxicity |
microtox tested ( | toxicity) |
reproductive | toxicity (ca prop. 65) |
reproductive | toxicity (ca prop. 65, female) |
reproductive | toxicity (ca prop. 65, male) |
low | toxicity to mice or fibroblast cells |
| toxin |
cardio- | toxin |
cholera | toxin inhibitor |
| toxin, liver |
marine | toxin/metabolite (algal/sponge/fish) |
anti-protozoal ( | toxoplasma gondii) |
tissue plasminogen activator ( | tpa) |
| tph-1 inhibitor (tryptophan hydroxylase) |
| tr-b antagonist (thyroid receptor) |
gfr | tracer (glomerular filtration rate) |
anti-bacterial ( | trachoma) |
| tranquilizer (anti-anxiety) |
| tranquilizer (major) |
| tranquilizer (minor) |
| tranquilizer (veterinary) |
gaba-t inhibitor (gaba | transaminase) |
stat-5 inhibitor (signal transducer activator of | transcript) |
stat-3 inhibitor (signal transducer activator of | transcript.3) |
anti-viral (hiv, reverse | transcriptase) |
inhibitor of gene | transcription |
stat-5 inhibitor (signal | transducer activator of transcript) |
stat-3 inhibitor (signal | transducer activator of transcript.3) |
cholesterolester | transfer protein inhibitor (cetp) |
microsomal triglyceride | transfer protein (mtp) inhibitor |
garft inhibitor (glycinamide ribonucleotide formyl | transferase) |
prmt-1 inhibitor (protein arginine methyl- | transferase) |
atp-prt inhibitor (atp phosphoribosyl | transferase) |
cpt-1a inhibitor (carnitine palmitoyl | transferase) |
cpt-1a activator (carnitine palmitoyl | transferase) |
carm-1 inhibitor (coactivator-assoc. arginine | transferase) |
icmt inhibitor (isoprenylcysteine carboxyl | transferase) |
mur-a inhibitor (bacterial | transferase) |
1nut inhibitor (adenyl | transferase) |
hmt-dot1l inhibitor (histone methyl | transferase) |
ppt inhibitor (phosphopantetheinyl | transferase) |
comt inhibitor (catechol-o-methyl- | transferase, ec 2.1.1.6) |
lysine methyl- | transferase g9a inhibitor |
glutathione-s- | transferase inducer (gst) |
geranylgeranyl | transferase inhibitor |
peptidyl | transferase inhibitor |
pyrimidine phosphoribosyl | transferase inhibitor |
histamine n-methyl- | transferase inhibitor |
ftase (farnesyl | transferase inhibitor) |
glutathione-s- | transferase inhibitor (gst, ec 2.5.1.18) |
n-myristoyl | transferase inhibitor (nmt) |
phenylethanolamine methyl- | transferase inhibitor (pnmt, ec 2.1.1.28) |
| transferrin inhibitor (tfr) |
tgf-b2 inhibitor ( | transforming growth factor) |
tgf-b1 inhibitor ( | transforming growth factor, alk5 dependent) |
aicar | transformylase inhibitor |
| transglutaminase-2 inhibitor (tg-2) |
tgt inhibitor (t-rna guanine | transglycolase) |
trpa1 agonist ( | transient receptor potential ankyrin) |
trpa1 antagonist ( | transient receptor potential ankyrin) |
trpm8 antagonist ( | transient receptor potential melastatin) |
mptp inhibitor (mitochondrial permeability | transition pore) |
ribosomal | translation inhibitor |
cap-dependent m-rna | translation inhibitor |
| translation initiation inhibitor |
tspo binder ( | translocator protein) |
cftr potentiator (cycstic fibrosis | transmembrane conductance regulator) |
cftr corrector (cystic fibrosis | transmembrane conductance regulator) |
cftr blocker (cystic fibrosis | transmembrane conductuctance regulator) |
hsc | transplant enhancer (human stem cell) |
treatment renal | transplant rejection |
glyt-1 inhibitor (glycine | transport) |
urat-1 inhibitor (uric acid | transport) |
glut-1 inhibitor (glucose | transport) |
ut-b inhibitor (urea | transport) |
kif5b-ret inhibitor (kinase fusion, rearranged during | transport) |
eaat-1 inhibitor (excitory amino acid | transport-1) |
eaat-2 inhibitor (excitory amino acid | transport-2) |
mitochondrial electron | transport complex i inhibitor |
mitochondrial electron | transport complex ii inhibitor |
mitochondrial electron | transport complex iii (qi) inhibitor |
mitochondrial electron | transport complex iv inhibitor |
fatty acid | transport inhibitor |
abcb1 | transport inhibitor |
abcg2 | transport inhibitor |
nucleoside | transport inhibitor |
anion | transport inhibitor |
dopamine | transport inhibitor (dat) |
noradrenaline/norepinephrine | transport inhibitor (net) |
polyamine | transport inhibitor (pat) |
5-ht serotonin | transport inhibitor (sert) |
anesthetic ( | transport of fish) |
bbb+ actively | transported |
vacht ligand (vesicular acetylcholine | transporter) |
huratat-1 inhibitor (human uric acid | transporter) |
cact inhibitor (carnitine-acylcarnitine | transporter) |
pcft inhibitor (proton-coupled folate | transporter) |
asbt inhibitor (apical sodium-dependent bile acid | transporter) |
abca-1 activator (atp-binding cassette | transporter) |
ibat inhibitor (ileal bile acid | transporter) |
vmat-2 inhibitor (vesicular monoamine | transporter) |
mct-1 blocker (monocarboxylate | transporter-1) |
sodium-dependent glucose | transporter-2 inhibitor (sglt2) |
dopamine | transporter binder |
oatp1-b1 inhibitor (organic anion | transporting polypeptide) |
oatp1-b3 inhibitor (organic anion | transporting polypeptide) |
oatp2-b1 inhibitor (organic anion | transporting polypeptide) |
telomerase inhibitor human ( | trap assay) |
corneal | trauma indicator |
thyrotropin-releasing hormone agonist ( | trh) |
anti-protozoal ( | trichomonas) |
anti-fungal ( | trichophyton mentagrophytes) |
anti-fungal ( | trichophyton rubrum) |
anti-fungal ( | trichophyton spp., ringworm, jock-itch) |
| triglyceride synthesis inhibitor |
microsomal | triglyceride transfer protein (mtp) inhibitor |
| tripeptidyl peptidase 2 inhibitor |
dutp inhibitor (deoxyuridine | triphosphatase) |
guanosine | triphosphatase inhibitor (gtp-ase) |
ip3 inositol | triphosphate agonist |
tnbc treatment ( | triple-negative breast cancer) |
| triple reuptake inhibitor (serotonin, norepinephrine, dopamine) |
| triterpene natural product |
| trk-a inhibitor (tropomyosin-related kinase) |
| trk-b agonist (tyrosine kinase) |
| trk-b inhibitor (tropomyocin-related kinase) |
| trmd inhibitor (t-rna-n1-g37 methyltransferase) |
anti-fungal (candida | tropicalis) |
trk-b inhibitor ( | tropomyocin-related kinase) |
trk-a inhibitor ( | tropomyosin-related kinase) |
| trpa1 agonist (transient receptor potential ankyrin) |
| trpa1 antagonist (transient receptor potential ankyrin) |
| trpm8 antagonist (transient receptor potential melastatin) |
vanilloid agonist ( | trpv1) |
vanilloid antagonist ( | trpv1) |
| trpv2 agonist (vanilloid) |
| trpv3 agonist (vanilloid) |
| trpv3 antagonist (vanilloid) |
vanilloid agonist ( | trvp4) |
thioredoxin reductase inhibitor ( | trxr, ec 1.8.1.9) |
| try-r inhibitor (trypanothione reductase) |
anti-protozoal ( | trypanosoma) |
anti-protozoal ( | trypanosoma cruzi or t.brucei, chagas, sleeping sickness) |
try-r inhibitor ( | trypanothione reductase) |
human pancreatic | trypsin inhibitor |
| trypsin inhibitor |
b- | tryptase inhibitor |
tdo inhibitor ( | tryptophan-2,3-dioxygenase, ec 1.13.11.11) |
tph-1 inhibitor ( | tryptophan hydroxylase) |
| tsd/sd treatment (tay-sachs, sandhoff diseases) |
anti-prion ( | tse, cjd, scrapie, misfolded protein) |
| tspo binder (translocator protein) |
mps-1 inhibitor (monopolar spindle, | ttk) |
amyloidosis treatment ( | ttr, sodi, or p53) |
anti-bacterial (mycobacterium | tuberculosis) |
anti-bacterial ( | tuberculosis,dormant,non-replicating) |
anti-bacterial (mycobacterium | tuberculosis, mdr) |
| tuberculostatic |
microtubule stabilizer (binder, | tubulin inhibitor) |
| tubulin polymerization inhibitor |
anti-bacterial (francisella | tularensis, bio-warfare agt.) |
anoikis ( | tumor adhesion reducer) |
| tumor necrosis factor blocker (tnf-a, tace, adam-17) |
tumorogenic or | tumor promoter |
| tumorogenic or tumor promoter |
anti-neoplastic (chemo-induced | tumors) |
anti-neoplastic (solid | tumors) |
insecticide ( | turf) |
| turf growth regulator (grass) |
beta | turn mimetic |
anti- | tussive |
k2p potassium channel modulator ( | twin pore) |
prrb-prra | two-component histidine kinase |
thromboxane a2 antagonist ( | txa2) |
thromboxane antagonist ( | txra) |
| tyk-2 inhibitor (tyrosine kinase) |
calcium channel blocker (l- | type) |
anti-diabetic ( | type-2, t2dm) |
l- | type calcium channel blocker |
t- | type calcium channel blocker |
n- | type voltage gated calcium channel blocker (vgcc, vdcc) |
anti-bacterial (salmonella | typhi gram-ve) |
anti- | tyrosinaemia |
| tyrosinase inhibitor (rtk, ec 1.14.18.1) |
| tyrosine hydroxylase inhibitor |
lck sh2 inhibitor (lymphocyte-specific protein | tyrosine kinase) |
flt-3 inhibitor ( | tyrosine kinase) |
tyk-2 inhibitor ( | tyrosine kinase) |
syk inhibitor (spleen | tyrosine kinase) |
irtk activator (insulin receptor | tyrosine kinase) |
c-kit inhibitor (cd 117, | tyrosine kinase) |
dyrk-1a inhibitor (dual-specificity | tyrosine kinase) |
pyk2 inhibitor (proline-rich | tyrosine kinase) |
mer-rtk inhibitor (receptor | tyrosine kinase) |
trk-b agonist ( | tyrosine kinase) |
| tyrosine kinase-a inhibitor |
btk inhibitor (bruton's | tyrosine kinase, beta cells) |
erb- | tyrosine kinase inhibitor |
c-src | tyrosine kinase inhibitor |
cmet | tyrosine kinase inhibitor |
protein | tyrosine kinase inhibitor (ptk) |
dyrk-1b (dual-specificity | tyrosine kinase, mirk) |
lmw-ptp inhibitor (low mw protein | tyrosine phosphatase) |
mptp-b inhibitor (microbacterium | tyrosine phosphatase) |
ptp-1b inhibitor (protein | tyrosine phosphatase) |
ptpn-22 inhibitor (lymphoid | tyrosine phosphatase, lyp) |
ptp-shp2 inhibitor (protein | tyrosine phosphatase-src) |
tdp1 inhibitor ( | tyrosyl-dna phosphodiesterase) |
tdp2 inhibitor ( | tyrosyl-dna-phosphodiesterase-2) |
| u1061-a rna binder |
usp1/ | uaf1 inhibitor (ubiquitin-specific protease) |
| ubiquitin conjugation inhibitor (e1/e2) |
| ubiquitin conjugation inhibitor (e3) |
fraxin/ | ubiquitin interaction inhibition |
usp1/uaf1 inhibitor ( | ubiquitin-specific protease) |
uch-l1 inhibitor ( | ubiquitin-specific protease) |
| uch-l1 inhibitor (ubiquitin-specific protease) |
mur-b inhibitor ( | udp-ep-glu-nac reductase) |
| udp-galactose-4'-epimerase (ec 5.1.3.2) |
| ul-97 kinase inhibitor |
anti- | ulcer |
analgesic ( | ulcer) |
anti- | ulcerative colitis |
| ultraviolet screen (sunscreen) |
oxidative phosphorylation | uncoupler |
upps inhibitor ( | undecaprenyl diphosphate synthase) |
photo- | unstable |
urokinase plasminogen activator ( | upa) |
| upa inhibitor (urokinase plasminogen activator) |
anti- | upper intestinal disorders |
| upps inhibitor (undecaprenyl diphosphate synthase) |
apo-a1 | upregulator |
mediates | uptake blood to liver (hepatocytes) |
anandamide | uptake inhibitor |
5-ht serotonin | uptake inhibitor |
5-htp serotonin | uptake inhibitor |
pzu antagonist (protamine zinc | uracil) |
| urat-1 inhibitor (uric acid transport) |
ut-b inhibitor ( | urea transport) |
| urease inhibitor |
uricosuric ( | uric acid excretor, gout treatment) |
urat-1 inhibitor ( | uric acid transport) |
huratat-1 inhibitor (human | uric acid transporter) |
| uricosuric (uric acid excretor, gout treatment) |
| uridine phosphorylase inhibitor |
anti-bacterial ( | urinary) |
analgesic ( | urinary) |
anti-septic ( | urinary) |
| urinary acidifier |
| urinary acidifier (veterinary) |
| urinary incontinence (dysuria, overactive bladder, oab) |
| urokinase inhibitor |
upa inhibitor ( | urokinase plasminogen activator) |
| urokinase plasminogen activator (upa) |
anti- | urolithic |
| urotensin-2 agonist |
| urotensin ii antagonist |
| usp1/uaf1 inhibitor (ubiquitin-specific protease) |
| ut-b inhibitor (urea transport) |
anti-neoplastic (hela cervical | uterine endometrial) |
| uterine relaxant |
| uterotonic (uterus muscle tone) |
uterotonic ( | uterus muscle tone) |
vasopressin | v1a antagonist |
vasopressin | v1b antagonist |
vasopressin | v2 agonist |
vasopressin | v2 antagonist (avpr2) |
| vaccine adjuvant |
anti-viral orthopox ( | vaccinia/cow, smallpox) |
| vacht ligand (vesicular acetylcholine transporter) |
atp-ase inhibitor (incl. | vacuolar, v-atp-ase) |
| vaginal disinfectant |
p97 inhibitor (vcp, | valosine containing protein) |
anti-bacterial (enterococcus casselflavus gram-, | vancomycin resistant) |
anti-bacterial ( | vancomycin-resistant enterococcus faecalis, vre) |
trpv2 agonist ( | vanilloid) |
trpv3 antagonist ( | vanilloid) |
trpv3 agonist ( | vanilloid) |
| vanilloid agonist (trpv1) |
| vanilloid agonist (trvp4) |
| vanilloid antagonist (trpv1) |
| vap-1 inhibitor (vascular adhesion protein) |
vzv-tk inhibitor ( | varicella-zoster thymidine kinase) |
vap-1 inhibitor ( | vascular adhesion protein) |
vcam-1 inhibitor ( | vascular cell adhesion molecule) |
anti-cerebral | vascular disease |
anti- | vascular disorders |
vda | vascular disruptive agent |
vegf-3 inhibitor ( | vascular endothelial) |
vegf-2 inhibitor ( | vascular endothelial g.f., kdr, fr) |
| vasoconstrictor (vasopressor, anti-hypotensive) |
| vasodilator |
| vasodilator (cerebral) |
| vasodilator (coronary) |
| vasodilator (nasal) |
| vasodilator (peripheral) |
| vasodilator (renal) |
| vasodilator (topical) |
| vasopeptidase inhibitor |
| vasopressin v1a antagonist |
| vasopressin v1b antagonist |
| vasopressin v2 agonist |
| vasopressin v2 antagonist (avpr2) |
vasoconstrictor ( | vasopressor, anti-hypotensive) |
| vasoprotectant |
| vcam-1 inhibitor (vascular cell adhesion molecule) |
p97 inhibitor ( | vcp, valosine containing protein) |
| vda vascular disruptive agent |
n-type voltage gated calcium channel blocker (vgcc, | vdcc) |
cbi- | vdr (coactivator binding inhibitor vitamin d) |
anti-bacterial (salmonella typhi gram- | ve) |
gene delivery | vector |
fruit & | vegetable setting agent |
| vegf-2 inhibitor (vascular endothelial g.f., kdr, fr) |
| vegf-3 inhibitor (vascular endothelial) |
anti- | venous disorders |
anti-arrhythmic ( | ventricular) |
anti- | vertigo |
| vesicant |
vacht ligand ( | vesicular acetylcholine transporter) |
vmat-2 inhibitor ( | vesicular monoamine transporter) |
anti-bacterial ( | veterinary) |
sedative ( | veterinary) |
insecticide ( | veterinary) |
anti-protozoal ( | veterinary) |
muscle relaxant ( | veterinary) |
food additive ( | veterinary) |
vulnerary ( | veterinary) |
urinary acidifier ( | veterinary) |
tranquilizer ( | veterinary) |
abortifacient ( | veterinary) |
progestin ( | veterinary) |
phosphorus source ( | veterinary) |
parasiticide ( | veterinary) |
flukicide ( | veterinary) |
anaplasmodastat ( | veterinary) |
ectoparasiticide ( | veterinary) |
cns stimulant ( | veterinary) |
anthelmintic ( | veterinary) |
appetite stimulant ( | veterinary) |
anti-spasmodic ( | veterinary) |
anti-microbial ( | veterinary) |
anti-inflammatory ( | veterinary) |
anesthetic ( | veterinary) |
anti-plasmodial ( | veterinary) |
analgesic ( | veterinary) |
anabolic ( | veterinary) |
glycosuric ( | veterinary) |
n-type voltage gated calcium channel blocker ( | vgcc, vdcc) |
voltage gated sodium channel blocker ( | vgsc) |
tissue factor | vii-a inhibitor |
cfviia inhibitor (coagulation factor | viia) |
anti- | viral |
anti-dna | viral |
anti- | viral (bvdv, hcp) |
bv-ca inhibitor (hepatitis b | viral capsid assembly) |
anti- | viral (cmv, herpes-2 cytomegalo) |
anti- | viral (coxsackie) |
anti- | viral (flavivirus, dengue, west nile) |
| viral helicase inhibitor |
anti- | viral (hepatitis) |
anti- | viral (hepatitis c, hcv) |
anti- | viral (herpes genitalis) |
anti- | viral (hiv) |
anti- | viral (hiv, attachment/ entry inhibitor) |
anti- | viral (hiv, reverse transcriptase) |
anti- | viral (hiv, tat) |
anti- | viral (hsv-1 herpes simplex) |
anti- | viral (hsv-1 & hsv-2) |
anti- | viral (human rhinovirus) |
anti- | viral (influenza) |
anti- | viral measles (paramyxovirus) |
anti- | viral (neurotropic, alpha) |
anti- | viral (ophthalmic) |
anti- | viral orthopox (vaccinia/cow, smallpox) |
anti- | viral (polio t1 maheney) |
hbvp inhibitor (hepatitis-b | viral polymerase) |
anti- | viral (poultry) |
rsv anti- | viral (respiratory syncytial fusion) |
anti- | viral (rous sarcoma) |
anti- | viral (rubella) |
anti- | viral (sars-corona) |
anti- | viral (vzv, pox) |
anti- | viral (warts) |
anti- | viral (west nile) |
| virulence signaling inhibitor |
anti-hpv (human papilloma | virus) |
chikv inhibitor (chikungunya | virus) |
ebi-2 antagonist (epstein-barr | virus-induced) |
hematopoietic | vitamin |
| vitamin |
nutrition aid: | vitamin b deficiency |
| vitamin b1 source |
| vitamin b2 therapeutic |
pro- | vitamin d |
cbi-vdr (coactivator binding inhibitor | vitamin d) |
| vitamin d activity |
| vitamin e |
| vitamin k |
| vitronectin antagonist (a5b3) |
anti-plasmodium ( | vivax) |
| vla4 antagonist (very late antigen, eosinophil integrin) |
| vlcfa synthesis inhibitor (very long chain fatty acid) |
| vmat-2 inhibitor (vesicular monoamine transporter) |
kca1.1 potassium channel opener (ca and | voltage gated) |
n-type | voltage gated calcium channel blocker (vgcc, vdcc) |
| voltage gated sodium channel blocker (vgsc) |
high | volume industrial chem. epa (450,000 kg/yr) |
pi-3kc inhibitor (phosphoinositide kinase) ( | vps-34) |
anti-bacterial (vancomycin-resistant enterococcus faecalis, | vre) |
| vulnerary (cicatrizant, wound healer) |
| vulnerary (veterinary) |
anti-viral ( | vzv, pox) |
| vzv-tk inhibitor (varicella-zoster thymidine kinase) |
anti-neoplastic ( | walker 256) |
inhibitor cell- | wall synthesis |
chemical | warfare agent |
anti-bacterial (francisella tularensis, bio- | warfare agt.) |
anti-viral ( | warts) |
poison (hemlock | water dropwort) |
negative inotrope ( | weakens muscle contraction) |
anti-asthenia ( | weakness) |
anti-viral ( | west nile) |
anti-viral (flavivirus, dengue, | west nile) |
anti-enuresis (bed- | wetting) |
anti-fungal ( | wheat rust) |
anti- | wilson's disease |
anti-autistic (social | withdrawal) |
discontinued ( | withdrawn) |
| wnt inhibition (porcn) |
| wood preservative |
ovarian inhibitor ( | worker bees) |
insecticide (spodoptura eridania, southern army | worm) |
taeniacide (tape | worm) |
metacestocide (tape | worm) |
filaricide ( | worms) |
vulnerary (cicatrizant, | wound healer) |
ccxr1 antagonist (chemokine- | x1) |
mrg- | x1 antagonist (mas-related genes) |
| xanthine oxidase inhibitor |
| xeroderma pigmentosum-g (xpg) |
anti- | xerophthalmic |
anti- | xerostomia (dry mouth) |
factor | xia antagonist (fxia) |
| xiap antagonist (x-linked inhibitor apoptosis protein) |
bcl- | xl inhibitor (anti-apoptotic protein) |
xeroderma pigmentosum-g ( | xpg) |
npy-1 antagonist (neuropeptide- | y1) |
npy-5 antagonist (neuropeptide- | y5) |
| yaws treatment |
yoph inhibitor ( | yersinia outer protein phosphatase) |
anti-bacterial ( | yersinia pestis) |
anti-plasmodial ( | yoelii) |
| yoph inhibitor (yersinia outer protein phosphatase) |
high volume industrial chem. epa (450,000 kg/ | yr) |
ezh-2 inhibitor (enhancer | zeste homolog) |
pkcz inhibitor (protein kinase-c | zeta) |
lpx-c inhibitor ( | zinc-dependent acetylase) |
pzu antagonist (protamine | zinc uracil) |
dlk,map3k12 inhibitor (dual leucine | zippper kinase) |
vzv-tk inhibitor (varicella- | zoster thymidine kinase) |